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WoRk And REPRoduCtivE HEAltH

11 Work and reproductive health
1. gEnERAl intRoduCtion
With the increasing labour force participation among women in Western countries, many 
women will work during their reproductive years. This will increase the likelihood that women 
during their reproductive years will be exposed to a variety of risk factors at work that may effect 
their reproductive abilities and the outcome of their pregnancy, such as spontaneous abor-
tion, hypertensive disorders, intrauterine growth restriction, and adverse birth outcomes.1,2 
Occupational exposures may also interact with foetal development, resulting in health effects 
in the offspring, such as congenital malformations and neurobehavioural disorders at young 
age.3-6 For several work-related risk factors the associations with reproductive effects are well 
established and translated into legislation, such as mandatory provisions for pregnant women 
preparing antineoplastic drugs or being exposed to lead.7 However, for many other work-related 
risk factors, the scientific evidence is less consistent. Work-related risk factors can be divided 
into chemical agents such as metals, solvents, pesticides, physical agents such as radiation and 
noise, and ergonomic factors such as heavy workload, shift work, and psychosocial stress.8
Research into occupational exposures and effects on the reproductive system has made impor-
tant scientific contributions in the past years. Early studies focussed on the possible effects 
on pregnancy and the foetus rather than on the reproductive health of women. Later, it was 
realised that reproductive toxins may also induce hormonal alterations affecting other aspects 
of reproductive health such as menstrual cycle disorders, and fertility. Attention has shifted 
to the entire spectrum of occupational hazards among women and the reproductive health 
of both genders. Since the 1950s, adverse trends in the reproductive health of certain wildlife 
populations have been observed. Concerns over the release of an array of hormone mimick-
ing chemicals into the environment were raised when populations of certain wildlife species 
started to decline as result of individuals within the population exhibiting strange behaviour 
or displaying physical malformations.9 With the recognition that even low concentrations of 
endocrine disrupting substances can devastate the health and fertility of wildlife populations, 
their effects on human reproductive health have become a major concern.
2. EndoCRinE diSRuPtoRS
An endocrine disruptor (ED) is an exogenous substance or mixture that alter(s) the normal 
functioning of the endocrine system and causes adverse health effects in an intact organism, 
or its progeny.10,11 Rachael Carson was among the first to report the endocrine disrupting 
abilities of man made chemicals, when she observed a decline in birds of prey populations. 
Egg shell thinning and other reproductive disorders were ascribed to dichlorodiphenyltrichlo-
roethane (DDT) exposure, and it was noted that the species most affected were at the top of 
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the food chain, due to the bioaccumulative properties of organochlorine chemicals.12 EDs are 
widely spread in the environment and display estrogenic, anti-estrogenic or anti-androgenic 
activity. The main targets of ED chemicals are the homeostasis of sex steroids and the thyroid. 
EDs are a broad and diverse group of chemicals, as regards use, chemical structure and modes 
of action. They include a long list, such as persistent bioaccumulative pollutants (dioxins, 
DDT), chemicals used in plant or animal food production (several types of pesticides), and 
compounds widely used in industry or consumer products (phthalates, Bisphenol A).13 Poten-
tial routes for exposure are food products, the general environment, consumer products, and 
occupation.
3. CHEmiCAlS, EndoCRinE diSRuPtoRS And REPRoduCtivE HEAltH
3.1 Reproductive toxicity
Reproductive toxicity is defined as a condition causing deleterious response in the post-
pubescent male or female manifested by the interference with normal physiological pro-
cesses or regulatory mechanisms, organ functioning, or the genetic integrity of the sperm 
or egg cells. In the human population, the alleged adverse reproductive health effects of 
chemicals or exogenous hormone-like substances include reduced number and deteriora-
tion in the quality of sperm, reduced fertility, delayed development and abnormality of 
the reproductive organs, increased incidence of testicular and breast cancers, and possible 
cardiovascular effects.
Fecundity, the capacity of couples to conceive and have children, depends on numerous 
biological processes including spermatogenesis, oogenesis, transport of gametes, fertilisation 
of the oocyte, implantation of the embryo, and the development of the foetus thereafter.14 
Hence, the time it takes to become pregnant since actively trying to conceive, time to preg-
nancy (TTP), was reported by Baird et al. as a good measure for estimating fecundity15,16 and 
has recently been described as a sensitive and feasible measure for studying occupational 
exposures as well as for monitoring of fecundity.17 TTP as outcome has been extensively used 
in epidemiological studies to detect the effects of occupational exposures.16,18-20 To gain more 
insight in how EDs influence human fecundity, studies assessing exposure to EDs and TTP are 
valuable. Currently, the number of studies relating occupational ED exposure to TTP is limited. 
Several studies investigated distinct exposures in specific occupations in relation to TTP, most 
notably pesticide exposure among greenhouse and agricultural workers. Reviews by Roeleveld 
et al., Hanke et al., and Bretveld et al. found limited evidence for an influence of exposure to 
pesticides among fathers or mothers on reproduction.21-23 However, the focus on either male or 
female exposure and subsequent lack of adjustment for a partner’s exposure make the results 
difficult to interpret.1
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Effects of chemicals, possibly through endocrine disrupting mechanisms, on sperm quality 
have also been extensively studied. A report by Carlsen et al. suggested a possible global 
decrease in sperm concentration.24 The authors conducted a meta-analysis of 61 studies 
involving 14947 men from 23 different countries. They found that sperm concentration had 
dropped from 113x106 spermatozoa per millilitre of ejaculate in 1940 to 66x106 spermatozoa 
per millilitre in 1990. Since Carlsen et al. reported that mean sperm counts decreased by 
50% during the second half of the last century and suggested that this decline in sperm 
quality and the increasing prevalence of genitourinary abnormalities may have a common 
environmental aetiology, there has been widespread anxiety about the effects of environ-
mental pollutants on human reproduction. These concerns are contradicted by the results 
of various population studies in Europe and the US on secular trends in fecundity, indicating 
that population fecundity has either improved or remained unchanged over the past 30–40 
years. Sperm concentration in Toulouse (France) has remained stable25 but it has dropped 
over time in Paris.26 In Finland, sperm concentrations increased27 while remaining stable in 
Belgium28 and the United States29 and decreasing in the United Kingdom.30 So, the results 
of sperm studies are diverse, complex, and difficult to interpret. The claims that population 
fecundity is declining and that environmental pollutants are involved, can neither be con-
firmed nor rejected.17
EDs have also been linked to cryptorchidism and hypospadia and its increased incidence 
in recent years. EDs supposed to play a role in cryptorchidism mimic the action of hormones 
involved in the testicular decent, and act mainly as estrogens and anti-androgens. According 
to the testicular dysgenesis syndrome (TDS) theory presented by Skakkebaek et al., crypt-
orchidism, hypospadias, testicular cancer, and spermatogenic impairment share the same 
risk factors and have a foetal origin, caused by a combination of genetic and environmental 
factors, including EDs.31 This hypothesis is supported by evidence that exogenous estrogens 
and anti-androgens cause disorders of genital development in animals.32 One of the main 
facts that prompted the formulation of this theory was the evidence that boys born to women 
who had been exposed to diethylstilbestrol (DES) in early pregnancy had an increased inci-
dence of cryptorchidism and other genital defects.33 Recently, some evidence was presented 
that over-the-counter mild analgesics may also increase the risk of cryptorchidism in the off-
spring.34 This study showed that paracetamol, even at low plasma concentrations of 1μM, is a 
potent inhibitor of testosterone production, reducing anogenital distance and testosterone 
production in rats. Experimental rat models have shown that normal androgen action during 
a critical male programming window is crucial for the programming of the testis decent.35 
These experimental observations have found echoes in human observational studies,34,36 but 
further research is urgently needed to corroborate or refute these recent findings. Since the 
proportion of women using mild analgesics during pregnancy is high, population impact 
may be substantially.
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3.2 developmental toxicity
Developmental toxicity is a condition producing adverse effects on the developing organism 
reflected in prenatal or early postnatal death, altered growth, structural abnormalities and 
functional deficits.37
The Health Council of the Netherlands has listed the possible effects of in utero exposure to 
chemicals with ED properties, which are summarised below:38,39
 −  Abnormal development of the reproductive system (cryptorchidism, hypospadia).
 −  Cancer promotion (testicular, cervical, and uterine cancers).
 −  Decreased sperm concentration or quality, and reduced spermatogenesis.
 −  Abnormal development of the Central Nervous System (neurological, cognitive and 
behavioural disorders).
 −  Other developmental abnormalities (shortened pregnancy, low birth weight, disturbed 
hormonal regulation, sex ratio effects).
The aforementioned effects of chemicals or EDs on reproductive health have increased concerns 
about effects of occupational exposures on pregnancy outcome and foetal development.11,40-42 
These concerns come from an increased understanding that the foetus is extremely sensitive 
during certain critical windows of development. Windows of sensitivity exist for many systems 
- respiratory, immune, reproductive, nervous, cardiovascular, and endocrine - as well as for 
general growth and later outcomes such as childhood and adult onset cancers.43 The placenta 
was at one time thought to offer a highly effective barrier minimising contaminant exposure, 
although research in recent decades has documented that it is far from impenetrable.44,45 
Chemicals can cross the placenta and enter the foetus, and a number of chemicals measured 
in maternal urine and serum have also been found in amniotic fluid, cord blood, and meco-
nium.46 This is also illustrated in Figure 1, whereby transplacental transfer is well recognised for 
most EDs. In some cases, the placenta may actually magnify maternal exposures, depending 
on mechanism of transport across the placenta, protein binding of the chemical in maternal 
and foetal serum and physicochemical characteristics of the agent. Cord blood levels of methyl 
mercury, for example, have been shown to be nearly two times higher than corresponding 
maternal levels.47 A recent study by Woodruff et al. showed that pregnant women in the US 
were exposed to multiple chemicals.48 The mechanism by which chemicals affect foetal devel-
opment are not completely understood. Direct toxic effects may occur when normal processes 
such as differentiation, mitosis, meiosis, intracellular communication, DNA repair are altered, 
but also indirect toxic effects may occur, the underlying routes are not yet clarified.
Adverse birth outcomes, such as low birth weight, small-for-gestational-age, and preterm 
delivery, are major determinants of infant mortality and morbidity.49,50 Environmental 
exposures and lifestyle behaviours, acting at different stages of foetal development, are held 
partly responsible for adverse birth outcomes.5,51-54 Parental occupation55,56 and occupational 
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exposures to chemicals such as pesticides,57,58 phthalates,59 and metals,60,61 have also been 
associated with adverse birth outcomes. The effects of occupational risk factors, including 
exposure to chemicals or EDs, on birth outcomes have been studied extensively, but stud-
ies on the effects of these risk factors on intrauterine growth are scarce. Since occupational 
exposure to chemicals with ED properties may affect foetal organ development as shown by 
its associations with hypospadias and cryptorchidism,31 it is hypothesised that chemicals may 
also delay foetal growth from early pregnancy onwards. Information on the effects of maternal 
occupational exposure to chemicals during pregnancy on important parameters of foetal 
growth during pregnancy, such as estimated foetal weight, foetal head circumference, and 
foetal length, may provide insight in how to counsel pregnant women occupationally exposed 
to certain chemicals.
4. PHySiCAlly dEmAnding WoRk
As previously mentioned, women constitute a substantial part of the labour force in the 
European Union (EU). In 2010, about 58% of the women aged between 15-64 years had paid 
employment, which was a substantial increase from 54% in 2002.62 With the increasing labour 
force participation among women in European countries, the likelihood that women will 
be exposed to a variety of chemical, physical, and psychological risk factors at work during 
Figure 1. Schematic presentation of EDs distribution in the materno-foeto-placental unit
Figure 1: Schematic presentation of EDs distribution in the materno-foeto-placental unit 
 
 
 
 
 
 
 
 
 
 
 
 
 
From: Caserta et al. 201113
Transplacental transfer is well recognised for most EDs: a synthesis of the exposure pathway of the placental-foetal unit is 
shown in Figure 1.
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pregnancy will also increase.63 Although women in paid employment have better pregnancy 
outcomes than those without paid jobs,64,65 certain work-related risk factors, such as exposure 
to chemicals,51 and physically demanding work66 may adversely influence pregnancy outcome. 
In theory, long working hours, prolonged standing, heavy lifting or unusual workload may 
pose a number of treats to the pregnant worker. For example, the high demand of uterine and 
placental blood flow in the third trimester could limit reserve capacity for vigorous exercise, the 
gravid uterus could limit venous return and cardiac output, especially in those who stand, and 
the release of catecholamines could increase the risk of premature contractions.67 Furthermore, 
heavy physical work is thought to reduce the blood flow to the uterus and placenta, thereby 
reducing the availability of oxygen and nutrients for the foetus.68,69 Practical management of 
pregnant women is made more difficult, because the activities of concern, although suspected 
of being hazardous, could also be beneficial.
To help clarify the way forward, epidemiological studies are needed relating physically 
demanding work not only to adverse birth outcomes, but also to effects on intrauterine growth, 
and other pregnancy complications, such as hypertensive disorders during pregnancy.
5. ExPoSuRE ASSESSmEnt
Exposure assessment, the study of the distribution and determinants of substances or factors 
affecting human health, is an important issue in occupational epidemiology. Exposure can be 
classified, measured, or modelled and different tools are available for this, such as question-
naires, air pollution monitors, and statistical techniques, respectively. The methods are often 
classified as direct and indirect (Figure 2). Time and location play an important role. Tradition-
ally, exposure in the workplace tends to be higher than in the general environment and the 
duration of exposure is generally shorter. Quantification of the association between exposure 
and adverse human health effects requires the use of exposure estimates, which are accurate, 
precise and biologically relevant for the critical exposure period, and show a range of exposure 
levels in the population under study. Subjects in an epidemiological study can be classified 
for their exposure with different strategies. This can be, for example, achieved by: 1) expert 
assessment, a member of the research team decides based on prior knowledge, whether the 
subject in the study is exposed on unexposed, and 2) self-assessment by questionnaire, the 
subject fills out a questionnaire with questions whether he/she is exposed to particular sub-
stances, and 3) measurements, which are a more objective way to assess exposure, important 
for obtaining information on concentration, for example uptake levels of the substance in the 
body estimated by biomonitoring.
All these different approaches are not exclusive and often combined to obtain the best 
exposure index. In occupational epidemiology ‘job title’ is also frequently used as exposure 
surrogate. However, it is important to remember that the use of surrogates may lead to 
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attenuation in risk estimates. A related issue is that mothers or fathers are often exposed to a 
number of chemicals simultaneously. In epidemiological studies, it is often not possible and 
feasible to obtain detailed exposure information on each subject in the study. For example, 
in a large cohort study, it is not feasible to take measurements from each subject for a variety 
of chemicals. In this case, it is desirable to carry out a small validation study in a subset. The 
Job-Exposure-Matrix (JEM), an instrument for exposure assessment, list occupations and/or 
industries on one axis, and exposure agents on the other, and the cells of the matrix present 
the probability of exposure to a specific agent in a specific job. In large cohort studies, the 
JEM is a valuable tool for exposure assessment, since job title and job description are usually 
recalled quite easily. To estimate the exposure to EDs, a new updated JEM has been published 
recently, and this JEM is specific for the Dutch work environment. With this updated JEM it is 
possible to estimate the ‘probable’ and ‘possible’ exposure to various chemicals with ED prop-
erties. However, the characterisation of exposure in the JEM must be interpreted as exposure 
probabilities, which are only a crude measure of exposure, which have to be interpreted with 
caution. Furthermore, the JEM does not contain specific chemicals, but only contains broad 
groups of chemicals, and the mechanisms of action can vary between specific chemicals in a 
group. A major drawback of JEMs is that they do not account for variability in tasks and work-
ing environments within job titles. However, from the task description, it may become clear 
that some subjects within a specific job title, for example subjects who have odd jobs around 
a farm (feeding animals) are less likely to be exposed to pesticides. In this context it is very 
important to validate the JEM for certain groups of chemicals, for example with biomonitor-
ing. Urine of women characterised as exposed by the JEM can be analysed for metabolites, 
and compared to non-exposed women.
Figure 2. Different approaches to human exposure assessment70
Exposure assessment approaches 
Direct methods Indirect methods 
Biological 
monitoring 
Personal 
monitoring 
Environmental 
monitoring/ 
modelling 
Questionnaires/ 
diaries 
Figure 2: Different approaches to human exposure assessment70 
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5.1 Biomonitoring
Biological monitoring is the analysis of human biological samples, which may include, for 
example, exhaled breath, urine, or blood for a particular substance of interest and/or its 
metabolites to provide an index of exposure and/or dose. Advantages of biological monitoring 
compared to personal exposure monitoring are: 1) biological monitoring enables estimation of 
uptake through all exposure routes, 2) exposure may fluctuate widely over time, biomonitoring 
could provide information on long term exposure when the biological half-life is sufficiently 
long, and 3) individual differences are known to exist between subjects, these differences could 
be reflected in biomonitoring results. But feasibility issues, costs, and time may restrict biologi-
cal monitoring in epidemiological studies and it is rare that biological samples can be obtained 
from the entire study population, particularly in large epidemiological studies.
The main goals of many ongoing biomonitoring studies in the general population include 
identifying exposures of potential concern and setting priorities among chemicals for further 
research and evaluation. Health based values for assessment of human biomonitoring data 
need to be developed, so that biomonitoring data can be evaluated across chemicals and 
populations.71 Efforts to date have resulted in the publication of human biomonitoring values 
for more than 80 chemicals. Nowadays, the values available for the general population, and for 
pregnant women can be used in epidemiological studies to assess the impact of chemicals on 
various health outcomes.
6. CoRE Study mAtERiAl in tHiS tHESiS
6.1 methods and data source
Almost all of the studies were embedded within the Generation R Study, except for one study, 
the HAVEN Study. The Generation R Study is a prospective population-based cohort study con-
ducted in Rotterdam, The Netherlands, which was designed to identify early environmental and 
genetic causes of normal and abnormal growth, development and health from foetal life until 
young adulthood.72 Pregnant women with a delivery date between April 2002 and January 
2006 were invited to participate. While enrolment ideally took place in early pregnancy, it was 
also possible after birth of the child. Detailed measurements were planned in early pregnancy 
(<18 weeks of gestation), mid-pregnancy (18-25 weeks of gestation), and late pregnancy (>25 
weeks of gestation) and were performed using ultrasound, physical examinations, biological 
samples and questionnaires. In total, 9778 women were included, of whom 8880 during preg-
nancy and another 898 at birth of their child.
For the majority of studies in this thesis we used information collected by questionnaire 
in mid-pregnancy, which contained questions on the current economic status, work status, 
date of starting/stopping work, working hours per week, job title, a description of the work 
tasks, and name of employer. Furthermore, nine questions from the Dutch Musculoskeletal 
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Questionnaire which concerned long periods of standing, long periods of sitting, long periods 
of working behind a computer screen, long periods of walking, long periods of working in a 
warm environment, lifting of heavy loads (>5 and >25 kilograms), long periods of driving and 
night shifts.73 These question were followed by a question on self-reported exposure to several 
types of chemicals.64
This study provides ample information to study research questions regarding the influence 
of occupation on pregnancy. Furthermore, maternal urine was available for biomonitoring. 
Biological materials, including urine, have been collected in early, mid and late pregnancy and 
at birth. Urine samples (65ml) were added to the data collection between February 2004 and 
November 2005.74 Among 2000 women, urine samples have been collected three times during 
pregnancy and an additional 1000 women have at least one urine sample.
The HAVEN study is a case-control family study, designed to investigate determinants in the 
pathogenesis and prevention of congenital heart defects (CHDs). Recruitment of case and con-
trol children took place between June 2003 and January 2010 and case children with CHD were 
enrolled with both parents from four university medical centres, the Erasmus Medical Centre in 
Rotterdam, Leiden University Medical Centre in Leiden, VU University Medical Centre in Amster-
dam, and Amsterdam Medical Centre, the Netherlands. Children with CHD diagnosed in the 
first 16 months after birth by paediatric cardiologists, were identified from the hospital registry, 
and invited to participate. Diagnoses were confirmed by echocardiography and/or cardiac 
catheterisation and/or surgery. Healthy control children, without any major congenital malfor-
mation, were ascertained in regular health checks by child physicians, and both parents were 
randomly selected from medical records from child health centres and invited to participate. At 
the fixed study moment, 17 months after delivery, case and control families visited the hospital 
for the standardised collection of information on general characteristics and outcomes.75-77 The 
information for the present study was collected in the questionnaire, filled out approximately 
17 months after child birth. This questionnaire contained questions on the current economic 
status, job title, and contained a description of the work tasks.
6.2 ContAmEd project
CONTAMED is an EU-funded project, from the European Union’s Seventh Framework Pro-
gramme (FP7) for Research and Technology Development. This project is coordinated by 
Professor Andreas Kortenkamp from the School of Pharmacy, University of London. It brings 
together leading European research teams in toxicology, reproductive biology, endocrinology, 
epidemiology, metabolomics, chemical analysis and chemicals regulation.
CONTAMED stands for contaminant mixtures and human reproductive health – novel strate-
gies for health impact and risk assessment of EDs. This project aims to make a link between 
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epidemiological observations and laboratory studies. We will explore the hypothesis that 
combined exposure to EDs in foetal life may lead to adverse delayed impacts on human repro-
ductive health.
Generation R participates in work package 6, the epidemiological analysis of case-control stud-
ies using biomarkers for cumulative ED exposure. The aim is to explore associations between 
cumulative ED exposure and the risk of congenital urogenital malformations. Using a case-
control study design, the objective is to assess whether mothers of sons with cryptorchidism 
or hypospadia had higher urinary concentrations of ED during pregnancy in their urine. 
Furthermore, since multiple maternal urine samples are available across different trimesters of 
pregnancy, this will yield important information about the variability of exposure over time and 
during the most critical time window of exposure.
The other studies presented in this thesis are closely related to this hypothesis; ED exposure 
may impose different effects on human reproduction, including effects on fertility, and the 
development of the foetus during pregnancy.
7. AimS
The overall aim of this thesis is to study the influence of work-related and environmental risk 
factors on several aspects of human reproduction, such as fertility, foetal growth and develop-
ment, pregnancy complications, and congenital malformations.
The specific aims are:
1.  To study the influence of occupational exposure to chemicals on reproduction, specifically 
fecundity, intrauterine growth, hypertensive disorders during pregnancy, and birth out-
comes.
2.  To study the influence of physically demanding work on intrauterine growth, hypertensive 
disorders during pregnancy, and birth outcomes.
3.  To study the relation between exposure to EDs and the occurrence of congenital malforma-
tions, including congenital heart defects and male reproductive tract abnormalities, such as 
cryptorchidism and hypospadia.
8. outlinE
In Part 2, studies addressing the first aim, namely the relationship between occupational expo-
sure to chemicals and the effects on human reproduction are presented. Chapter 2.1 sum-
marises the literature regarding occupational exposure to chemicals and time to pregnancy. 
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The influence of (occupational) exposure to chemicals on time to pregnancy, intrauterine 
growth, and congenital malformations are presented in Chapters 2.2, 2.3, 2.4, and 2.5. Part 3 
addresses the second study aim, and focusses on the association between physically demand-
ing work, intrauterine growth, pregnancy complications such as hypertensive disorders, and 
adverse birth outcomes. Part 4 covers the last study aim. Chapter 4.1 studies the association 
between maternal exposure to mild analgesics during pregnancy, in particularly paracetamol, 
which acts as ED by inhibiting the testosterone production, on the occurrence of cryptorchidism 
and hypospadia in their offspring. Part 5 provides an overall discussion of the main findings in 
this thesis, including recommendations for further research, and implications for policy and 
practice.
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ABStRACt
Background: Fertility problems are an important health issue, as 10-15% of couples have dif-
ficulties conceiving. Reproductive function is thought to be compromised by life style behav-
iours, but environmental contaminants and work-related factors are also thought to play a role. 
The objective of this review was to systematically summarise the available evidence concerning 
the influence of occupational exposure to chemicals on time to pregnancy (TTP).
Methods: A structured search on occupational exposure to chemicals and TTP was carried out 
in Pubmed and Embase. Studies were included if TTP was used as outcome measure and expo-
sure to chemicals at job level was described. In total, 49 studies were included in this review.
results: Studies varied widely in characterisation of exposure, hampering a meta-analytic 
approach across all studies. For lead strong indications for adverse effects on TTP were present, 
supporting the mandatory provisions for pregnant women being exposed to lead in many 
countries. These indications were also found for pesticide exposure, and one could argue that 
couples working in agriculture or horticultural trades must be informed about the risks of 
pesticide exposure. Epidemiologic evidence on other chemicals, such as organic solvents, and 
other metals remains equivocal, hampering clear counselling of couples who are trying to get 
pregnant.
Conclusion: Despite some uncertainties in the evidence base, it may still be prudent to advise 
against lead and pesticide exposure at the workplace for couples trying to conceive. This review 
also identifies several priorities for future studies in the field of occupational epidemiology.
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intRoduCtion
Fertility problems are an important health issue, as 10-15% of couples have difficulties conceiv-
ing a child and seek specialist fertility care at least once during their reproductive lifetime.1 The 
ability of a couple to procreate is determined by the chance of conception leading to a live birth 
per menstrual cycle given unprotected intercourse, fecundability in demographic terms, and 
is influenced by various male and female factors. The distribution of individual couple prob-
abilities is extremely heterogeneous, varying from a zero chance (sterile couples, who never 
become pregnant) to an estimated upper limit of 60% per menstrual cycle for ‘super fertile’ 
couples who conceive in the first month.2,3 Hence, the time it takes to become pregnant since 
actively trying to conceive, time to pregnancy (TTP), is a measure of couple fertility. TTP as 
outcome measure has been extensively used in epidemiological studies aiming to identify the 
effects of, for example, adverse lifestyle or changes in fertility over time.4-7
Lifestyle factors related to postponement of motherhood,8,9 smoking,10,11 and alcohol or caffeine 
intake12 may interfere with the reproductive system.13 However, work-related and environmental 
risk factors may also reduce fertility.14 Findings from contaminant residue analyses in human blood, 
follicular fluid and semen,15,16 together with reports of a purported decline in semen quality,17 led 
to the hypothesis that chemical contaminants may negatively affect the reproductive process 
causing reduced fertility and adverse pregnancy outcomes in the general population. However, 
there is an ongoing debate whether human fecundity is really declining in Western countries,18 
and it is of great importance to establish whether environmental chemicals adversely affect human 
reproduction, so that preventive measures, if needed, could be taken. A number of reviews have 
reported on associations between exposure to specific chemicals or groups of chemicals and TTP, 
and support the notion that environmental exposures may be hazardous for human fertility.19-23 
However, all of these reviews focussed on the effects of, mainly male, exposure to one specific 
chemical or a group of chemicals on fertility or reproductive function rather than focussing on the 
broader spectrum of chemical exposure and their effects on TTP in both men and women.
From an obstetric point of view, chemicals that influence TTP may subsequently influence 
pregnancy and birth outcomes, either directly or indirectly. Several studies showed that a 
prolonged TTP is associated with a greater risk of adverse pregnancy outcomes.24-26 Exposure 
to chemicals during foetal development may increase the risk of adverse health consequences, 
including adverse birth outcomes, childhood morbidity, and adult disease and mortality.27,28
A comprehensive review of the literature concerning occupational exposure to chemicals 
in relation to TTP, supported by findings from animal studies, and observational studies on the 
influence of chemicals on other fertility outcomes such as semen quality, might improve the 
clinician’s ability to counsel couples who are trying to conceive or women who have concerns 
about their pregnancy.29 With this review, we aimed to summarise the evidence on occupa-
tional exposure to chemicals and TTP, and to describe exposure-response relationships in order 
to determine hazardous levels of exposure for prolonged TTP.
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mAtERiAlS And mEtHodS
literature search
The first author (CS) conducted a systematic literature search on articles up to December 2010 
in Pubmed and Embase using the following key words: toxic actions, environmental pollution, 
chemical, hazard, accident, occupational exposure, occupation, occupational diseases, work, 
worker, workplace, vocation, job, employment, industry, business, profession, trade, enterprise. 
These keywords were combined with key words used for TTP, fertility, fecundity, fecundability, 
subfertility, infertility, infertile, and time to pregnancy (TTP). In addition, a hand search was 
done to explore the references of articles retrieved. The complete search strategy is available 
on request.
Eligibility and selection
Articles were initially selected based on title and abstract according to the following inclu-
sion criteria: (1) TTP was used as outcome measure in occupational or general populations, 
(2) a quantitative description of measures of exposure to chemical agents at the workplace 
or a description of a distinct exposure pattern at job level was presented, (3) the associations 
between work-related exposure and TTP were expressed in a quantitative measure, such as 
odds ratio (OR), relative risk (RR), or fecundability ratio (FR) or sufficient raw data were presented 
to calculate such measures of association and (4) the article was published in a peer reviewed 
scientific journal written in the English, German, French, or Dutch language.
The literature search identified 1412 articles in Pubmed and 1304 articles in Embase, 
resulting in a total of 2017 unique articles. The initial selection on title and subsequently on 
abstract was done by the first author (CS) and verified by the last author (AB) and resulted 
in a selection of 147 articles (Supplement 1). Subsequently, the second (EV) and last author 
(AB) independently made a further selection based on abstracts which resulted in 85 relevant 
articles (overlap between both authors was 83%). The selected full articles were then judged by 
two authors (CS, AB) based on the above-mentioned inclusion and exclusion criteria. Six articles 
were excluded due to TTP not being used as an outcome measure. Five articles were excluded 
because they were reviews and one study because it was based on preliminary results. No 
distinct pattern of occupational exposure was present in 21 articles. One article was excluded 
because no quantitative measure of association was reported, a second article because it was 
published in Spanish, and a third article because no full text was available. This resulted in a 
total of 49 relevant articles for this review.
Assessment of methodological quality
The quality of the epidemiological studies was assessed by two reviewers (CS and AB) using a 
standardised form based on seven items in a modified version of the guidelines for method-
ological quality assessment of the Dutch Cochrane Centre:30
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1. Research hypothesis: prior to the study, the researchers should have formulated an hypoth-
esis setting out the relation between exposure to chemicals in a particular profession and 
the possible effects on TTP;
2. Study population: the study groups should be clearly defined (exposed versus non-
exposed), and at least age, sex and occupation should be described in detail;
3. Selection bias: any attempt to detect selection bias requires that the study groups’  inclu-
sion and exclusion criteria be clearly defined. It is important that the response at baseline 
should exceed 50%;
4. Exposure: exposure should be clearly defined. Details should also be provided of the 
instrument used to identify the determinant, and of when and under what circumstances 
this was done. This should be performed in the same way in each study group. Exposure 
assessment is done in the relevant time window (assessment during TTP period).
5. Outcome: the outcome itself and the criteria used to determine the outcome should be 
sufficiently clearly defined to enable the work to be reproduced by other researchers. The 
outcome should be determined using a valid measurement method. The outcome should 
be blind for exposure status.
6. Confounding: the analysis should be adjusted for confounders;
7. General opinion: assessment of the study’s validity and applicability.
Each criterion was rated when applicable, with a score of 1 being sufficiently met, a score of 0 
being not sufficiently met, and a question mark when the information was lacking to rate this 
item. The total quality score ranged from 0 to 7. The influence of quality score on the reported 
measures of associations was evaluated.
data extraction
The data extraction on selected articles comprised the study setting, study population, study 
design, outcome(s), exposure assessment, confounders or effect modifiers, and effect estimates 
(with 95% confidence intervals). The data extraction for the study population included the 
following items: number of invited employees, eligibility criteria, participation, total number 
in the analyses and number of lost to follow up, if applicable. For characteristics of exposure 
the definition of magnitude, frequency or duration of exposure as well as the prevalence of 
exposure was extracted. In addition, it was ascertained whether the study addressed only 
maternal occupational exposure, paternal occupational exposure, or occupational exposure 
among both partners of the couple involved. Whenever possible, the measure of association 
was retrieved from the original article, together with the variables that were used for adjust-
ment in the statistical analyses. If articles adjusted for relevant confounders and concluded that 
the confounders did not significantly influence the effect estimates, and therefore presented 
unadjusted estimates, the unadjusted estimates were presented in the Tables and adjust-
ment for confounders was summarised as ‘no significant adjustments’. When the measure of 
C
h
ap
te
r 
2.
1
34
association was not present, available raw data were used in a 2 x 2 Table to calculate the OR 
and 95% confidence interval as measure of association.
Data extraction was performed by one author according to a standardised format (CS) and 
extracted data were reviewed by the last author for consistency and completeness (AB). In case 
of doubt, data were discussed until agreement was reached.
Construction of plots
Supplement 2 represents a funnel plot to identify potential publications bias. Since most studies 
used FR as measure of association, the funnel was constructed for studies with a FR. When a job title 
was used as proxy for exposure, we used the FR for comparing TTP among workers in this job with 
workers in other jobs. When a direct measurement or comprehensive method of exposure assess-
ment was used, we included the highest exposure category with the accompanying FR. Figure 1 
provides an overview of the studies included in this review, where a division in male, female, and 
couples studies was based on occupational exposure to chemicals, and estimates were sorted by 
occupations or jobs studied, groups of chemicals, and specific chemicals, in order of specificity of the 
exposure. Risk estimates of individual studies were used to calculate pooled estimates when studies 
had comparable outcome measures (FRs or ORs), and when studies were considered sufficiently 
comparable with respect to exposure parameters, which resulted in pooled estimates for studies 
using a standardised job title as proxy for exposure. We used the computer program epi-sheet to 
calculate pooled FRs, applying a fixed model assumption by default.31
RESultS
In total, 49 relevant articles were included in this review in accordance with the flow chart 
depicted in Supplement 1. The studies were divided into three separate categories, based 
on occupational exposure to chemicals, namely studies concerning men, studies concerning 
women, and studies addressing couples, and corresponding Tables were constructed. Table 1 
describes the core results of all occupational studies concerning men and is subdivided into 
four groups of chemicals: pesticides, heavy metals, (organic) solvents, and miscellaneous 
chemicals. In a similar way, Table 2 presents all occupational studies concerning women, 
and Table 3 reports on studies concerning couples. The full version of Tables 1-3 is available 
in Supplement 3-5. We also made a division into three types of exposure groups: 1) articles 
concerning a specific occupation, 2) articles focussing on various groups of chemicals, and 3) 
articles reporting on a specific chemical.
Figure 1 summarises all studies that estimated a fecundability ratio (FR) (37 out of 49 studies), 
and provides an overview by exposure status (maternal, paternal, and parental occupational 
exposure to chemicals), gender, and type of study. In the first group of studies, addressing a 
specific occupation in relation to TTP, 23 studies reported 28 FRs, of which ten FRs (36%) were 
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Thonneau
40
 1999 – agricultural workers – France 
Kolstad
60
 2000 – plastic industry workers 
Thonneau
40
 1999 – farmers – Denmark  
Larsen
38
 1998 – farmers 
Sallmen
39
 2003 – greenhouse workers 
Thonneau
40
 1999 – gardeners – Denmark 
Luderer
61
 2004 – painters 
Cocco
74
 2005 – Anti-malaria campaign workers 
Luderer
61
 2004 – millwrights 
Bretveld
36
 2008 – greenhouse workers 
De Cock
37
 1994 – fruit growers 
Eskenazi
58
 1991 – dry cleaners 
 
Bull
73
 1999 – oil products 
Hjollund
50
 1998 – metals 
 
Modigh
76
 2002 – phthalates 
Joffe
51
 2003 – lead 
Sallmen
52
 2000 – lead 
Sallmen
62
 1998 – solvents 
Shiau
53
 2004 – lead 
Apostoli
47
 2000 – lead 
 
  
  
 
Abell
32
 2000 – flower greenhouse workers 
Dahl
63
 1999 – dentists 
Zhu
68
 2005 – laboratory technicians 
Lauria
35
 2006 – flower greenhouse workers 
Idrovo
34
 2005 – flower production workers 
Axmon
65
 2006 – hairdressers 
Bretveld
33
 2006 – greenhouse workers 
Rowland
64
 1994 – dentists 
Fransman
71
 2007 – nurses 
Ahlborg
70
 1996 – midwives 
Chen
72
 2002 – semiconductor manufacturing workers 
 
Taskinen
56
 1999 – wood workers – solvents  
Sallmen
45
 1995 – lead 
Wennborg
57
 2001 – solvents 
Sallmen
55
 2008 – solvents 
Sallmen
54
 1995 – solvents 
 
 
 
 
 
Harley
43
 2008 – farmers – fathers 
Plenge-bonig
78
 1999 – printing industry workers – fathers 
Harley
43
 2008 – farmers – mothers 
Spinelli
79
 1997 – working in industrial occupation – fathers 
Plenge-bonig
78
 1999 – printing industry workers – mothers 
 
Curtis
42
 1999 – pesticides-herbicides – fathers 
Spinelli
79
 1997 – exposure to solvents – mothers 
Spinelli
79
 1997 – exposure to solvents – fathers 
Curtis
42
 1999 – pesticides-herbicides – mothers 
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statistically significantly reduced. In the second group, addressing exposure to a group of 
chemicals, two studies reported a FR, and both showed no statistically significant association. 
Group 3 addressed exposure to one specific chemical and 13 studies reported 15 FRs, of which 
six (40%) were statistically significantly reduced. One study reported both exposure based on 
occupation and exposure to a specific chemical and was included in both groups. In all stud-
ies among men, 17 studies reported 20 FRs, of which five (25%) were statistically significantly 
reduced. In 16 studies among women, 16 FRs were reported, of which seven (44%) were statisti-
cally significantly reduced.
We summarised all studies that used an OR to quantify the relation between chemicals 
exposure and TTP in Figure 2, using the same division as in Figure 1.
Occupations most studied in relation to fecundability were occupations with exposure to 
pesticides and heavy metals. Nearly all studies performed a cross-sectional analysis, either as 
part of a cross-sectional study design or as part of an analysis of the baseline within a cohort 
study. Various methods were used to assess occupational exposure to chemicals: 20 studies used 
a questionnaire, ten studies interviewed participants, one study solely used direct measurements, 
eight studies used both a questionnaire and direct measurements, while ten studies used a com-
bination of a questionnaire, expert judgement, an interview, or (in)direct measurements.
Quality of evidence
Supplement 6 presents the methodological quality assessment of the studies included. The 
two reviewers initially agreed on 72% of the studies (307 out of 343 items); all initial disagree-
ments were resolved in a consensus meeting. The quality scores ranged from 3 to 7. A crude 
measure of exposure and an unclear definition of assessment of TTP were the most prevalent 
shortcomings in quality. We observed that studies with a low quality score, namely a score of 
3, less often reported statistically significant associations than high quality studies with a score 
of 7, 25% and 50%, respectively. The median number of participants in the various studies was 
541 (range: 40-7079). Most of the studies focussed on TTP as a continuous outcome enabling 
analyses with Cox Proportional Hazards models, producing FRs.
Publication bias
The funnel plot in Supplement 2 clearly suggests publication bias, whereby smaller studies 
with a decreased FR were more likely to be published since almost no small studies published 
negative findings.
occupational exposure to pesticides
In total, 13 studies addressed occupational exposure to pesticides in relation to TTP. Four 
studies were performed among women, and FRs ranged from 0.64 to 1.11,32-35 while only two 
studies found statistically significant effects.32,34 Six studies were performed among men, with 
FRs ranging from 0.43 to 1.18,36-40 and Petrelli and Figa-Talamanca presented ORs of a TTP more 
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than six months ranging between 1.6 to 2.4.41 Four of these studies found statistically signifi-
cant effects.36,37,39,41 Three studies addressed both women and men, with FRs ranging from 0.64 
to 1.1342,43 and ORs for a TTP of 12 months or longer ranging from 0.65 to 1.90.44 Among these 
13 studies, seven studies used a job title as proxy for exposure,33-35,36,38,40,44 two studies used 
a more comprehensive method, such as an exposure index,37,41 three studies combined job 
title with another method of exposure assessment,32,39,43 and one study relied on self-reported 
exposure to pesticides.42 Eight studies with job title as proxy for exposure to pesticides reported 
a FR, as shown in Figure 3. The pooled estimates were FR 0.95 (95%CI 0.84-1.08) for men and FR 
0.89 (95%CI 0.82-0.97) for women. Figure 4 shows the forest plot summarising female and male 
studies using a more comprehensive method of exposure assessment that reproduced a FR. 
These four studies showed most FRs as being statistically significantly reduced.
Figure 2. Associations between specific occupations (1), groups of chemicals (2), and specific chemicals 
(3) with TTP, expressed as Odds Ratio (TTP>12 months), stratified by paternal, maternal, and parental 
exposure
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Figure 2: Associations between specific occupations (1), groups of chemicals (2), and specific 
chemicals (3) with TTP, expressed as Odds Ratio (TTP>12 months), stratified by paternal, maternal, 
and parental exposure 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1) specific occupations for which we took either the specific occupation or, if an exposure index was used, the 
highest exposure category, 2) groups of substances, 3) specific substances.
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occupational exposure to heavy metals
Nine studies reported exposure to heavy metals in relation to TTP, of which two studies were 
performed among women,45,46 and seven studies among men.47-53 In the two studies among 
women, the FRs ranged from 0.80 to 0.93 for lead exposure and from 0.82 to 0.91 for exposure 
to a mixture of metals. In men, four studies reported that lead exposure (measured as blood 
lead levels) reduced fecundability,47,51-53 two studies observed increased risks of TTP longer 
than 12 months among welders and tannery workers (OR 2.02; 95%CI 1.02-4.00, OR 2.8; 95%CI 
0.9-9.0, respectively),48,49 and another study among welders found FRs ranging from 0.85 to 
1.12.50 Figure 5 depicts the exposure-response relationship between different levels of blood 
lead values and FRs, showing a clear trend of increasing blood lead levels with decreasing FRs.
occupational exposure to (organic) solvents
Nine studies addressed occupational exposure to (organic) solvents in relation to TTP. Four 
studies were conducted among women,54-57 with FRs ranging from 0.44 to 1.09, for different 
solvents. Five studies were conducted among men,58-62 with FRs ratios ranging from 0.52 to 
1.09. Three studies performed (in)direct measurements, and found FRs ranging from 0.52 to 
1.09,58,60,62 and one study was based on interviews, with FRs raging from 0.65-0.80.61 A large 
study by Hooiveld et al., combining questionnaires and indirect measurements, presented ORs 
around unity.59
Figure 3. Forest plot summarising studies concerning male and female pesticide exposure (with job title 
as proxy for exposure) and fecundability
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Figure 3: Forest plot summarising studies concerning male and female pesticide exposure (with job title as proxy for exposure) and fecundability 
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occupational exposure to ‘other’ chemicals
In both women and men, several studies addressed occupational exposure to a mixture of 
chemicals or a specific chemical, most often in one specific occupation. In women, occupations 
investigated were dentists,63,64 hairdressers,65,66 cosmetologists,67 laboratory technicians,68 
pharmacists,69 health care workers, such as nurses and midwives,70,71 and semiconductor 
manufacturing workers.72 For dentists, hairdressers, midwives working with nitrous oxide, 
nurses working with antineoplastic drugs, and semiconductor manufacturing workers in 
thin film area, some indications were found for a prolonged TTP.64,65,70-72 In men, occupations 
studied were offshore mechanics, operators, drilling personnel, car mechanics,73 antimalaria 
campaign workers,74 mint workers,75 and workers in plants producing di(2-ethylhexyl)phthal-
ate (DEHP),76 while one study addressed various occupations.77 In studies on couples, printing 
industry workers were studied,78 as well as occupations in industry with self-reported exposure 
to solvents and fumes.79 In a case-control study on couples with or without infertility treatment, 
several occupations and work situations were studied80 of which several seemed to be risk fac-
tors for subfertility.
Figure 4. Forest plot summarising studies concerning male and female pesticide exposure (more 
comprehensive measure of exposure) and fecundability
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Figure 4: Forest plot su marising studies concerning m le and female pesticide exposure (more comprehensive measure of exposure) and fecundability 
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diSCuSSion
From this review we can conclude that there are strong indications that certain occupational 
exposures, such as pesticides and lead, adversely influence male and female fertility. These 
associations were primarily observed in studies with a detailed exposure assessment strategy, 
whereby different levels of exposure could be distinguished. In studies with job title as proxy 
for exposure these findings could not be corroborated, since only moderate or non-statistically 
significant associations were reported in most. For other chemicals, such as exposure to 
(organic) solvents and specific occupations, the evidence of effects on time to pregnancy (TTP) 
is less clear, hampering clear advice for couples who intend to become pregnant.
Lack of exposure-response associations, weak exposure assessments, and the large het-
erogeneity in exposure characterisation across studies were the primary limitations to the 
hypothesis that occupational chemical exposure adversely affects human reproduction. The 
evaluation of possible publication bias indicates that this is a serious threat, since smaller 
studies tended to get published more often when reporting a significantly longer TTP with 
occupational exposure to chemicals.
Figure 5. Forest plot summarising studies concerning dose response relations between blood lead 
levels and time to pregnancy
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Figure 5: Forest plot summarising studies concerning dose response relations between blood lead levels and time to pregnancy 
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time to pregnancy studies: weight of evidence and biological plausibility 
with regard to chemical exposure
Couple fertility depends on complex biological processes such as the production of sperm and 
oocytes, the fertilisation process, the implantation of the embryo, the transition from embryo to 
foetus, and the growth of the foetus into a matured child. Although little is known about chemi-
cal agents interacting with these processes, exposure to chemicals may adversely affect this 
chain of reproductive events at any phase but the sensitivity may vary. With regard to female 
gametes, we speculate that oocytes may be most vulnerable to toxicants, chemotherapy or 
radiation during the foetal period when they are formed and multiply in both ovaries when 
a maximum number of some seven million oocytes are created. Thereafter, oocytes are sur-
rounded by a protective layer of granulosa cells and will remain inactive until adulthood, and 
eventually only a few oocytes will mature and can be fertilised to become embryos.81 Damage 
to oocytes during foetal development, may become manifest as reduced fertility. But also toxic 
exposure later in life, for instance through occupational exposure may induce cytotoxic harm 
to the oocytes and subsequently subfertility. Adult men produce millions of sperm cells every 
day, and we hypothesised that the fastly dividing sperm producing epithelium of the testis may 
be vulnerable to chemical exposures, not only during the foetal period when it is established, 
but throughout life. This may result in suboptimal sperm DNA integrity and semen quality 
and consequently, in reduced fertility.82 To our knowledge, it is currently unknown, whether 
occupational exposure to chemicals affects male or female reproduction equally, or whether 
males or females have a different susceptibility for chemicals.
Existing literature
Several reviews summarised the literature regarding occupational exposure and fertility. How-
ever, to our knowledge, no previous reviews specifically focussed on occupational chemical 
exposure and TTP as a measure of fertility. Until now, three reviews assessed the influence of 
pesticides on male and/or female fertility.19,21,22 They conclude that although the results of the 
studies are often equivocal, there are indications for an association between pesticide expo-
sure and prolonged TTP. The majority of studies included in these reviews are also included 
in our study, but a few studies failed to fulfil our criteria, as they did not provide TTP but some 
other measure of fertility. Since we had several studies regarding pesticide exposure and TTP, 
we carried out a pooled analysis, combining effect estimates from studies that used job title 
as proxy for exposure. This meta-analysis showed no reduced fecundability ratios (FRs) (see 
Figure 3). However, several studies with a detailed exposure assessment strategy, characterised 
as an exposure index of (in)direct measurements, clearly suggest that pesticide exposure 
may increase the risk of a prolonged TTP (see Figure 4). Thus, it seems that using a job title as 
proxy for pesticide exposure is not a sensitive enough measure for assessing exposure, since 
it will introduce non-differential misclassification and consequently bias of the measure of 
association towards unity. In addition, the assessment of exposure to pesticides was not able 
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to pinpoint to the role of specific pesticides as often a cocktail of various pesticides was used 
in the occupational groups studied. Three reviews summarised the literature on occupational 
exposure to lead and the evidence is quite consistent, showing that lead exposure reduces 
fertility and prolongs TTP.23,83,84 From our review, we can also conclude that there are strong 
indications that lead exposure prolongs TTP, since higher blood lead levels were often associ-
ated with a longer TTP.
We also identified some more generic reviews on occupation and reproductive function, not 
only focussing on chemical exposure, but also on other potentially harmful working conditions, 
such as physical load, and psychological stress. From these studies, it is clear that the number 
of substances potentially hazardous to male reproduction is large, but that for few agents only 
the evidence is unequivocal.20,85 Figa-Talamanca et al. reported several associations between 
exposure to metals, solvents, and pesticides and male reproductive effects.86 These reviews 
present the picture that the reproductive function of males is vulnerable to many different 
environmental and occupational agents. However, only a few of these external agents have so 
far been identified with certainty, most often limited to men intoxicated by a specific chemical 
or among workers with high exposures. Several studies have identified alterations in fertility, 
but the results are difficult to replicate in other settings with different patterns of exposure.
Recall bias
Ascertainment of TTP requires only a few simple questions (such as: How many months did 
it take to become pregnant?). Refusal to answer these questions is rare, as this question is 
readily accepted in a wide range of cultures.87 Validation studies have shown that self-reports 
on TTP give an accurate representation of the true TTP distribution,88-90 even with recall up 
to 20 years.91 Men can also provide valid information, generating the same distributions and 
analytical results as women in the same study population.9,92 Since most studies included in 
this review collected data on occupational characteristics, such as a job title, work activities, or 
obtained direct measurements from workers, and did not rely on self-reported exposures, we 
think that recall bias does not seem to be a major issue in the studies included in this systematic 
review.
Exposure assessment
Exposure assessment, the study of the distribution and determinants of substances or factors 
affecting human health, is an important area in occupational epidemiology. Traditionally, 
exposure in the workplace tends to be higher than in the general environment whereas the 
duration of exposure is generally shorter. Quantification of the association between exposure 
and adverse human health effects requires the use of exposure estimates, which are valid, 
precise and biologically relevant for the critical exposure period, and show a range of exposure 
levels in the population under study.93 In this review, most studies relied on exposure assess-
ment through questionnaires, but also other techniques, such as expert judgement, direct 
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measurements in body fluids or tissues, and comprehensive measures such as an integrated 
exposure index were used. This heterogeneity in exposure assessment made it impossible to 
perform a meta-analysis across all studies. However, we noticed that studies with direct mea-
surements or comprehensive measures more often showed an association between exposure 
and TTP. This was also illustrated by the fact that studies with lower quality less often reported 
statistically significant findings compared to high quality studies. An important reason for a 
lower quality was a poor characterisation of exposure. Use of expert judgements, for example 
through a job-exposure-matrix, is easier and cheaper than using direct measurements, and 
will resolve some of the problems encountered using self-assessment or a job title as proxy for 
exposure. Exposure assessment with a job-exposure-matrix is done independently from the 
health outcome and blinded to participants, both aspects that will avoid information bias. If 
sufficient information on work tasks and type of business is available, non-differential misclas-
sification of exposure can be reduced. A more objective way to assess exposure is through 
measurements, which is generally expensive and time-consuming, especially in community-
based studies. This systematic review shows that improvements in exposure assessment in 
studies on occupational risk factors for TTP is urgently required, whereby a combination of 
different methods may be the way forward.94 Whenever possible, studies should be designed 
to provide effect estimates for chemical mixtures and take into account the combined effects 
of chemicals.95 Exposure timing also needs more consideration in future studies. Assessment 
of occupational exposure during the TTP period is essential, and possible changes in these 
periods must be addressed to prevent misclassification.
Background exposure to various chemicals through diet and environment may occur. 
However, it is unlikely that background exposure will contribute substantially to the exposure 
patterns in selected occupational populations.93 In community-based studies the high preva-
lence of background exposure will most likely not be associated with occupational exposure 
with a much lower prevalence. Thus, background exposure has probably not confounded the 
reported associations between occupational chemical exposure and TTP in this review.
Study design and confounding
A prospective study design has definite advantages, but since this is very time-consuming, 
retrospective studies on TTP are far more common. Most of the studies included in this review 
were cross-sectional studies, and information on occupational exposures often was collected 
retrospectively. Therefore, interpretation of the results from these studies may be hampered 
by biases related to recruitment, treatment, accidental pregnancies, degree of planning and 
persistency of trying, social background, sexual behaviour, female age, and non-response.4,6,96 
In order to reduce various sources of bias, the analysis should focus on first pregnancies, as 
it will avoid pregnancy planning issues in which past-pregnancy experiences are taken into 
account.97 Only a few studies included in this review have provided a separate analysis on 
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primigravidous couples, and thus, future studies should focus more on first pregnancies, since 
this will provide more valid effect estimates.
Confounding is a major concern within observational studies, since these pose a serious 
threat to the internal validity. We tried to address confounding and selection bias in the included 
studies by a comprehensive quality assessment based on the guidelines for quality assessment 
of the Dutch Cochrane Centre. Age, educational level, body mass index, and smoking are fac-
tors associated with TTP, and these factors may act as confounders if they are also associated 
with chemical exposure at the workplace. Future studies need to adjust for age by default, 
since age will influence the reproductive abilities of both men and women. Furthermore, TTP 
is a measure of couples’ fecundability, and if only men or women are studied, confounding by 
partner could occur. Therefore, studies should focus more on couples instead of only focussing 
on men or women.
Publication bias
We addressed publication bias with a funnel plot. Studies that report statistically significant 
associations are more likely to be published and this may bias reviews towards concluding that 
associations truly exist. It appeared that smaller studies more often showed lower FRs, thus a 
prolonged TTP and it seemed that smaller studies reporting null effects were published less 
than what would be expected based on the funnel plot. We may conclude that the results of 
this review, to some extent, may suffer from publication bias. However, we must note that the 
smaller studies that more often showed an association with TTP also used more comprehensive 
methods or direct measurement for assessing exposure. Since these measurements are expen-
sive, it is obvious that these studies have smaller sample sizes.
limitations
This systematic review has several limitations. Although we searched through all the references 
of the articles selected, it cannot be ruled out that relevant publications have been missed. The 
second limitation is that the majority of studies found were of cross-sectional design and, as 
a consequence, causality cannot be established. Third, the large heterogeneity in the articles 
retrieved, made it impossible to perform a meta-analysis across all studies.
ConCluSion
In total, 49 studies reported associations between occupational exposure to chemicals and 
TTP. On the basis of this systematic review, the evidence from studies regarding exposure to 
pesticides and lead is suggestive for adverse effects on human reproduction, in particular a 
prolonged TTP. For other chemical exposures and specific occupations, the evidence is less 
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clear, not justifying mandatory restrictions on occupational activities of couples who try to 
become pregnant.
In an effort to achieve more specificity and replication in this field, the next wave of studies 
investigating the effects of occupational chemical exposure on fertility should attempt to 1) 
evaluate the effects of specific individual chemicals, as well as mixtures, 2) use biomonitor-
ing methods to quantify the compounds in human fluids such as blood and urine, enabling 
dose response studies, 3) focus on couples, since TTP is a measure of couples’ fecundability, 
specifically for occupational exposures to chemicals in the workplace among partners in order 
to provide more insight into the separate effects of maternal and paternal exposure on TTP, 
and 4) ensure adequate control for confounders. Further human studies are necessary to clarify 
both the effects of current occupational exposures on reproductive health and the physiologic 
mechanisms underlying these effects.
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Abell et al. 200032 7 1 1 1 1 1 1 1
Ahlborg et al. 199670 7 1 1 1 1 1 1 1 
Apostoli et al. 200047 7 1 1 1 1 1 1 1 
Axmon et al. 200665 6 1 1 0 1 1 1 1 
Bonde et al. 199048 6 1 1 1 1 0 1 1 
Bretveld et al. 200836 3 1 1 0 0 0 1 0 
Bretveld et al. 200633 4 1 1 0 0 0 1 1 
Bretveld et al. 200844 4 1 1 0 0 0 1 1 
Bull et al. 199973 6 1 1 1 0 1 1 1 
Chen et al. 200272 4 1 1 0 1 0 1 0 
Cocco et al. 200574 3 1 0 1 1 0 0 0 
Curtis et al. 199942 5 1 0 1 1 0 1 1 
Dahl et al. 199963 6 1 1 1 1 0 1 1 
De Cock et al. 199437 5 1 1 0 1 0 1 1 
Eskenazi et al. 199158 3 1 1 0 1 0 0 0 
Figa-Talamanca et al. 200075 7 1 1 1 1 1 1 1 
Ford et al. 200277 4 1 0 1 0 0 1 1 
Fransman et al. 200771 7 1 1 1 1 1 1 1 
Greene et al. 201049 5 1 1 1 0 1 0 1 
Harley et al. 200843 5 1 1 0 1 1 1 0 
Hjollund et al. 199850 6 1 1 0 1 1 1 1 
Hooiveld et al. 200659 5 1 1 0 1 0 1 1 
Idrovo et al. 200534 6 1 1 1 0 1 1 1 
Joffe et al. 200351 7 1 1 1 1 1 1 1 
Kersemaekers et al. 199766 4 1 1 1 0 0 1 0 
Kolstad et al. 200060 6 1 1 1 1 0 1 1 
Larsen et al. 199838 6 1 1 1 1 0 1 1 
Lauria et al. 200635 5 1 1 1 0 1 1 0 
Luderer et al. 200461 6 1 1 1 0 1 1 1 
Modigh et al. 200276 7 1 1 1 1 1 1 1 
Peretz et al. 200967 3 1 1 0 0 0 1 0 
Petrelli et al. 200141 5 1 0 1 1 0 1 1 
Plenge-Bonig et al. 199978 6 1 1 0 1 1 1 1 
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suPPleMenT 6 (continued). Results of the quality assessment of the 49 selected studies with 
information on associations between occupational exposure to various chemicals and time to pregnancy
study (first author)
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Rachootin et al. 198380 4 1 1 1 0 0 1 0 
Rowland et al. 199464 6 1 1 1 1 0 1 1 
Sallmen et al. 199545 5 1 0 1 1 0 1 1 
Sallmen et al. 200339 5 1 1 0 1 1 1 0 
Sallmen et al. 199862 6 1 1 1 1 0 1 1 
Sallmen et al. 200052 6 1 1 1 1 0 1 1 
Sallmen et al. 199554 6 1 1 1 1 0 1 1 
Sallmen et al. 200855 7 1 1 1 1 1 1 1 
Schaumberg et al. 198969 4 1 0 1 0 0 1 1 
Shiau et al. 200453 7 1 1 1 1 1 1 1 
Spinelli et al. 199779 4 1 1 1 0 0 1 1 
Taskinen et al. 199956 7 1 1 1 1 1 1 1 
Thonneau et al. 199940 6 1 1 1 1 1 1 0 
Wennborg et al. 200157 5 1 1 1 0 0 1 1 
Wulff et al. 199946 6 1 0 1 1 1 1 1 
Zhu et al. 200568 5 0 1 0 1 1 1 1 
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ABStRACt
Objective: To study the influence of occupational exposure to endocrine disruptors (EDs) on 
time to pregnancy (TTP).
Design: Cross-sectional analysis within a prospective population-based cohort study.
setting: Rotterdam, The Netherlands.
Patient(s): Mothers and fathers who filled out a questionnaire during mid-pregnancy (response 
77% and 82% of enrolment, respectively) were selected if the pregnancy was planned and 
either parent performed paid employment. In total, 2774 mothers and 2728 partners were 
included in the statistical analyses.
interventions(s): None.
Main outcome measure(s): Self-reported time to pregnancy (months).
result(s): There was no correlation between maternal and paternal exposure, because kappa 
values for agreement for all exposure categories ranged from 0.03 to 0.13. Paternal occupa-
tional exposure to heavy metals (hazard ratio of pregnancy 0.83; 95% confidence interval 0.71-
0.97), and overall exposure to EDs (hazard ratio 0.85; 95% confidence interval 0.75-0.96) was 
statistically significantly associated with an increased TTP. Maternal occupational exposure to 
all categories of EDs showed prolonged TTP, but the decreased hazard ratios were not statisti-
cally significant.
Conclusion: This birth cohort study provides indications for adverse effects of parental occu-
pational exposure to EDs on TTP.
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intRoduCtion
Fertility problems are an important health issue: 10%-15% of couples have difficulties conceiv-
ing, or conceiving the number of children they want, and seek specialist fertility care at least 
once during their reproductive lifetime.1 Time to pregnancy (TTP) was reported by Baird et al. as 
a good measure for estimating fecundability2,3 and has recently been described as a sensitive 
and feasible method for studying effects of occupational exposures, as well as for monitoring of 
fecundity.4 Endocrine disruptors (EDs), a group of substances that have the potential to alter the 
normal functioning of the endocrine system, are of growing concern.5 It has been suggested 
that exposure to EDs in early pregnancy influences male reproductive development, leading 
to disorders such as low sperm count, subfertility, and testicular cancer.6 Potential routes for 
exposure are food products, the environment, consumer products, and occupation.
The number of studies relating occupational ED exposure to TTP is limited. Several studies 
investigated distinct exposures in specific occupations in relation to TTP, most notably pesticide 
exposure among greenhouse and agricultural workers. Reviews by Roeleveld et al., Hanke et al., 
and Bretveld et al. found limited evidence for an influence of exposure to pesticides among 
fathers or mothers on reproduction.7-9 Indications exist for delayed TTP after exposure to heavy 
metals or organic solvents, but the focus on either male or female exposure and subsequent 
lack of adjustment for partner’s exposure makes the results difficult to interpret.10
The aim of the present study was to study the separate influence of maternal and paternal 
occupational exposure to a comprehensive set of potential EDs on TTP.
mEtHodS
design and study population
The Generation R Study is a population-based prospective cohort study on growth, develop-
ment, and health from early foetal life until young adulthood in Rotterdam, the Netherlands. 
The study design has been described in detail previously.11,12 Briefly, all pregnant women who 
had an expected delivery date between April 2002 and January 2006 and living in the study area 
of Rotterdam were invited to participate. In total, 9778 pregnant women (response 61%; 8880 
women during pregnancy and another 898 at birth of their child) and 6347 partners (response 
71%) were enrolled. The study was approved by the Medical Ethics Committee at Erasmus 
University Medical Centre Rotterdam, The Netherlands. The information required for this study 
was collected in the questionnaire completed during mid-pregnancy by 6830 women (77% 
of enrolment) and 5177 partners (82% of enrolment). The questions on occupational status 
(paid employment), planned pregnancy (affirmative), and TTP were used for the selection of 
the study population. For each couple, we included the first pregnancy within the Generation R 
cohort in our study, because some women participated with more than one child in the study. 
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In total, 2774 women and 2728 partners were included in the analysis, the flowchart is depicted 
in Figure 1.
Figure 1. Flowchart of the selected study population
Figure 1: Flowchart of the selected study population 
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were excluded, 
participating 
with second or 
third child in 
Generation R 
 
Enrolment 
Mothers 9778 
8880 in pregnancy, 898 at birth of their 
child 
Fathers 6347 
N=6830 women completed 
questionnaire during mid-pregnancy 
N=5154 women had paid employment 
N=3278 women 
answered 
affirmative 
N=841 women 
answered 
negative 
N=2774 women provided information 
on time to pregnancy 
N=5177 partners completed 
questionnaire during mid-pregnancy 
N=2728 women provided information 
on time to pregnancy, so these 
partners were selected 
N=4119 women completed the 
question on planned pregnancy 
N=697 women 
were excluded, 
participating 
with second or 
third child in 
Generation R 
N=4670 men had paid employment 
Of these men, N=4067 women 
completed the question on planned 
pregnancy 
N=3239 women 
answered 
affirmative 
N=828 women 
answered 
negative 
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time to pregnancy
The primary outcome in this study was TTP as a measure of fecundability. The questionnaire 
participants filled out during mid-pregnancy or thereafter at delayed enrolment included 
a question on the natural origin of the pregnancy (yes/no) and, in case of a positive answer, 
women with a planned pregnancy were asked about the number of months it took the couple 
to conceive.13
occupation and working conditions
The questionnaire contained questions about work status, occupation, and working condi-
tions and focussed on the start of the period of unprotected intercourse. Work status, based 
on a single question on the current economic status with seven categories (paid labour, self-
employed, unemployed, disabled, homemaker, student, or other), was used to select women 
and men with paid employment. Questions on starting date of current work, quitting date, job 
title, type of business, name of employer, and activities in the job were used to classify jobs into 
the Dutch Classification of Occupations14 and subsequently link these codes to standard occu-
pational classification (SOC) codes and the job-exposure-matrix (JEM). The JEM is based on the 
judgement of experts who estimated the probability of exposure to ten categories of potential 
EDs, namely polycyclic aromatic hydrocarbons, polychlorinated organic compounds, pesti-
cides, phthalates, organic solvents, bisphenol A, alkylphenolic compounds, flame retardants, 
metals, and miscellaneous agents,15 for 353 job titles in three levels: ‘unlikely’(0), ‘possible’(1), 
and ‘probable’(2). For this study we collate the last two categories into one category indicating 
the occurrence of exposure to EDs.
Potential confounding factors
Information on age, height, weight, education, country of origin, parity, smoking habits, and 
alcohol use was collected from the first questionnaire available. Maternal and paternal age was 
determined at intake in the study, and we calculated maternal and paternal age at start of the 
time to pregnancy period by subtracting the gestational age (in weeks) at intake and the TTP 
(in months). Educational level was defined as the highest educational program successfully 
completed and was categorised as low (primary school, lower vocational training, intermediate 
general school, three years general secondary school), mid-low (>three years general second-
ary school, intermediate vocational training), mid-high (higher vocational training, Bachelor’s 
degree) or high (higher academic education). The country or origin of the pregnant mother 
was based on the country of birth of her parents, as defined by Statistics Netherlands. The 
country of origin assigned to non-natives (mother born abroad or at least one of the parents 
of the mother born abroad) is the country of the mother when both parents are born abroad 
in different countries, or when one parent is born abroad, the country of birth of that parent.16 
Three groups were defined: (1) Antilleans and Surinamese, (2) Turks and Moroccans, and (3) all 
other non-native groups. Smoking and alcohol use was assessed during early-pregnancy by a 
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dichotomous question asking whether the subject had smoked or drunk alcohol in the past 
two months.17 The Body Mass Index (BMI) was calculated by weight divided by squared height, 
information available in the first questionnaire concerning the pre-pregnancy period.
Statistical analysis
The statistical analyses were performed by means of SAS version 9.2 (SAS Institute, Cary, NC) 
using a discrete proportional hazard model with TTP as time variable, including both natural 
and non-natural pregnancies. Censoring took place in case of a non-natural pregnancy at 12 
months of TTP. Log-minus-log plots were made for the exposure category any EDs for mothers 
and fathers separately to inspect possible deviations from the proportional hazard assumption. 
The resulting hazard (HR) from the discrete proportional hazards model represents the fecund-
ability of exposed subjects in a certain category of the JEM relative to non-exposed subjects 
in that category of the JEM. Initially, crude HRs with 95% confidence intervals were calculated 
for all non-occupational and occupational variables; second, multivariable analyses were 
performed. We selected all reported potential confounders, such as parental age, ethnicity, 
educational level, parity, BMI, alcohol and smoking. Variables were retained in the multivariable 
model as confounder when they changed the HR of ED exposure by more than 10%. Parental 
age as important confounder in many studies was included by default. The agreement between 
maternal and paternal occupational exposures, and between the various exposure categories 
was calculated by the weighted Cohen’s Kappa.18
We carried out several sensitivity analyses. The first analysis evaluated whether women and 
men who started working in their current job during the TTP period differed from women and 
men starting before the TTP period. The second analysis investigated potential bias introduced 
owing to different exposure patterns among couples with complete TTP information and those 
with missing values on TTP as well as couples with a planned pregnancy and those with an 
unplanned pregnancy.19
RESultS
The characteristics of the study population are shown in Table 1. For both mothers and fathers a 
lower education and overweight were associated with prolonged TTP (Table 2). The crude and 
adjusted HRs for exposure to EDs are shown in Table 3. The curves for exposed and non-exposed 
in the log-minus-log plots ran parallel, indicating that the proportional hazard assumption was 
met. Models were solely adjusted for parental age, since the other covariates did not change 
the HRs by more than 10%. Maternal occupational exposure to pesticides, phthalates, organic 
solvents, and alkylphenolic compounds showed a prolonged TTP. However, these associations 
failed to reach the conventional level of statistical significance of 0.05. Paternal occupational 
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exposure to heavy metals and any EDs was associated with prolonged TTP (HR 0.83; 95%CI 
0.71-0.97 and HR 0.85; 95%CI 0.75-0.96, respectively).
The sensitivity analyses on start of work before or during the TTP period showed very similar 
HRs. The sensitivity analysis on potential bias due to missing TTP information or unplanned 
pregnancy showed that the likelihood of exposure to EDs was not associated with availabil-
ity of TTP information and did not differ between couples with a planned pregnancy versus 
unplanned pregnancy or spontaneous vs. nonspontaneous conceived pregnancies. The pos-
sibility of a pregnancy planning bias was further investigated by a repeated analyses without 
TaBle 1. General characteristics of mothers and fathers enrolled in a prospective prenatally recruited 
birth cohort, Generation R
individual characteristics Mothers
(n=2774)
Fathers
(n=2728)
Age start TTP period (mean, SD) years 30.57 (4.13) 32.67 (5.04)
Age start TTP period < 25 years 276 (32.3%) 154 (5.6%) 
25-30 years 896 (32.3%) 619 (22.7%) 
30-35 years 1253 (45.2%) 1191 (43.7%) 
>35 years 349 (12.6%) 763 (28.0%) 
Educational level Low 324 (11.7%) 514 (18.8%) 
Mid-low 776 (28.0%) 672 (24.6%) 
Mid-high 704 (25.4%) 548 (20.1%) 
High 935 (33.7%) 934 (34.2%) 
Ethnicity Netherlands 1910 (68.9%) 1968 (72.1%) 
Surinam and Dutch Antilles 160 (5.8%) 168 (6.2%) 
Morocco and Turkey 194 (7.0%) 185 (6.8%) 
Other 494 (17.8%) 406 (14.9%) 
Parity First child 1872 (67.5%) 1831 (67.1%) 
Second child or higher 900 (32.4%) 895 (32.8%) 
Body Mass Index at start TTP 
period 
<25 kg/m2 1797 (64.8%) 1365 (50.0%) 
25-30 kg/m2 694 (25.0%) 1144 (41.9%) 
30-35 kg/m2 197 (7.1%) 184 (6.7%) 
>35 kg/m2 70 (2.5%) 32 (1.2%) 
Smoking before pregnancy yes 1079 (38.9%) 1100 (40.3%) 
Alcohol use before pregnancy yes 2137 (77.0%) 2379 (87.2%) 
Time to pregnancy (TTP) 
(median, min-max) 
3.0 (1.0-120.0) 3.0 (1.0-120.0) 
Time to pregnancy 0-6 months 2102 (75.8%) 2083 (76.4%) 
6-12 months 457 (16.5%) 445 (16.3%) 
12-24 months 157 (5.7%) 144 (5.3%) 
24+ months 58 (2.1%) 56 (2.1%) 
Values are absolute numbers (percentages) unless otherwise indicated.
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TTP values of 0 and 1, which excluded 599 couples. This analysis showed in general similar HRs 
values, with changes of less than 10%.
For all groups of EDs, the agreement between maternal and paternal exposure was poor, 
with kappa values ranging between 0.03 and 0.13. When maternal and paternal occupational 
risk factors were mutually adjusted for each other within the same exposure category, the 
HRs remained largely the same. Maternal exposure to phthalates, solvents, and alkylphenolic 
compounds were interrelated (kappa values 0.47 to 0.77), and mutual adjustments by groups 
of exposure changed the HRs for specific groups by more than 10%, and the corresponding 
95% CIs widened (data not shown).
TaBle 2. Univariable analyses on fecundability ratios for non-occupational variables for mothers and 
fathers within the Generation R Cohort a
individual characteristics Mothers
(n=2774)
Fathers
(n=2728)
HR 95% CI HR 95% CI
Age at intake <25 years 1.00 1.00
25-30 years 1.13 (0.98-1.29) 1.10 (0.92-1.32) 
30-35 years 1.12 (0.98-1.28) 1.17 (0.99-1.39) 
>35 years 0.98 (0.83-1.15) 1.10 (0.92-1.32) 
Educational level Low 0.81 (0.71-0.92)* 0.86 (0.77-0.96)* 
Mid-low 0.89 (0.81-0.98)* 0.89 (0.80-0.98)* 
Mid-high 0.99 (0.89-1.09) 0.93 (0.84-1.04) 
High 1.00 1.00 
Country of origin Netherlands 1.00 1.00 
Surinam and Dutch Antilles 0.86 (0.73-1.01) 0.90 (0.77-1.06) 
Morocco and Turkey 1.00 (0.86-1.16) 1.06 (0.91-1.23) 
Other 0.94 (0.85-1.04) 0.95 (0.85-1.05) 
Parity First child 1.00 1.00 
Second child and higher 1.12 (1.03-1.21)* 1.10 (1.02-1.20)* 
BMI <25 kg/m2 1.00 1.00 
25-30 kg/m2 0.90 (0.82-0.98)* 0.93 (0.86-1.01) 
30-35 kg/m2 0.88 (0.75-1.02) 0.83 (0.71-0.97)* 
>35 kg/m2 0.82 (0.64-1.04) 0.73 (0.50-1.06) 
Smoking No 1.00 1.00 
Yes 0.96 (0.88-1.03) 0.98 (0.91-1.06) 
Alcohol No 1.00 1.00 
Yes 1.11 (1.00-1.22)* 1.03 (0.92-1.16) 
a Data analysed using a Cox Proportional Hazards model (SPSS v17.0).
* p-value < 0.05.
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diSCuSSion
In this population-based study, we found associations between paternal occupational exposure 
to heavy metals, and any EDs with a prolonged TTP. Maternal occupational exposure to EDs was 
not statistically significantly associated with a prolonged TTP.
Exposure assessment in this study was based on questions regarding several occupational 
characteristics in a ‘general’ questionnaire, which reduced the possibility of recall bias because 
the study subjects were not aware of the hypothesis tested. A recently updated JEM was used 
for exposure assessment; this approach assured that exposure was classified independently 
from the outcome, and blinded to participants - both aspects that avoid information bias. 
However, no specific data on occupational hygiene measurements from the companies or 
biomonitoring of the workers were available. Another shortcoming is that the JEM does not 
account for variability in tasks and working environment within job titles. Thus, the outcome 
of this matrix must be interpreted as exposure probabilities, which are a crude measure of 
exposure. Therefore, it is necessary to be cautious in interpreting the reported risk estimates.
Agreement between the different exposures was considerable for mothers for the categories 
phthalates, organic solvents, and alkylphenolic compounds, indicating that women exposed to 
one of these substances are likely to be exposed to the other substances as well. When we 
adjusted by group of exposure we noticed that the HRs changed by more than 10%. Because 
of these interrelationships among exposure groups, we could not disentangle the specific role 
of these groups of EDs in the observed prolonged TTP. Among fathers there was little overlap 
among the exposure categories. Furthermore, the analyses showed that no overlap existed 
between mothers and fathers exposed to EDs and, in addition, that mutual adjustments did 
not change the observed associations. This may suggest that in findings from previous research 
on occupational exposure of either females or males, the risk of residual confounding due to 
work of the partner can be largely ruled out.
Our main finding, that paternal occupational exposure to heavy metals and any EDs 
prolonged TTP, is partly in line with the current literature. For exposure to heavy metals, the 
comparison with the existing literature is complex, because we have studied heavy metals as a 
group, whereas in most other studies the effects of separate heavy metals are reported. For lead 
exposure, Sallmen et al. concluded that studies have consistently shown that lead exposure 
reduces fertility.20 In a study by Bonde et al.,21 a prolonged TTP was found among welders, 
but after adjustments for potential confounders this association was no longer statistically 
significant.
Study design issues play a role in interpreting the results from our study. A limitation of a 
population-based approach in studying occupational risk factors is that it may lack power to 
identify the role of a specific occupational exposure on fecundability, due to the low preva-
lence of exposure and the small to moderate effects of exposure on fecundability. On the other 
hand, population-based studies present estimates of the proportion of couples with fecundity 
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problems in the general population that may be attributed to particular occupational expo-
sures. This information may be used to guide the need for preconception counselling of parents 
to be. Furthermore, the population-based approach with recruitment during the prenatal 
period allows adjustments for a large number of potential confounders.
A limitation of this study is the initial participation of 61% and the response on the mid-
pregnancy questionnaire of mothers and fathers of 77% and 82%, respectively. Selective 
participation occurred, because mothers from ethnic minorities and lower socioeconomic 
status were less represented in the study population.11 This selection toward a more affluent 
and healthy study population may have influenced the prevalence of exposure to EDs at the 
workplace but did not bias the results because exposure status was assessed independently 
from TTP. Additionally, educational level was not a confounding factor in the analyses. Further-
more, we choose to collate the two exposure categories ‘possible’ and ‘probable’ exposure into 
one category reflecting the presence of exposure; the analyses showed that the HRs were com-
parable, only because of the low prevalence of exposure, the CIs in the analyses with separate 
exposure categories were much larger. Several sensitivity analyses were carried out to assess 
the influence of the selection criteria applied to our study population. The sensitivity analyses 
on the start of the current occupation showed that restricting the analysis to couples who had 
started working before the start of their TTP resulted in similar HRs. Furthermore, we found that 
the exposure to EDs was not associated with TTP information and planning of pregnancy; thus, 
the restrictions to couples with complete TTP information and planned pregnancies will not 
have influenced the presented results. The exclusion of couples with a TTP of 0 or 1 from the 
analysis showed no differences in HRs, indicating little evidence for the presence of wantedness 
bias.
In conclusion, we found associations among men occupationally exposed to heavy metals 
and overall exposure to EDs with a prolonged TTP. Maternal occupational exposure to all cat-
egories of EDs showed prolonged TTP, but the decreased HRs were not statistically significant. 
There was no overlap in exposure patterns between mothers and fathers. These results indicate 
that working with EDs may carry a reproductive hazard that warrants further studies to investi-
gate the specific role of EDs in reproductive health.
C
h
ap
te
r 
2.
2
86
REfEREnCES
 1. Evers JL. Female subfertility. Lancet 2002;360:151-159.
 2. Baird DD. Using time-to-pregnancy data to study occupational exposures: methodology. Reprod 
Toxicol 1988;2:205-207.
 3. Baird DD, Wilcox AJ, Weinberg CR. Use of time to pregnancy to study environmental exposures. Am J 
Epidemiol 1986;124:470-480.
 4. te Velde E, Burdorf A, Nieschlag E, Eijkemans R, Kremer JA, Roeleveld N et al. Is human fecundity 
declining in Western countries? Hum Reprod 2010;25:1348-1353.
 5. Damstra T, Barlow S, Bergman A, Kavlock R, Van der Kraak G. Global assessment of the State-of-the-
Science of Endocrine Disruptors. World Health Organisation 2002.
 6. Joffe M. What has happened to human fertility? Hum Reprod 2010;25:295-307.
 7. Bretveld R, Brouwers M, Ebisch I, Roeleveld N. Influence of pesticides on male fertility. Scand J Work 
Environ Health 2007;33:13-28.
 8. Hanke W, Jurewicz J. The risk of adverse reproductive and developmental disorders due to occupa-
tional pesticide exposure: an overview of current epidemiological evidence. Int J Occup Med Environ 
Health 2004;17:223-243.
 9. Roeleveld N, Bretveld R. The impact of pesticides on male fertility. Curr Opin Obstet Gynecol 
2008;20:229-233.
 10. Burdorf A, Figa-Talamanca I, Jensen TK, Thulstrup AM. Effects of occupational exposure on the repro-
ductive system: core evidence and practical implications. Occup Med 2006;56:516-520.
 11. Jaddoe VW, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Verhulst FC et al. The Generation R 
Study: Design and cohort profile. Eur J Epidemiol 2006;21:475-484.
 12. Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA, Steegers EA et al. The Genera-
tion R Study: design and cohort update until the age of 4 years. Eur J Epidemiol 2008;23:801-811.
 13. Bonde JP, Joffe M, Sallmen M, Kristensen P, Olsen J, Roeleveld N et al. Validity issues relating to time-
to-pregnancy studies of fertility. Epidemiology 2006;17:347-349.
 14. Statistics Netherlands. Dutch Standard Classification of Occupations (SBC) 1992. The Hague; Statistics 
Netherlands; 1992.
 15. Brouwers MM, van Tongeren M, Hirst AA, Bretveld RW, Roeleveld N. Occupational exposure to 
potential endocrine disruptors: further development of a job exposure matrix. Occup Environ Med 
2009;66:607-614.
 16. Kleij I. Number of foreigners according to various definitions (in Dutch, summary in English). The 
Hague; Statistics Netherlands; 2000; Volume 48; 14-17.
 17. Jaddoe VW, Verburg BO, de Ridder MA, Hofman A, Mackenbach JP, Moll HA et al. Maternal smok-
ing and fetal growth characteristics in different periods of pregnancy: the generation R study. Am J 
Epidemiol 2007;165:1207-1215.
 18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 
1977;33:159-174.
 19. Joffe M, Key J, Best N, Keiding N, Scheike T, Jensen TK. Studying time to pregnancy by use of a retro-
spective design. Am J Epidemiol 2005;162:115-124.
 20. Sallmen M. Exposure to lead and male fertility. Int J Occup Med Environ Health 2001;14:219-222.
 21. Bonde JP. Subfertility in relation to welding. A case referent study among male welders. Dan Med Bull 
1990;37:105-108.


Chapter 2.3
Chemicals and 
foetal growth
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Claudia A. Snijder
nel Roeleveld
Egbert te velde
Eric A.P. Steegers
Hein Raat
Albert Hofman
vincent W.v. Jaddoe
Alex Burdorf
Human Reproduction, 
march 2012; volume 27: 910-920
C
h
ap
te
r 
2.
3
90
ABStRACt
Background: Developmental diseases, such as birth defects, growth restriction and preterm 
delivery account for more than 25% of infant mortality and morbidity. Several studies have 
shown that exposure to chemicals during pregnancy is associated with adverse birth outcomes. 
The aim of this study was to identify whether occupational exposure to various chemicals might 
adversely influence intrauterine growth patterns and placental weight.
Methods: Associations between maternal occupational exposure to various chemicals and 
foetal growth were studied in 4680 pregnant women participating in a population-based pro-
spective cohort study from early pregnancy onwards in the Netherlands (2002-2006), the Gen-
eration R Study. Mothers who filled out a questionnaire during mid-pregnancy (response 77% 
of enrolment), were included if they conducted paid employment during pregnancy and had a 
spontaneously conceived singleton liveborn pregnancy (n = 4680). A job-exposure-matrix was 
used, linking job titles to expert judgement on exposure to chemicals in the workplace. Foetal 
growth characteristics were repeatedly measured by ultrasound and were used in combination 
with measurements at birth. Placental weight was obtained from medical records and hospital 
registries. Linear regression models for repeated measurements were used to study the associa-
tions between maternal occupational exposure to chemicals and intrauterine growth.
results: We observed that maternal occupational exposure to polycyclic aromatic hydrocar-
bons (PAHs), phthalates, alkylphenolic compounds, and pesticides adversely influenced several 
domains of foetal growth, being foetal weight, foetal head circumference, and foetal length. 
We found a significant association between pesticide and phthalate exposure with a decreased 
placental weight.
Conclusions: Our results suggest that maternal occupational exposure to several chemicals is 
associated with impaired foetal growth during pregnancy and a decreased placental weight. 
Further studies are needed to confirm these findings and to assess postnatal consequences.
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intRoduCtion
Developmental diseases, such as structural alterations (birth defects), functional alterations, 
growth restriction and preterm delivery, account for more than 25% of infant mortality and 
morbidity.1,2 Foetal growth is generally assessed by surrogate measures, including length of 
gestation and foetal size, and these endpoints are important determinants of later health and 
morbidity.3-5 Common risk factors for adverse foetal development include ethnicity,6 smoking 
and alcohol use,7 previous children with low birth weight or preterm birth, older maternal age, 
and low socioeconomic status.8 Recently, it has been suggested that environmental risk factors 
and parental occupation may also play an important role.9-11
Women constitute a substantial part of the labour force in the European Union (EU). In 
2010, about 58% of the women aged between 15-64 years had paid employment, which 
was a substantial increase from 54% in 2002.12 With the increasing labour force participation 
among women in European countries, the likelihood that women will be exposed to a variety of 
chemical, physical, and psychological risk factors at work during pregnancy will also increase.13 
Although women in paid employment have better pregnancy outcomes than those without 
paid jobs,14-16 certain work-related factors, such as exposure to chemicals,17 physically demand-
ing work18 and psychological job strain19 may adversely influence pregnancy outcome.
Exposure to chemicals during foetal development may increase the risk of adverse health 
consequences, including adverse birth outcomes, childhood morbidity, and adult disease and 
mortality.2,20 Chemicals that have been associated with adverse foetal development are lead, 
and other heavy metals,21,22 phthalates23 and pesticides.24-26 Chemicals can cross the placenta 
and enter the foetus, and a number of chemicals measured in maternal urine and serum have 
also been found in amniotic fluid, cord blood, and meconium.27 A recent study by Woodruff 
et al. showed that pregnant women in the US were exposed to multiple chemicals.28 The 
mechanism by which chemicals affect reproductive events are not completely understood, 
direct toxic effects may occur when normal processes such as differentiation, mitosis, meiosis, 
intracellular communication, DNA repair are altered. In this regard, the foetus is particularly 
vulnerable due to its fast growth, the process of cellular differentiation, the immaturity of their 
metabolic pathways, and the stage of development of vital organs.29
Since several studies have shown that exposure to chemicals during pregnancy adversely 
influence foetal development, as demonstrated by an increased occurrence of low birth weight, 
small-for-gestational-age and preterm delivery,2,11,30 we expect that exposure to chemicals 
might already influence foetal growth in the different trimesters during pregnancy. Although 
birth outcomes are important from an obstetric perspective, they are rather crude measures of 
foetal growth during pregnancy.
The aim of this study was to identify, within a population-based prospective birth cohort 
study, whether occupational exposure to various chemicals might adversely influence intra-
uterine growth patterns and placental weight.
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mAtERiAlS And mEtHodS
Study design
The Generation R Study is a population-based prospective cohort study on growth, develop-
ment, and health from early foetal life until young adulthood in Rotterdam, the Netherlands. 
The study design has previously been described in detail.31,32 Briefly, all pregnant women who 
had an expected delivery date between April 2002 and January 2006 and lived in the study 
area of Rotterdam were invited to participate. In total, 9778 pregnant women (response 61%) 
were enrolled in the study of which 8880 women were enrolled during pregnancy and another 
898 at birth of their child. Extensive assessments were carried out during the first trimester 
(gestational age < 18 weeks), second trimester (gestational age 18-25 weeks), and third trimes-
ter (gestational age > 25 weeks), including physical examinations, questionnaires, interviews, 
and biological samples. The study was approved by the Medical Ethics Committee at Erasmus 
University Medical Centre Rotterdam, The Netherlands (MEC 198.782/2001/31).
The occupational information required for this study was collected in the questionnaire 
completed during mid-pregnancy, which was filled out by 6830 women (77% of enrolment). 
For this study we selected women who were prenatally enrolled, with paid employment before 
or during pregnancy, and with a spontaneously conceived singleton liveborn pregnancy. For 
each couple, we included the first pregnancy within the Generation R cohort in our study, since 
some women participated with more than one child in the study. Finally, the study population 
consisted of 4680 women, the flowchart of the study population is depicted in Figure 1. Our 
results are based on the second and third trimester ultrasonography measures in combination 
with birth outcomes.
foetal ultrasounds
For this study we used the ultrasound measures of foetal head circumference, femur length, and 
estimated foetal weight, since these three measures are essential characteristics to describe 
foetal growth. Foetal ultrasound examinations were carried out in two dedicated research cen-
tres in each trimester of pregnancy. We measured foetal head circumference (HC), abdominal 
circumference (AC), and femur length (FL) to the nearest millimetre using standardised ultra-
sound procedures in the second (median 20.5, minimum-maximum 18.0-25.0 weeks) and third 
(median 30.4, minimum-maximum 25.8-37.0 weeks) trimester. Since use of the last menstrual 
period for pregnancy dating has several limitations,33 and a large number of women in our 
study population did not know the exact date of their last menstrual period (76%), we used 
crown-rump length for pregnancy dating until a gestational age of 12 weeks (2308 women) 
and biparietal diameter for pregnancy dating thereafter (2372 women) in all women.34,35 First 
trimester measurements (3459 women) were primarily used to establish gestational age and 
therefore not included in the growth analysis. Estimated foetal weight (EFW) was calculated 
using the formula by Hadlock et al.36 Ultrasound examinations were performed using an Aloka 
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model SSD-1700 (Tokyo, Japan) or the ATL-Philips Model HDI 5000 (Seattle, WA, USA). Custom-
ised growth curves for the entire study population were constructed, and standard deviation 
(SD) scores for each individual women were calculated as deviation from the ‘overall’ average 
at that gestational week, and represent the equivalent z-scores.33 The intraclass correlation 
coefficient of foetal growth measurements was 0.95, tested on 21 subjects, indicating a high 
reproducibility of foetal biometry measurements.37
Figure 1. Flowchart of the study population
Figure 1: Flowchart of the study population 
 
 
Enrolment 
Mothers 9778 
8880 in pregnancy, 898 at birth of their child 
Fathers 6347 
N=6830 women completed questionnaire during 
mid-pregnancy 
N=5154 women had paid employment 
N=4680 women were included in the analysis 
N=76 women were 
excluded for twin 
pregnancies 
N=84 women were 
excluded for a 
pregnancy of non-
spontaneous origin 
N=4 women were 
excluded for foetal 
death 
N=310 women were 
excluded, 
participating with 
second or third child 
in Generation R 
C
h
ap
te
r 
2.
3
94
Placenta and birth outcomes
Placental weight was obtained from medical records and hospital registries. Information about 
gender at birth, gestational age, weight, length, and head circumference at birth was obtained 
from medical records and hospital registries. For the analysis, we used birth weight, head cir-
cumference at birth, and length of the infant at birth.
occupation and working conditions
The mid-pregnancy questionnaire contained questions about work status, occupation, and 
working conditions and focussed on the periconception and pregnancy period. Work status, 
based on a single question on the current economic status with seven categories: paid labour, 
self-employed, unemployed, disabled, homemaker, student, or other, was used to select 
women with paid employment. This question was followed by questions whether the mother 
had worked before conception in this current occupation, and the starting and (optional) stop 
date of this current occupation. We selected women who started working before conception 
and women who started working somewhere during the first trimester of pregnancy. Further 
questions on job title, type of business, name of employer, and activities in the job were used 
to classify jobs into the Dutch Classification of Occupations38 and subsequently link these 
codes to a Job-Exposure-Matrix (JEM) for chemical exposure.39 This new JEM was developed 
according to a general strategy, comprising of a literature search to identify chemicals, infor-
mation gathering on occupations at risk, and literature on occupational settings in which the 
selected chemicals were encountered and exposure measurements were performed. This 
reference material served as a starting point for the expert assessment. Three experts were 
asked to estimate exposures based on their knowledge of tasks and working environment in 
various occupations. Finally, exposure probability scores were added based on the judgement 
of three experts. For various chemicals, subjects experience a certain level of exposure through 
diet, environment or widely used consumer products. The JEM exposure score refers to the 
probability of occupational exposure, which is assumed to exceed the background level in 
the general population. The exposure probability scores were assigned by means of consen-
sus discussions in which the original scores were taken into account where possible, but no 
prior individual assessments were performed. The JEM comprises ten categories of chemicals, 
namely polycyclic aromatic hydrocarbons, polychlorinated organic compounds, pesticides, 
phthalates, organic solvents, bisphenol A, alkylphenolic compounds, flame retardants, metals, 
and miscellaneous agents.39 For 353 job titles probability scores were classified in three levels: 
‘unlikely’ (0), ‘possible’ (1), and ‘probable’ (2). Different country specific JEMs have been used 
in several studies and the JEM is a valuable tool for exposure assessment in epidemiological 
studies on the health risks of chemical exposure.14,40-42 For this study we collated the last two 
categories into one category indicating the occurrence of exposure to chemicals.
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Potential confounders
Information about maternal age, pre-pregnancy weight, educational level, ethnicity, parity, and 
folic acid supplement use was obtained by questionnaire at enrolment in the study. Maternal 
smoking habits and alcohol use were assessed on the basis of three questionnaires (in early, 
mid- and late pregnancy) and classified as no, until pregnancy was known, or during preg-
nancy.43 Maternal height was measured at intake in the study. The questions on physical work 
load were obtained from the Dutch Musculoskeletal Questionnaire and concerned questions 
on long periods of standing, manually handling loads of 5 kg or more, manually handling loads 
of 25 kg or more, and night shifts. The presence of doctor-diagnosed preeclampsia, pregnancy 
induced hypertension, and diabetes gravidarum was retrieved from medical records and was 
based on the criteria of the International Society for the Study of Hypertension in Pregnancy.44,45
Statistical analysis
We assessed the associations between maternal occupational exposure to various chemicals 
and longitudinally measured SD scores of head circumference, length (second- and third 
trimester femur length and birth length), and weight (second- and third trimester estimated 
foetal weight and birth weight) using a mixed model for repeated measurements with an 
unstructured error term. This is a commonly used method to analyse data from longitudinal 
studies.46 First, customised growth curves for the entire study population were constructed, 
and standard deviation (SD) scores for each individual women were calculated as deviation 
from the ‘overall’ average at that gestational week.33 This approach resembles the common 
measure weight-for-age z-scores (WAZ), used in international studies on undernutrition and 
child mortality in order to increase comparability of effects independent of underlying differ-
ences in distributions.47 These gestational age adjusted SD scores were used as parameters 
of foetal growth, the dependent variables in the statistical analyses. Second, a linear model 
was used to study the influence of occupational exposure to chemicals on these gestational 
age adjusted SD scores. The final model can be written as (for example for foetal weight): SD 
score of foetal weight = ß0 + ß1 x gawks + ß2 x exposuregroup + ß3 x gawks x exposuregroup 
(gawks=gestational age in weeks). In this model, ß0 reflects the intercept and ß2 expresses the 
systematic difference between exposed en non-exposed groups. The coefficient ß3 reflects 
whether exposed and non-exposed foetus grow at the same rate over time. The later coef-
ficient is the main interest of this analysis, since it represents the average decline or increase 
in SD for foetal weight per gestational week for exposed women versus non-exposed women. 
Different beta coefficients of interaction were estimated for weight, head circumference, and 
length, representing growth velocity for several domains of foetal growth. The regression 
models were adjusted for lifestyle and socioeconomic confounders used in previous studies on 
maternal occupational exposure14,42 and known determinants of foetal growth: maternal age, 
educational level, ethnicity, parity, pre-pregnancy weight, height at intake, smoking during 
pregnancy, alcohol use during pregnancy, folic acid supplement use, foetal gender, physically 
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demanding work (long periods of standing, handling of loads > 5 kg, handling of loads > 25 
kg, and night shifts), and pregnancy complications (preeclampsia, pregnancy induced hyper-
tension, and diabetes gravidarum). For the important confounders ethnicity and educational 
level, potential interaction with exposure was investigated for each multivariable model with a 
significant effect of exposure on foetal growth.
Missing values in covariates were handled by multiple imputations (MCMC method) by 
generating five independent datasets for all analyses. Imputations were based on the relations 
between all covariates included in this study and the threshold for imputation was set on a 
maximum of 30% of missing values. We used the pooled adjusted effect estimates to generate 
the Figures 2-4. No differences were observed between analyses with imputed missing data or 
complete cases only. We performed a sensitivity analysis in order to evaluate whether women 
who started working in their current job before conception differed from women who started 
working during pregnancy. All levels of associations are presented with their 95% confidence 
intervals. The repeated measurement analyses were conducted with the Proc Mixed module of 
the Statistical Analysis System (version 9.2; SAS Institute Inc, Cary NC).
RESultS
Table 1 shows the baseline characteristics of the study population. The mean age of the women 
at intake in the study was 31.1 years. Of all women, 30.3% had completed high education and 
the largest group was from Dutch origin (64.0%). The majority of women were nulliparous 
(63.9%). A total of 11.7% of the mothers continued smoking and 39.4% of the mothers con-
tinued drinking alcohol after the pregnancy was known. According to the JEM, 1.3% of the 
women were exposed to polycyclic aromatic hydrocarbons (PAHs), 0.5% to pesticides, 1.5% to 
phthalates, 4.7% to organic solvents, 3.3% to alkylphenolic compounds, 1.1% to metals, and 
6.7% to any chemicals. In total, 4197 (89.7%) women visited our clinic for second trimester 
ultrasonography, and 4294 (91.8%) for third trimester ultrasonography. The median gestational 
age at birth was 40.1 weeks (minimum 22.7, maximum 43.4 weeks), while mean birth weight 
was 3450 grams (standard deviation 549 grams). Slightly more than 50% of the infants were 
boys. The three characteristics of foetal growth were interrelated with the highest association 
TaBle 1. Baseline characteristics of pregnant women participating in a birth cohort study, The 
Generation R Study (n = 4680)
Variables results
Maternal characteristics
Age at intake (yrs) 31.08 (4.56) 
Weight before pregnancy (kg) 64.00 (34.00-145.00) 
Height measured at intake (cm) 168.80 (7.12) 
 Chemicals and foetal growth 97
Educational level Low 653 (14.0%) 
Mid-low 1333 (28.5%) 
Mid-high 1129 (24.1%) 
High 1419 (30.3%) 
Missing 146 (3.1%) 
Ethnicity Netherlands 2993 (64.0%) 
Surinam and Dutch Antilles 380 (8.1%) 
Marocco and Turkey 328 (7.0%) 
Other 885 (18.9%) 
Missing 94 (2.0%) 
Parity Nulliparous 2992 (63.9%) 
Multiparous 1565 (33.4%) 
Missing 123 (2.6%) 
Smoking Yes, during pregnancy 546 (11.7%) 
Yes, until pregnancy was known 355 (7.6%) 
No 3031 (64.8%) 
Missing 748 (16.0%) 
Alcohol Yes, during pregnancy 1846 (39.4%) 
Yes, until pregnancy was known 587 (12.5%) 
No 1524 (32.6%) 
Missing 723 (15.4%) 
Folic acid use No 580 (12.4%) 
Yes, post conception start 1163 (24.9%) 
Yes, preconception start 1735 (37.1%) 
Missing 1202 (25.7%) 
Occupational characteristics 
Exposure to: 
PAH 63 (1.3%) 
Pesticides 23 (0.5%) 
Phthalates 68 (1.5%) 
Organic solvents 221 (4.7%) 
Alkylphenolic compounds 156 (3.3%) 
Metals 52 (1.1%) 
Any chemicals 313 (6.7%) 
Growth outcomes 
Second trimester ultrasonography 4197 (89.7%) 
Third trimester ultrasonography 4294 (91.8%) 
Birth outcomes 
Gestational age at birth (wk) 40.14 (22.71-43.43) 
Birth weight (grams) 3449.81 (549.28) 
Male 2365 (50.5%) 
Head circumference at birth (mm) 33.89 (1.65) 
Length at birth (mm) 50.33 (2.38) 
Values are means (standard deviation) for normal distributed continuous variables or medians (minimum-maximum) for 
skewed distributed continuous variables, and absolute numbers (percentages) for categorical variables.
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between foetal weight and length (Pearson correlation coefficient r = 0.59, at birth) and the 
smallest association between head circumference and length (r = 0.43, at birth).
Table 2 shows the results of the linear regression analysis on occupational exposure to 
chemicals and placental weight. Women occupationally exposed to pesticides and phthalates 
showed a significantly lower placental weight compared with non-exposed women, respec-
tively 65.90 grams for pesticides (95%CI -129.86;-1.94) and 45.88 grams for phthalates (95%CI 
-85.15;-6.60).
Table 3 shows the results of the univariable and multivariable longitudinal models for the 
associations between occupational exposure to various chemicals and foetal weight, head cir-
cumference, and foetal length. The average decline in standard deviation per gestational week 
is graphically illustrated in Figure 2-4. Maternal occupational exposure to several chemicals 
showed similar trends with lower growth rates for all three parameters. Women occupationally 
exposure to polycyclic aromatic hydrocarbons and phthalates showed significant lower foetal 
weight growth rates (average decline in SD per gestational week 0.01660 for PAHs and 0.01691 
for phthalates) compared to non-exposed mothers, adjusted for potential confounders. In 
the fully adjusted model, the following covariates statistically significantly influenced foetal 
growth in order of decreasing importance: weight, height, parity, smoking, ethnicity, and dia-
betes gravidarum, but adjustments did not change the effect estimates of chemical exposure 
on foetal growth (Supplement 1). No interaction for exposure with ethnicity and educational 
level was observed in the multivariable models, indicating that ethnicity and education do not 
TaBle 2. Associations between occupational exposure to chemicals and placental weight among 
pregnant women participating in a birth cohort study
Occupational chemical exposure Placental weight (grams)
Crude# Adjusted†
Exposure to:
PAH -21.21 (-65.17; 22.75) -7.64 (-52.03; 36.76) 
Pesticides -74.84 (-138.34; -11.35) * -65.90 (-129.86; -1.94) * 
Phthalates -59.55 (-98.11; -21.00) * -45.88 (-85.15; -6.60) * 
Organic solvents -17.74 (-39.21; 3.74) -10.00 (-32.36; 12.36) 
Alkylphenolic compounds -15.81 (-41.01; 9.39) -5.43 (-32.03; 21.16) 
Metals -37.14 (-80.53; 6.26) -35.22 (-78.54; 8.09) 
Any chemicals -18.71 (-37.20; -0.22) * -11.03 (-30.28; 8.23) 
Results from simple and multiple linear regression analysis. Values are regression coefficients (95% confidence intervals) 
and reflect the difference in grams for placental weight between women exposed to chemicals in the workplace 
compared to non-exposed women. Based on 3185 measurements of placental weight.
# adjusted for gestational age at birth
† adjusted for gestational age at birth, maternal age, educational level, ethnicity, foetal gender, weight before pregnancy, 
height at intake, smoking during pregnancy, alcohol use during pregnancy, folic acid use, parity, long periods of 
standing, handling loads of >5 kg, handling loads of >25kg, night shifts, preeclampsia, pregnancy induced hypertension, 
and diabetes gravidarum.
* P-value < 0.05.
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Figure 2. Adjusted relative differences in foetal weight (SD scores) in various chemical groups compared 
with the non-exposed group
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Figure 2: Adjusted relative differences in foetal weight (SD scores) in various chemical groups compared with the non-exposed group  
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* 
Values are based on repeated linear regression models and reflect the difference in SD score of foetal weight 
measurements (based on 12748 measurements) in the offspring of mothers occupationally exposed to various groups 
of chemicals compared to the offspring of non-exposed mothers. The reference value is a SD score of 0. * P-value < 0.05. 
Estimates are adjusted for the following confounders: maternal age, educational level, ethnicity, foetal gender, weight 
before pregnancy, height at intake, smoking during pregnancy, alcohol use during pregnancy, folic acid use, parity, long 
periods of standing, handling loads of >5 kg, handling loads of >25kg, night shifts, preeclampsia, pregnancy induced 
hypertension, and diabetes gravidarum.
Figure 3. Adjusted relative differences in head circumference (SD scores) in various chemical groups 
compared with the non-exposed group
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Figure 3: Adjusted relative differences in head circumference (SD scores) in various chemical groups compared with the non-exposed group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are based on repeated linear regression models and reflect the difference in SD score of foetal head circumference 
measurements (based on 10789 measurements) in the offspring of mothers occupationally exposed to various groups 
of chemicals compared to the offspring of non-exposed mothers. The reference value is a SD score of 0. * P-value < 0.05. 
Estimates are adjusted for the following confounders: maternal age, educational level, ethnicity, foetal gender, weight 
before pregnancy, height at intake, smoking during pregnancy, alcohol use during pregnancy, folic acid use, parity, long 
periods of standing, handling loads of >5 kg, handling loads of >25kg, night shifts, preeclampsia, pregnancy induced 
hypertension, and diabetes gravidarum.
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moderate or explain the observed associations between occupational exposure and foetal 
growth parameters.
For foetal head circumference, only maternal occupational exposure to alkylphenolic com-
pounds showed a statistically significant lower growth rate (-0.0175 SD per gestational week) 
compared to non-exposed mothers, adjusted for potential confounders. For foetal length, we 
observed statistically significant lower growth rates between mothers occupationally exposed 
to pesticides and phthalates (-0.0361 SD per gestational week, and -0.0185 SD per gestational 
week, respectively) compared to non-exposed mothers, with a much steeper decline during 
the course of pregnancy for pesticides than for other occupational chemicals.
In total, 4177 (89.3%) women filled out the question concerning the starting date of their cur-
rent occupation, 4068 women (97.4%) started working before conception, whereas 109 (2.6%) 
women started working somewhere during their first trimester of pregnancy. In the sensitivity 
analyses no differences in effect estimates were observed between women who started work-
ing before conception compared to women who started working during the first trimester of 
pregnancy. The differences in standard deviation scores for all foetal growth characteristics for 
unadjusted model, the adjusted model (pooled estimates), and for the five multiple imputation 
models are shown in Supplement 1. Supplement 2 and 3 show the individual data points of 
Figure 4. Adjusted relative differences in foetal length (SD scores) in various chemical groups compared 
with the non-exposed group
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Figure 4: Adjusted relative differences in foetal length (SD scores) in various chemical groups compared with the non-exposed group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
* 
Values are based on repeated linear regression model and reflect the difference in SD score of foetal length 
measurements (based on 11401 measurements) in the offspring of mothers occupationally exposed to various groups 
of chemicals compared to the offspring of non-exposed mothers. The reference value is a SD score of 0. * P-value < 0.05. 
Estimates are adjusted for the following confounders: maternal age, educational level, ethnicity, foetal gender, weight 
before pregnancy, height at intake, smoking during pregnancy, alcohol use during pregnancy, folic acid use, parity, long 
periods of standing, handling loads of >5 kg, handling loads of >25kg, night shifts, preeclampsia, pregnancy induced 
hypertension, and diabetes gravidarum.
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exposed and non-exposed women for foetal weight and foetal head circumference in the second 
trimester, third trimester and at birth.
diSCuSSion
This large population-based prospective cohort study showed that maternal occupational 
exposure to several chemicals, such as polycyclic aromatic hydrocarbons (PAHs), phthalates, 
alkylphenolic compounds and pesticides during pregnancy, adversely influenced their foetal 
growth rates of weight, head circumference and length. These differences in foetal growth rates 
could already be demonstrated during pregnancy, and were partly reflected in a decreased 
placental weight. These findings suggest that early exposure during the critical window of 
foetal development is crucial.
In this study we used ultrasound measurements for pregnancy dating,34,35 this method 
appears to be superior to dating based on the last menstrual period.33 A disadvantage of 
pregnancy dating by ultrasound is that growth variations in crown-rump length and biparietal 
diameter in early pregnancy are assumed to be zero, impairing detailed analysis on foetal 
growth in the first trimester. In a sensitivity analyses on the subset of women with a certain 
last menstrual period and regular cycle (n = 1221), the direction of the effect estimates did not 
change. Reference curves for foetal growth were constructed for our cohort, which enables 
linear analyses of foetal growth characteristics. These curves are based on a large, urban, non-
hospital based population, which makes these curves generalisable to normal foetal develop-
ment in industrialised countries.33 For the repeated measurements concerning foetal length, 
we used the SD score of birth length in combination with SD scores of femur length in second 
and third trimester in order to assess relative changes in foetal skeletal growth. However, the 
results should be interpreted with caution, since these measurements reflect different body 
parts. The repeated measurements based on gestational age adjusted SD scores were used in 
previous studies within the same cohort.7,48 This method enables us to identify pathological 
smallness instead of constitutional smallness, which may be normal intrauterine growth. The 
advantage of SD scores as relative measure of difference is that the SD scores can be used in 
linear regression models, whereas absolute differences in foetal growth were highly skewed 
since growth curves during pregnancy have a typical parabolic shape that must be described 
by fractional polynomials instead of normal distributions. We demonstrated two of these curves 
with absolute differences in Supplement 2 and 3.
The strength of this study is the population-based approach with recruitment during the 
prenatal period and the availability of a large number of potential confounders. A limitation 
of this study is the selective participation with mothers from ethnic minorities and with lower 
socio-economic status less represented in the study population.31 This selection may have 
influenced the prevalence of exposure to chemicals at the workplace, but bias is unlikely since 
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exposure status was assessed independently from and prior to the foetal growth characteristics 
by a recently updated job-exposure-matrix (JEM). This approach assured that exposure status 
was blinded to participants and researchers, both aspects which avoid information bias. The 
characterisation of exposure in the JEM must be interpreted as exposure probabilities, which 
are only a crude measure of exposure, which have to be interpreted with caution. Background 
exposure to various chemicals through diet and environment may occur. Previous research 
within the Generation R Study,49 but also within the NHANES national survey showed that 
almost all pregnant women are exposed to chemicals, and that levels are comparable between 
pregnant and non-pregnant women.28 However, there is reason to believe that occupational 
exposure is generally much higher than background exposure through diet and environ-
ment.50 For example, for phthalates, Hines et al. showed that for several occupations the 
urinary phthalate concentrations exceeded the levels of the general population.51 However, 
biomonitoring data comparing occupational exposures with exposure from non-occupational 
sources are scarce. In the current study we did not assess background exposure and, thus, it is 
not possible to distinguish the importance of different routes of exposure. Since it is unlikely 
that the widespread environmental exposure is associated with occupational exposure in spe-
cific jobs, background exposure will most likely not confound the observed relation between 
occupational chemical exposure and foetal growth.
Furthermore, the JEM does not contain specific chemicals, but only contains broad groups 
of chemicals, and the mechanisms of action can vary between specific chemicals in a group. 
A major drawback of JEMs is that they do not account for variability in tasks and working 
environments within job titles. However, from the task description, it may become clear that 
some subjects within a specific job title, for example subjects who have odd jobs around a 
farm (feeding animals) are less likely to be exposed to pesticides. The overlap between the 
categories phthalates, organic solvents, and alkylphenolic compounds was considerable for 
mothers (kappa values 0.47 to 0.77), indicating that women exposed to one of these substances 
were likely to be exposed to other substances as well. We must conclude that due to this inter-
relationship among exposure groups, it was not possible to disentangle the specific role of 
phthalates and alkylphenolic compounds in the observed lower foetal growth rates.
Women with lower education and women from ethnic minorities were more often exposed 
to chemicals in the workplace, but in our study this did not introduce confounding. As can 
be seen from Table 2 and Supplements, adjustments for education and ethnicity only slightly 
changed our effect estimates. Even though we were able to control for a large number of 
potential confounders, residual confounding cannot be ruled out completely. In this study we 
used multiple imputation for missing values in covariates. This reduces selection bias due to 
non-random missing in the covariates.
In this study we measured foetal growth, comprising three characteristics of foetal growth, 
namely weight, head circumference and length. Intrauterine growth restriction has been 
classified as symmetric and asymmetric, although the clinical relevance of this concept is 
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controversial.52 Recent studies have shown that asymmetric foetal growth is associated with an 
increased neonatal morbidity.53 Although it proved to be too difficult to distinguish between 
symmetric and asymmetric growth restriction in our study, we hypothesised that the compa-
rable effects of occupational exposure to chemicals on all characteristics of foetal growth might 
be suggestive for symmetric growth restriction.
Several chemicals were associated with impaired foetal weight, resulting in a decrease in 
SD at birth varying between 0.2 and 0.7. This corresponds to approximately 100-400 grams 
difference in birth weight. The effect of occupational exposure to chemicals seems of similar 
magnitude than other well-known lifestyle factors, such as smoking, alcohol use, and caffeine 
intake. Bakker et al. showed a reduction of 0.3 SD in birth weight for mother who consumed caf-
feine > 6 units/day.48 Jaddoe et al. showed that smoking impaired foetal growth, in particular 
head circumference, femur length, and abdominal circumference, with 0.1-0.3 SD.7 However, 
the population attributable fraction is low, due to the low prevalence of exposure to these 
chemicals compared to other well-known lifestyle factors.
Workplace health is an important topic since women who intend to become pregnant and 
pregnant women are at risk for adverse pregnancy outcomes, thus, it is important to identify 
occupational related risk factors for prevention. Occupations in which women have a high expo-
sure probability are agricultural and horticultural workers (pesticide exposure), hairdressers, 
beauticians, furniture makers (phthalate exposure), and cleaners (alkylphenolic compounds). 
Since the effects of occupational exposures on foetal growth are considerable, one could argue 
that pregnant women working in agriculture or horticultural trades must be informed about 
the risks of pesticide exposure in the workplace. However, the underlying mechanism of these 
exposures is largely unclear, and results from earlier studies are conflicting, which poses further 
research into this important topic.
This study supports existing evidence from human studies regarding occupational exposures 
and adverse pregnancy outcomes.30 Although the chemicals in our study were considered to 
be potential endocrine disrupters, is remains to be established whether the mode of action 
is through endocrine disruption. A recent review by Caserta et al. summarises the literature 
regarding exposure to endocrine disrupting chemicals on pregnancy outcome.54 They con-
clude that epidemiological studies on endocrine disruptors are not always consistent. This is 
further illustrated by occupational studies, for example in hairdressers, that show conflicting 
results.55-57 Further studies are urgently needed to identify the molecular basis of the effects, to 
study the epigenetic effects of these exposures, and to develop strategies to prevent exposure 
to these agents to improve birth outcomes.58
Our results suggest that maternal occupational exposure to several chemicals adversely 
influence foetal growth patterns. Further studies are needed to confirm these findings and to 
identify potential targets for prevention.
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suPPleMenT 1. Overview of the estimates in univariable and multivariable models for SD scores for 
foetal weight, head circumference and length of exposed mothers versus non-exposed mothers
TaBle 1. Foetal weight
unadjusted 
estimate
p‑value adjusted 
estimate
p‑value
Exposure to:
PAH -0.01647 0.0390 -0.016598 0.0375 
Pesticides -0.01892 0.1375 -0.018908 0.1379 
Phthalates -0.01675 0.0244 -0.016907 0.0231 
Organic solvents -0.00411 0.3321 -0.004100 0.3334 
Alkylphenolic compounds -0.00757 0.1305 -0.007659 0.1258 
Metals -0.01682 0.0537 -0.016494 0.0585 
Any chemicals -0.00712 0.0495 -0.007095 0.0504 
TaBle 2. Foetal head circumference
unadjusted 
estimate
p‑value adjusted 
estimate
p‑value
Exposure to:
PAH -0.01053 0.3451 -0.010555 0.3433 
Pesticides -0.02619 0.1242 -0.026027 0.1264 
Phthalates -0.01632 0.0972 -0.015530 0.1138 
Organic solvents -0.00975 0.0817 -0.009022 0.1068 
Alkylphenolic compounds -0.01834 0.0056 -0.017517 0.0080 
Metals -0.00937 0.4210 -0.008884 0.4449 
Any chemicals -0.00912 0.0588 -0.008605 0.0742 
TaBle 3. Foetal length
unadjusted 
estimate
p‑value adjusted 
estimate
p‑value
Exposure to:
PAH -0.00328 0.7483 -0.003139 0.7583 
Pesticides -0.03610 0.0247 -0.035071 0.0289 
Phthalates -0.01845 0.0425 -0.018183 0.0452 
Organic solvents -0.00743 0.1544 -0.007048 0.1763 
Alkylphenolic compounds -0.00954 0.1251 -0.008990 0.1479 
Metals -0.01246 0.2526 -0.012172 0.2629 
Any chemicals -0.00520 0.2470 -0.004850 0.2796 
Estimates are adjusted for the following confounders: maternal age, educational level, ethnicity, foetal gender, weight 
before pregnancy, height at intake, smoking during pregnancy, alcohol use during pregnancy, folic acid use, parity, 
long periods of standing, lifting >5 kg at work, lifting >25kg at work, night shifts, preeclampsia, pregnancy induced 
hypertension, and diabetes gravidarum.
Overview of the estimates of SD scores for foetal weight, head circumference and length of exposed mothers versus 
non-exposed mothers in the multiple imputation models.
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TaBle 1. Foetal weight
Mi 1 Mi 2 Mi 3 Mi 4 Mi 5 Pooled 
adjusted 
estimate
p‑value
Exposure to:
PAH -0.01658 -0.01658 -0.01657 -0.01661 -0.01664 -0.016598 0.0375 
Pesticides -0.01886 -0.01883 -0.01870 -0.01900 -0.01914 -0.018908 0.1379 
Phthalates -0.01688 -0.01694 -0.01684 -0.01692 -0.01696 -0.016907 0.0231 
Organic solvents -0.00409 -0.00410 -0.00410 -0.00412 -0.00410 -0.004100 0.3334 
Alkylphenolic compounds -0.00765 -0.00766 -0.00763 -0.00769 -0.00766 -0.007659 0.1258 
Metals -0.01652 -0.01644 -0.01641 -0.01655 -0.01655 -0.016494 0.0585 
Any chemicals -0.00709 -0.00709 -0.00709 -0.00712 -0.00709 -0.007095 0.0504 
TaBle 2. Foetal head circumference
Mi 1 Mi 2 Mi 3 Mi 4 Mi 5 Pooled 
adjusted 
estimate
p‑value
Exposure to:
PAH -0.01061 -0.01061 -0.01052 -001045 -0.01059 -0.010555 0.3433 
Pesticides -0.02572 -0.02647 -0.02577 -0.02578 -0.02638 -0.026027 0.1264 
Phthalates -0.01543 -0.01561 -0.01548 -0.01550 -0.01564 -0.015530 0.1138 
Organic solvents -0.00905 -0.00902 -0.00895 -0.00899 -0.00909 -0.009022 0.1068 
Alkylphenolic compounds -0.01754 -0.01755 -0.01743 -0.01748 -0.01760 -0.017517 0.0080 
Metals -0.00880 -0.00920 -0.00865 -0.00878 -0.00899 -0.008884 0.4449 
Any chemicals -0.00862 -0.00865 -0.00853 -0.00859 -0.00863 -0.008605 0.0742 
TaBle 3. Foetal length
Mi 1 Mi 2 Mi 3 Mi 4 Mi 5 Pooled 
adjusted 
estimate
p‑value
Exposure to:
PAH -0.00324 -0.00309 -0.00306 -0.00326 -0.00305 -0.003139 0.7583 
Pesticides -0.03473 -0.03537 -0.03497 -0.03521 -0.03507 -0.035071 0.0289 
Phthalates -0.01803 -0.01825 -0.01810 -0.01826 -0.01827 -0.018183 0.0452 
Organic solvents -0.00697 -0.00716 -0.00694 -0.00702 -0.00714 -0.007048 0.1763 
Alkylphenolic compounds -0.00889 -0.00918 -0.00887 -0.00894 -0.00906 -0.008990 0.1479 
Metals -0.01206 -0.01239 -0.01200 -0.01221 -0.01220 -0.012172 0.2629 
Any chemicals -0.00479 -0.00494 -0.00476 -0.00487 -0.00489 -0.004850 0.2796 
Abbreviations: MI=multiple imputation set. Estimates are adjusted for the following confounders: maternal age, 
educational level, ethnicity, foetal gender, weight before pregnancy, height at intake, smoking during pregnancy, alcohol 
use during pregnancy, folic acid use, parity, long periods of standing, lifting >5 kg at work, lifting >25kg at work, night 
shifts, preeclampsia, pregnancy induced hypertension and diabetes gravidarum.
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suPPleMenT  2. Estimated foetal weight in the second and third trimester, and birth weight (in grams) 
plotted against gestational age in weeks. The two lines resemble a quadratic line, fitted at the points of 
women exposed to any of the chemicals, compared to non-exposed women.
Supplement 2: Estimated foetal weight in the second and third trimester, and birth weight (in 
grams) plotted against gestational age in weeks. The two lines resemble a quadratic line, 
fitted at th  points of women xpos d to any of the chemicals, co pared to non-exposed 
women. 
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suPPleMenT  3. Head circumference in the second trimester, third trimester, and at birth (in mm) 
plotted against gestational age in weeks. The two lines resemble a quadratic line, fitted at the points of 
women exposed to any of the chemicals, compared to non-exposed women.
Supplement 3: Head circumference in the second trimester, third trimester, and at birth (in 
mm) plotted against gestational age in weeks. The two lines resemble a quadratic line, fitted 
at the points of women exposed to any of the chemicals, compared to non-exposed women. 
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ABStRACt
Background: Prenatal exposure to Bisphenol A (BPA) has been associated with adverse birth 
outcomes.
Objective: We investigate the relation of prenatal BPA exposure with intrauterine growth and 
evaluate the effect of the measurement strategy on observed associations.
Methods: This study was embedded in a Dutch population-based prospective cohort study, 
with urine samples collected during early, mid, and late pregnancy. The study comprised 219 
women, of which 99 had one measurement, 40 had two measurements, and 80 had three 
measurements of urinary BPA. Foetal growth characteristics were repeatedly measured by 
ultrasound during pregnancy and combined with measurements at birth. Linear regression 
models for repeated measurements of both BPA and foetal growth were used to study associa-
tions between log-transformed urinary concentrations of creatinine-based BPA (lnBPACB) and 
intrauterine growth.
results: The relationship between BPACB and foetal growth was sensitive to the number of 
BPA measurements per woman. Among women with three BPA measurements, women with 
BPACB > 4.22 μg/g Crea relative to women with BPACB <1.54 μg/g Crea had lower growth rates 
for foetal weight and head circumference, resulting in a difference at birth of 3.9 cm (11.5% 
of mean) in head circumference and 683 grams (20.3% of mean) in birth weight. When fewer 
measurements were available per woman, the exposure-response relationship became pro-
gressively attenuated and statistically non-significant.
Conclusion: In our study population findings are compatible with observations that higher 
concentrations of urinary BPA are inversely associated with foetal growth. Further evidence is 
needed to corroborate these findings to the general population.
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intRoduCtion
Pregnant women are exposed to a variety of chemicals during pregnancy,1,2 which may increase 
the risk of adverse health outcomes.3 Environmental exposures that have been associated with 
adverse foetal development are heavy metals,4,5 phthalates,6 and pesticides.7,8
BPA is used to make polycarbonate polymers and epoxy resins, along with other raw materi-
als in plastics production, and is present in dental fillings, plastic food and water containers, 
baby bottles, food wraps, as well as in the lining of beverage and food cans, presenting a large 
number of opportunities for human exposure.9-11 Given the ubiquity of BPA in the human 
environment, exposure to BPA is virtually universal.2 BPA is known to exert estrogenic activity 
and is considered an endocrine disrupting chemical (EDC).12 Concern about EDCs stems from 
their potential effects via diverse mechanisms, including estrogenic/antiandrogenic properties, 
antioxidant actions, inhibition of cell cycles, and cell differentiation.13,14 Some animal studies 
showed that exposure to EDCs mimicking sex steroids/steroids affected foetal growth and 
organ differentiation.15,16
Animal studies have shown that BPA reduced sperm quality, disturbed hormonal balance, 
and caused reproductive organ damage and malformations.17-19 In rats, prenatal exposure to 
BPA led to both a reduction as well as a gain in body weight.16,20 Recently, several epidemio-
logical studies have considered the effects of prenatal exposure to BPA on reproductive health. 
Miao et al. found that job-related maternal exposure to BPA during the index pregnancy was 
associated with a decreased birth weight.21 Lee and colleagues reported among 125 pregnant 
women, that maternal BPA levels in urine during the first trimester were inversely correlated 
with head circumference in the third trimester.22 In contrast, Wolff et al. suggested that higher 
urinary BPA concentrations in the third trimester of pregnancy were associated with slightly 
higher birth weight of the offspring23 and Philippat et al. showed an increase in head circumfer-
ence with increasing BPA concentrations.24
The limited, contradictory findings in epidemiological studies on effects of BPA on foetal 
weight and birth weight might be associated with methodological issues related to exposure 
assessment. Pharmacokinetic studies suggest that BPA is rapidly metabolised with a short half 
life, resulting in low to modest correlations between repeated BPA measurements over 1-6 
month periods.25,26 A recent study by Braun et al. reported an intraclass correlation coefficient 
of 0.11 for BPA across three repeated urine samples during pregnancy, illustrating the need for 
repeated urinary BPA measurements during pregnancy in order to obtain sufficiently precise 
exposure estimates.27
With this study we aimed to investigate the effects of prenatal exposure to BPA on intrauter-
ine growth and to evaluate the effects of the measurement strategy chosen on the observed 
associations.
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mAtERiAlS And mEtHodS
Study design
The Generation R Study is a population-based prospective cohort study on growth, develop-
ment, and health from early foetal life until young adulthood in Rotterdam, the Netherlands.28 
All pregnant women with an expected delivery date between April 2002 and January 2006 
in the study area of Rotterdam were invited to participate. In total, 9778 pregnant women 
(response 61%) participated in the study of which 8880 women enrolled during pregnancy 
and another 898 women at birth of their child. Extensive assessments were carried out during 
early pregnancy (gestational age < 18 weeks), mid-pregnancy (gestational age 18-25), and late 
pregnancy (gestational age > 25 weeks), including biological samples. The study was approved 
by the Medical Ethics Committee at Erasmus University Medical Centre Rotterdam, The Neth-
erlands (MEC 198.782/2001/31). Written informed consent was obtained from all participants.
urine collection and analysis
In 2006 among all women who provided one urine sample, a random sample of 100 women 
was taken and analysed for organophosphorous pesticide, BPA, and phthalate levels.1 In 2010 
among all women with multiple urine samples available, a random sample was taken of 120 
women, consisting of 40 women with two samples and 80 women with three samples. After 
exclusion of one twin pregnancy, a total of 219 women with 419 urine samples were available, 
with 26% in the first trimester, 28% in the second trimester, and 46% in the third trimester of 
pregnancy. All urine samples (65 ml) were collected between February 2004 and November 
2005. All samples were taken between 8 a.m. and 8 p.m. in 100 ml polypropylene urine col-
lection containers that were kept maximally 20 hours in a cold room (4°C) before being frozen 
in 20 ml portions in 25 ml polypropylene vials at -20°C. The urine specimens were analysed 
for BPA using tandem mass spectrometry. For the 100 specimens analysed in 2006, this was 
done at the Institute of Occupational, Social, and Environmental Medicine of the University 
of Erlangen-Nurnberg, Germany.1 The 120 specimens in 2010 were analysed at the Institute 
of Prevention and Occupational Medicine, German Social Accident Insurance, Institute of the 
Ruhr-Universitat, Bochum, Germany (IPA).29 To determine BPA, analytes were hydrolyzed and 
separated from 1 ml of urine using semi-automated steam distillation and solid-phase extrac-
tion. In Erlangen, the limit of detection (LOD) was 0.26 μg/L; at IPA the LOD was 0.05 μg/L. The 
between assay coefficient of variation was 8.3% in Erlangen and 5.6% at IPA. The within assay 
variability was between 3.4 and 6.5%. In Erlangen, derivatisation into tert-butyldimethylsilyl 
was needed, while in IPA, due to improvements in measurement method, no derivatisation 
was needed, which minimised the influence of BPA contamination due to sample workup, thus 
also allowing a lower LOD. Urinary creatinine concentrations were determined by the method 
described by Larsen.30
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foetal growth and birth outcomes
We combined second- and third trimester foetal ultrasound measurements with measurements 
of foetal size at birth. We measured growth characteristics to the nearest millimeter using stan-
dardised ultrasound procedures in the second (median 20.5, minimum-maximum 18.2-25.0 
weeks) and third (median 30.2, minimum-maximum 27.4-33.8 weeks) trimester. First trimester 
measurements were used to establish gestational age, since use of the last menstrual period for 
pregnancy dating has several limitations,31 and most women (76%) in our study population did 
not know the exact date of their last menstrual period. We used crown-rump length for preg-
nancy dating until a gestational age of 12 weeks and bi-parietal diameter for pregnancy dating 
thereafter in all women.32,33 Estimated foetal weight (EFW) was calculated using the formula by 
Hadlock et al.34 The intraclass correlation coefficient of foetal growth measurements was 0.95, 
based on 21 subjects, indicating a strong relation for different foetal biometry measurements 
between and among observers.35 Internal reference curves were made for foetal weight and 
foetal head circumference during pregnancy, showing typical parabolic patterns. For all growth 
characteristics in the second and third trimester standard deviation scores (SD), based on the 
whole Generation R cohort, were constructed.31 This method closely resembles the commonly 
used z-scores approach suggested by the World Health Organisation.36 Information about 
gestational age, gender, weight, length, and head circumference at birth was obtained from 
medical records and hospital registries. For almost all women (n = 217, 99.1%) two measures 
of foetal growth were available, of which 157 women (72%) had complete information on all 
three measurements.
Potential confounders
The following well-known determinants of foetal growth were included as confounders in 
the association between urinary BPA and foetal growth: maternal age, pre-pregnancy weight, 
height, educational level, ethnicity, parity, smoking, alcohol use, and folic acid supplement use. 
Maternal height was measured at intake in the study. Maternal age, educational level, ethnicity, 
parity, and folic acid supplement use were obtained by questionnaire at enrolment in the study. 
Maternal smoking habits and alcohol use were assessed by questionnaire in each trimester and 
classified as abstainer, user until pregnancy was known, or user during pregnancy.
Statistical analyses
The distributions of urinary BPA concentrations were highly skewed and therefore all values 
were log transformed (lnBPACB) in order to obtain normal distributions. Women with a value 
below the LOD, were imputed with LOD/sqrt(2). Repeated measurement analyses were con-
ducted with the Proc Mixed module of the Statistical Analysis System (version 9.2; SAS Institute 
Inc, Cary NC). First, a mixed effect model was used with lnBPACB as dependent variable in order 
to assess which time-independent maternal characteristics and lifestyle factors influenced 
BPA concentrations, taking into account random variation within and between subjects in BPA 
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concentrations. Second, mixed effect models were used with repeated measurements of foetal 
head circumference and foetal weight as dependent variables and lnBPACB as independent 
variable measured in the previous trimester. Thus, measurements of lnBPACB in urine samples 
at first, second, and third trimester during pregnancy were related to foetal growth measure-
ments at second and third trimester during pregnancy and at birth.
In these regression models, we used standard deviation (SD) scores as parameter of foetal 
growth (dependent variable). We used both lnBPACB as continuous variable and lnBPACB 
categorised into quartiles, based on distribution of BPA concentrations in all 219 women. This 
comparison allowed us to examine the shape of the relationship between lnBPACB and foetal 
growth. The final model can be written as (for example for foetal weight): SD score of foetal 
weight = ß0 + ß1 x GA [gestational age [in weeks]] + ß2 x quartiles lnBPACB + ß3 x GA x quar-
tiles lnBPACB.
37 In this model, the coefficient ß3 reflects the slope (interaction of lnBPACB with 
gestational age), and tests whether foetuseses of women in the highest quartiles of lnBPACB 
concentrations grow at the same rate as the foetuseses of women in the lowest quartile of 
lnBPACB concentrations. The latter coefficient expresses a higher or lower foetal growth rate 
per week (in change SD score per gestational week) in exposed groups relative to the refer-
ence group with the lowest lnBPACB concentration. The regression models were adjusted for all 
potential confounders.
Missing values in lifestyle and socioeconomic confounders were handled by multiple 
imputations (fully conditional specification, Markov Chain Monte Carlo method) by generating 
five independent datasets for all analyses, using SPSS version 17.0 for windows. All variables in 
Table 1 were included in the imputation procedure (these variables were imputed and used as 
predictor).
The influence of the availability of measurement information on the observed exposure-
response relationship was evaluated by comparing three approaches. In the first approach it 
was assumed that only a single BPA measurement was available per woman. For women with 
multiple measurements a random selection procedure was used to assign a single measure-
ment to each woman, resulting in a study sample of 219 women to study the association 
between a single lnBPACB measurement and measures of foetal growth across pregnancy 
periods. In the second approach the study sample was limited to 120 women with at least two 
lnBPACB measurements available. Again a random selection procedure was used to select two 
measurements among those women with three measurements. In the third approach the study 
sample was further restricted to the 80 women with three lnBPACB measurements available 
across every trimester. For each study sample a similar regression model was used to directly 
compare exposure-response relationships among all approaches. In a sensitivity analysis we 
applied these three approaches among the 80 women with complete information, in order 
to eliminate potential effects of selective participation in the urine sample procedures which 
might have biased the analyses with different numbers of women included.
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TaBle 1. Baseline characteristics of all women with at least one available BPA measurement (n=219) 
participating in the Generation R cohort
Maternal characteristics results
Age at intake in years, mean +/- SD 30.8 ± 5.2
Weight before pregnancy in kilograms, median (interquartile range) 63.0 (15.3) 
Height measured at intake in centimeters, median (interquartile range) 168.0 (11.0) 
Educational level 
Low 39 (17.8%) 
Mid-low 56 (25.6%) 
Mid-high 55 (25.1%) 
High 50 (22.8%) 
Missing 19 (8.7%) 
Ethnicity 
Dutch 120 (54.8%) 
Surinamese and Dutch Antilleans 19 (8.7%) 
Moroccan and Turkish 29 (13.2%) 
Other 34 (15.5%) 
Missing 17 (7.8%) 
Parity 
Nulliparous 112 (51.1%) 
Multiparous 99 (45.2%) 
Missing 8 (3.7%) 
Smoking 
Yes, during pregnancy 27 (12.3%) 
Yes, until pregnancy was known 10 (4.6%) 
No 158 (72.1%) 
Missing 24 (11.0%) 
Alcohol 
Yes, during pregnancy 74 (33.8%) 
Yes, until pregnancy was known 28 (12.8%) 
No 92 (42.0%) 
Missing 25 (11.4%) 
Folic acid use 
No 40 (18.3%) 
Yes, post conception start 49 (22.4%) 
Yes, preconception start 82 (37.4%) 
Missing 48 (21.9%) 
Birth outcomes 
Gestational age (GA) at birth in weeks, median (interquartile range) 40.00 (2.00) 
Birth weight in grams, mean +/- SD 3372.28 ± 589.14 
Male 105 (47.9%) 
Head circumference at birth in centimeters, mean +/- SD 33.84 ± 1.49 
Length at birth in centimeters, mean +/- SD 50.14 ± 2.17 
First trimester GA at urine collection in weeks, mean +/- SD 13.24 ± 1.74 
Second trimester GA at urine collection in weeks, mean +/- SD 20.67 ± 1.12 
Third trimester GA at urine collection in weeks, mean +/- SD 30.37 ± 1.53 
Urine creatinine in grams/Litre, median (interquartile range) 0.69 (0.66) 
Values are absolute numbers (percentages) for categorical variables unless otherwise indicated.
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In a second sensitivity analysis we investigated whether the adjustment for creatinine could 
influence the results. In this analysis lnBPA levels were used as an independent variable, with 
creatinine levels as an adjustment factor in the models. A third sensitivity analysis investigated 
whether the time lag model used in this study could influence our results, since within person 
variability in BPA is high. Measurements of lnBPACB in urine samples at first, second, and third 
trimester during pregnancy were related to foetal growth measurements at first, second, and 
third trimester during pregnancy.
RESultS
Table 1 shows the baseline characteristics of the study population. The mean age of the women 
at intake in the study was 30.8 years. Of all women, 22.8% had completed higher education 
and the largest group was from Dutch origin (54.8%). The majority of women were nulliparous 
(51.1%). A total of 12.3% of the mothers continued smoking and 33.8% of the mothers contin-
ued drinking alcohol after the pregnancy was known.
There were no significant differences between the Bisphenol A (BPA) concentrations in the 
first, second, and third trimester of pregnancy nor for the analytical procedure by year. Further-
more, there were no differences in BPA concentration in different trimesters, or overall, by site 
(Erlangen or IPA) of analysis. BPA and creatinine-based BPA concentrations in three trimesters of 
pregnancy stratified by year of analyses are shown in Supplement 1. A lower educational level 
and being from Moroccan or Turkish origin was associated with a lower creatinine-based lnBPA 
(lnBPACB). Alcohol use during pregnancy was associated with a higher lnBPACB (Table 2).
Table 3 shows the univariable and multivariable linear analyses of lnBPACB on foetal weight 
and foetal head circumference, using all 419 measurements from 219 women. The covariates 
did not confound the relation between BPA concentrations and foetal growth, since the effect 
estimates from the univariable and multivariable models were largely comparable (Supplement 
2). However, since these covariates are important determinants of foetal growth, we included 
these covariates by default in all further multivariable models. When comparing women 
included in our study population to the women who provided urine and women in the whole 
Generation R cohort, we noticed that the women in our sample were slightly higher educated, 
more often of Dutch origin, and more often multiparous (Supplement 3).
Table 4 shows the influence of the number of BPA measurements on growth rates for foetal 
weight and foetal head circumference. Among the 80 women with three BPA measurements 
significantly lower growth rates were observed for both foetal weight and foetal head circum-
ference. Foetuseses of women with higher exposure levels showed decreased foetal growth, 
but a significant trend across exposure groups was not observed. When fewer measurements 
were available per pregnant woman, the exposure-response relationship became progres-
sively attenuated and statistically non-significant. The effect estimates of the univariable and 
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multivariable analyses in the restricted study sample were comparable, suggesting little influ-
ence of the potential confounders.
In the sensitivity analysis on the 80 women with three BPA measurements the range of 
confidence limits around the estimates decreased, the number of measurements per woman 
increased and, in general, the magnitude of the estimate increased (Supplement 4). These 
women with complete urine samples were more often highly educated (33.8% versus 22.8%) 
and of Dutch origin (61.3% versus 54.8%). We found comparable effect estimates for foetal 
growth parameters for both lnBPACB as well as lnBPA with additional adjustment for creatinine 
TaBle 2. Determinants of urinary BPA concentrations in 219 pregnant women participating in the 
Generation R Cohort
Variables n intercept 
coefficient
regression coefficient
Change in lnBPaCB
% change in 
BPaCB
Educational level 1.25
Low 39 -0.37 (-0.70, -0.03)* -30.59%* 
Mid-low 56 -0.29 (-0.58, 0.00) -25.11% 
Mid-high 55 -0.31 (-0.58, -0.03)* -26.35%* 
High 50 Reference Reference 
Ethnicity 1.05 
Dutch 120 Reference Reference 
Surinamese and Dutch Antilleans 19 -0.00 (-0.38, 0.37) -0.42% 
Moroccan and Turkish 29 -0.43 (-0.79, -0.07)* -34.87%* 
Other 34 0.19 (-0.11, 0.49) 21.41% 
Parity 1.10 
Nulliparous 112 Reference Reference 
Multiparous 99 -0.14 (-0.35, 0.07) -12.80% 
Smoking 1.05 
No 158 Reference Reference 
Yes, until pregnancy was known 10 -0.21 (-0.69, 0.28) -18.72% 
Yes, during pregnancy 27 -0.06 (-0.44, 0.31) -6.17% 
Alcohol 0.86 
No 92 Reference Reference 
Yes, until pregnancy was known 28 0.39 (0.06, 0.72)* 47.45%* 
Yes, during pregnancy 74 0.22 (-0.02, 0.47) 24.87% 
Folic acid supplement use 1.01 
No 40 -0.02 (-0.32, 0.29) -1.84% 
Yes, post conception start 49 0.08 (-0.19, 0.34) 7.80% 
Yes, preconception start 82 Reference Reference 
lnBPACB = log transformed creatinine based total BPA concentration.
* p-value < 0.05.
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TaBle 3. Univariable and multivariable repeated linear regression analyses between prenatal exposure to 
BPACB and SD scores of foetal weight and foetal head circumference among 219 pregnant women
Variables Foetal weight
unadjusted beta 
coefficient (95%Ci)
Foetal weight
adjusted beta 
coefficient (95%Ci)
Foetal head 
circumference
unadjusted beta 
coefficient (95%Ci)
Foetal head 
circumference
adjusted beta
coefficient (95%Ci)
Foetal growth rates a
BPACB (μg/g Crea) 
< 1.54 Reference Reference Reference Reference 
1.54 < BPACB < 2.51 -0.009 (-0.033, 0.014) -0.010 (-0.033, 0.014) -0.016 (-0.045, 0.013) -0.018 (-0.047, 0.011) 
2.51 < BPACB < 4.22 -0.018 (-0.041, 0.006) -0.015 (-0.038, 0.009) -0.019 (-0.047, 0.009) -0.016 (-0.044, 0.013) 
> 4.22 -0.001 (-0.024, 0.023) 0.001 (-0.023, 0.025) -0.018 (-0.049, 0.012) -0.016 (-0.047, 0.014) 
Per unit increase in BPACB -0.013 (-0.025, -0.001)* -0.011 (-0.023, 0.002) -0.005 (-0.020, 0.009) -0.003 (-0.018, 0.011) 
BPACB = creatinine based total BPA concentration, * p-value < 0.05.
a beta coefficient represents the average decline/increase in SD score of foetal weight or foetal head circumference per 
gestational week.
TaBle 4. Multiple repeated linear regression analyses of the relation between number of urine samples 
analysed for BPA and effect on foetal growth rates during pregnancy
samples/women number of 
women
Foetal weight
Beta coefficient 
(95%Ci)
Foetal head 
circumference
Beta coefficient 
(95%Ci)
Three samples 80
BPACB (μg/g Crea) < 1.54 Ref Ref 
BPACB (μg/g Crea) 1.54 < BPACB < 2.51 -0.041 (-0.081, -0.001)* -0.052 (-0.098, -0.006)* 
BPACB (μg/g Crea) 2.51 < BPACB < 4.22 -0.043 (-0.082, -0.004)* -0.046 (-0.090, -0.003)* 
BPACB (μg/g Crea) > 4.22 -0.029 (-0.070, 0.012) -0.066 (-0.113, -0.019)* 
BPACB (μg/g Crea) Per unit increase in BPACB -0.017 (-0.033, -0.001)* -0.018 (-0.037, 0.000)+ 
Two samples 120 
BPACB (μg/g Crea) < 1.54 Ref Ref 
BPACB (μg/g Crea) 1.54 < BPACB < 2.51 -0.018 (-0.045, 0.009) -0.018 (-0.055, 0.018) 
BPACB (μg/g Crea) 2.51 < BPACB < 4.22 -0.029 (-0.056, -0.003)* -0.013 (-0.049, 0.022) 
BPACB (μg/g Crea) > 4.22 -0.003 (-0.033, 0.027) -0.017 (-0.057, 0.023) 
BPACB (μg/g Crea) Per unit increase in BPACB -0.008 (-0.024, 0.008) -0.005 (-0.024, 0.013) 
One sample 219 
BPACB (μg/g Crea) < 1.54 Ref Ref 
BPACB (μg/g Crea) 1.54 < BPACB < 2.51 0.003 (-0.027, 0.032) -0.011 (-0.049, 0.025) 
BPACB (μg/g Crea) 2.51 < BPACB < 4.22 0.008 (-0.025, 0.040) 0.003 (-0.036, 0.041) 
BPACB (μg/g Crea) > 4.22 0.025 (-0.002, 0.052) 0.015 (-0.022, 0.051) 
BPACB (μg/g Crea) Per unit increase in BPACB -0.007 (-0.023, 0.010) 0.011 (-0.008, 0.030) 
BPACB = creatinine based total BPA concentration
* p-value <0.05, + p-value <0.10
Beta coefficient represents the average decrease in SD of foetal weight per gestational week.
Adjusted for maternal age, educational level, ethnicity, parity, smoking during pregnancy, alcohol use during pregnancy, 
height at intake, weight before pregnancy, folic acid supplement use, and gender.
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levels. Relating first, second, and third trimester BPA concentrations to first, second and third 
trimester foetal growth showed very similar results as the lagged model.
Figures 1 depicts the associations between lnBPACB exposure categories and foetal weight 
and head circumference, based on the study population with three available BPA samples. 
Women in the highest BPA exposure group had the lowest growth rates for foetal head circum-
ference, resulting in an average decrease of 2.63 SD at birth, which corresponds to approxi-
mately 3.9 cm (11.5%) of the average head circumference of 33.8 cm at birth. For foetal weight, 
women in the second highest exposure group showed an average decrease of 1.66 SD in birth 
weight, which corresponds to a difference of 683 grams (20.3%) at birth.
The within and between individual variance was 1.0728 and 0.4286, respectively, based on 
120 women with more than one urine sample.
diSCuSSion
The findings from this population-based prospective cohort study are compatible with the 
view that higher concentrations of creatinine-based Bisphenol A (lnBPACB) in prenatal urine are 
associated with lower foetal weight and head circumference. Furthermore, we demonstrated 
Figure 1. Relative differences in SD scores for foetal weight and head circumference in various lnBPACB 
exposure groups, compared to the lowest (<1.54) exposure group, among 80 women.
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Figure 1: Relative differences in SD scores for foetal weight and head circumference in various lnBPACB exposure groups, compared to the lowest (<1.54) 
exposure group, among 80 women. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
* 
* 
* 
* 
Adjusted relative differences in foetal weight and head circumference (SD scores) in the highest BPA exposure groups 
compared with the lowest exposure group. Values are based on repeated linear regression models and reflect the 
difference in the SD score of foetal weight or foetal head circumference measurements (based on 238 measurements 
for foetal weight, and 213 measurements for foetal head circumference) in the offspring of mothers in the highest BPA 
exposure groups compared with the offspring of mothers in the lowest exposure group. The reference value is a SD score 
of 0. * P-value < 0.05. Estimates are adjusted for the following confounders: maternal age, educational level, ethnicity, 
foetal gender, weight before pregnancy, height at intake, smoking during pregnancy, alcohol use during pregnancy, folic 
acid use, and parity.
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that when three BPA measurements were used instead of a single BPA measurement, the 
associations between BPA and foetal growth were steeper and significant exposure-response 
estimates were obtained. In contrast, when three measurements were used, steeper and highly 
significant exposure-response estimates were obtained. Thus, increasing the number of mea-
surements per subject during pregnancy seems to increase power of the study and result in less 
biased exposure-response estimates.
Epidemiological studies on the effects of prenatal BPA exposure on foetal development 
are rare. Lee et al. showed in 125 pregnant women that first trimester maternal urinary BPA 
levels negatively influenced foetal head circumference and abdominal circumference in the 
third trimester of pregnancy.22 The present study corroborates these findings, although their 
effects on head circumference seem smaller. Furthermore, in a study among 587 children from 
families whereby occupational exposure to BPA of parents was ascertained through personal 
air sampling and exposure histories, prenatal exposure to BPA reduced birth weight, especially 
for maternal exposure.21 Another study among 97 women showed that elevated prenatal BPA 
exposure, measured in maternal blood and umbilical cord blood, increased the risk of low birth 
weight, small-for-gestational-age, and adverse actions of adipokines in neonates.38 In contrast, 
Wolff et al. suggested that higher urinary BPA concentrations in the third trimester of pregnancy 
were associated with slightly higher birth weight23 and Philippat et al. showed an increase in 
head circumference with increasing BPA concentrations.24
Until recently, BPA was considered a weak environmental estrogen, about 10000 to 100000 
fold less potent than estradiol.39 However, studies on molecular mechanisms have revealed a 
variety of pathways through which BPA can stimulate cellular response at very low doses in 
addition to effects initiated by binding of BPA to the classical α- or more recent β-form of the 
estrogen receptor.40 In humans, BPA is generally described as rapidly metabolised, with elimi-
nation thought to be virtually complete within 24 hours after exposure. Exposure is thought to 
be most exclusively from food, for example Wilson et al. estimated that 99% of exposure was 
of dietary origin, based on BPA measurements from a variety of sources such as food, air, and 
house dust.41 However, a recent study by Stahlhut et al. reported that BPA levels did not decline 
rapidly with fasting time, which suggests substantial non-food exposure, or accumulation in 
body tissues such as fat.42 Braun et al. observed numerous sources of BPA exposure during 
pregnancy, and recommended that epidemiological studies need to measure BPA concentra-
tions more than once during pregnancy.27
When comparing the current levels of BPA in different trimesters of pregnancy in our study 
to other studies we may conclude that levels are very similar. For example, Braun et al. found 
GMs of BPACB of 1.7 (at 16 weeks), 2.0 (at 26 weeks), while our levels ranged between 1.7 and 3.3 
(second and third trimester measurements).27
This study illustrates the profound influence of the chosen measurement strategy on the 
observed exposure-response associations. When using all available information on 219 women, 
no statistically significant associations were observed (see Table 3), whereas the analysis 
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restricted to 80 women with three BPA measurements clearly showed relevant associations 
(Table 4). These differences must be sought in two explanations. As mentioned before, women 
with complete information on BPA were more often of Dutch origin and highly educated, both 
determinants of higher BPA exposure. This restricted study population was more homogeneous 
for important determinants of exposure and, although the average exposure to BPA was higher 
the total variance in BPA was smaller. The observed within-individual variance reduced more 
than the between-individual variance compared with the full study sample. The latter will result 
in less biased estimates due to exposure variability. However, information on co-exposures, 
such as exposure to other endocrine disrupting chemicals was lacking. Braun et al. showed that 
BPA and phthalate concentrations were interrelated.27
A second explanation is that any exposure-response association will become attenuated 
when the exposure varies strongly over time and the relevant exposure to be considered is 
the long term average exposure. The attenuation depends on the ratio of the intra- and inter-
individual variance in exposure and this attenuation may be counteracted by increasing the 
number of replicates per subject.43 Based on a linear regression analysis with repeated exposure 
measurements and a continuous outcome measure, and the observed ratio of 2.5 for BPA mea-
surements in our study population, increasing the number of measurements from 1 to 3 per 
person will reduce the attenuation from 70% to 45%. The BPA-foetal growth relation may fit the 
profile of a setting where, in a small study population, more replicates will maximise power.44 
This influence of the measurement strategy chosen might partly explain the lack of significant 
findings from some epidemiological and animal studies of BPA on foetal growth.20,23,24
We acknowledge that our study has several limitations, most importantly the small num-
ber of women in the analyses, and the lack of detail on which time window of exposure is 
biologically most relevant for foetal growth. In this study we used ultrasound measurements 
for pregnancy dating, and this appears to be superior to dating based on the last menstrual 
period.31 A disadvantage is that growth variations in early pregnancy are assumed to be zero, 
impairing analyses on first trimester growth. The repeated measurements based on gestational 
age adjusted SD scores, comparable to standardised z-scores, enables us to identify patho-
logical smallness rather than constitutional smallness. Foetal growth curves during pregnancy 
have a typical parabolic shape, which can be modeled by using fractional polynomials, but the 
advantage of SD scores is that growth can be analysed with a linear model.
The strength of this study is the population-based approach with recruitment during the 
prenatal period with multiple urine samples and a large number of potential confounders. 
Another strength of this study is the multiple observations on foetal growth as well as repeated 
measurements of BPA per subject, which will improve the precision of the analyses conducted. 
A limitation is the selective participation at baseline, with mothers of lower socioeconomic sta-
tus less represented in the study population. However, we feel that selection had little influence 
on our results, since we randomly selected women from the study population, and exposure 
was ascertained independently from foetal growth characteristics.
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Our results are compatible with the view that higher concentrations of BPA relative to lower 
concentrations of BPA in urine during pregnancy are associated with a decreased foetal growth 
for both foetal weight and head circumference. Furthermore, this study shows the influence 
of the measurement strategy chosen on the observed effect estimates, suggesting that in a 
small study population more replicates will maximise power. However, because of limitations 
of our study, we certainly need further evidence before we can conclude that in the general 
population BPA during pregnancy adversely influences foetal growth.
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suPPleMenT 2. Overview of the covariates in the repeated linear regression analyses between prenatal 
exposure to lnBPACB and SD scores of foetal weight and foetal head circumference among 219 pregnant 
women
Variables Foetal weight
adjusted beta coefficient 
(95%Ci)
Foetal head circumference
adjusted beta coefficient 
(95%Ci)
Covariates a
Maternal age (per year increase) 0.003 (-0.021, 0.026) 0.016 (-0.006, 0.038) 
Pre-pregnancy weight (per kg increase) 0.004 (-0.006, 0.015) 0.003 (-0.006, 0.012) 
Height at intake (per cm increase) 0.011 (-0.009, 0.031) 0.004 (-0.014, 0.022) 
Gender (female) 0.053 (-0.150, 0.256) -0.285 (-0.479, -0.091)* 
Educational level 
Low 0.002 (-0.404, 0.407) -0.294 (-0.660, 0.073) 
Mid-low -0.134 (-0.442, 0.173) -0.043 (-0.342, 0.255) 
Mid-high -0.024 (-0.310, 0.263) 0.044 (-0.228, 0.315) 
High Reference Reference 
Ethnicity 
Dutch Reference Reference 
Surinamese and Dutch Antilleans -0.388 (-0.828, 0.052) -0.145 (-0.521, 0.232) 
Moroccan and Turkish 0.050 (-0.371, 0.471) -0.001 (-0.393, 0.391) 
Other -0.085 (-0.408, 0.238) -0.259 (-0.548, 0.029) 
Parity 
Nulliparous Reference Reference 
Multiparous 0.235 (0.006, 0.464)* 0.026 (-0.185, 0.238) 
Smoking 
No Reference Reference 
Yes, until pregnancy was known 0.188 (-0.249, 0.626) 0.271 (-0.166, 0.708) 
Yes, during pregnancy -0.226 (-0.544, 0.093) -0.095 (-0.406, 0.216) 
Alcohol 
No Reference Reference 
Yes, until pregnancy was known 0.110 (-0.242, 0.462) -0.054 (-0.381, 0.272) 
Yes, during pregnancy 0.086 (-0.187, 0.359) -0.038 (-0.286, 0.209) 
Folic acid supplement use 
No -0.123 (-0.411, 0.166) -0.065 (-0.323, 0.194) 
Yes, post conception start -0.089 (-0.450, 0.271) -0.162 (-0.521, 0.198) 
Yes, preconception start Reference Reference 
a beta coefficient is the overall effect of this covariate in the model in SD score of foetal weight or foetal head 
circumference.
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suPPleMenT 3. Characteristics of participants in the BPA foetal growth subset, those with a complete 
set of pregnancy urine specimens, and the overall Generation R cohort
Maternal characteristics BPa foetal 
growth subset
(n=219)
Three urine 
specimens
(n=2083)
generation r 
Cohort
(n=9778)
Age at intake (yr) 30.8 ± 5.2 29.3 ± 5.0 29.9 ± 5.4
Educational level 
Low 39 (17.8%) 459 (22.0%) 2270 (23.2%) 
Mid-low 56 (25.6%) 591 (28.4%) 2628 (26.9%) 
Mid-high 55 (25.1%) 426 (20.5%) 1655 (16.9%) 
High 50 (22.8%) 488 (23.4%) 2006 (20.5%) 
Missing 19 (8.7%) 119 (5.7%) 1219 (12.5%) 
Ethnicity 
Dutch 120 (54.8%) 1009 (48.4%) 4443 (45.4%) 
Surinamese and Dutch Antilleans 19 (8.7%) 224 (10.8%) 1055 (10.8%) 
Moroccan and Turkish 29 (13.2%) 324 (15.6%) 1321 (13.5%) 
Other 34 (15.5%) 443 (21.3%) 1931 (19.7%) 
Missing 17 (7.8%) 83 (4.0%) 1028 (10.5%) 
Parity 
Nulliparous 112 (51.1%) 1198 (57.5%) 5179 (53.0%) 
Multiparous 99 (45.2%) 867 (41.6%) 4213 (43.1%) 
Missing 8 (3.7%) 18 (0.9%) 386 (3.9%) 
Smoking 
Yes, during pregnancy 27 (12.3%) 283 (13.6%) 1304 (13.3%) 
Yes, until pregnancy was known 10 (4.6%) 171 (8.2%) 634 (6.5%) 
No 158 (72.1%) 1398 (67.1%) 5656 (57.8%) 
Missing 24 (11.0%) 231 (11.1%) 2184 (22.3%) 
Alcohol 
Yes, during pregnancy 74 (33.8%) 666 (32.0%) 2786 (28.5%) 
Yes, until pregnancy was known 28 (12.8%) 311 (14.9%) 1045 (10.7%) 
No 92 (42.0%) 895 (43.0%) 3808 (38.9%) 
Missing 25 (11.4%) 211 (10.1%) 2139 (21.9%) 
Values are means ± standard deviation for normal distributed continuous variables and absolute numbers (percentages) 
for categorical variables.
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suPPleMenT 4. Linear regression analyses for repeated measurements on the relation between number 
of urine samples analysed for BPA and effect on foetal growth rates during pregnancy
samples/women number 
of 
women
Foetal weight
Beta coefficient 
(95%Ci)
Foetal head 
circumference
Beta coefficient 
(95%Ci)
Three samples 80
BPACB (μg/g Crea) < 1.54 Ref Ref 
BPACB (μg/g Crea) 1.54 < BPACB < 2.51 -0.041 (-0.081, -0.001)* -0.052 (-0.098, -0.006)* 
BPACB (μg/g Crea) 2.51 < BPACB < 4.22 -0.043 (-0.082, -0.004)* -0.046 (-0.090, -0.003)* 
BPACB (μg/g Crea) > 4.22 -0.029 (-0.070, 0.012) -0.066 (-0.113, -0.019)* 
BPACB (μg/g Crea) Per unit increase in BPACB -0.017 (-0.033, -0.001)* -0.018 (-0.037, 0.000)+ 
Two samples 80 
BPACB (μg/g Crea) < 1.54 Ref Ref 
BPACB (μg/g Crea) 1.54 < BPACB < 2.51 -0.031 (-0.068, 0.006) -0.044 (-0.085, -0.002)* 
BPACB (μg/g Crea) 2.51 < BPACB < 4.22 -0.011 (-0.048, 0.026) -0.035 (-0.076, 0.005) 
BPACB (μg/g Crea) > 4.22 -0.006 (-0.044, 0.031) -0.065 (-0.111, -0.020)* 
BPACB (μg/g Crea) Per unit increase in BPACB -0.016 (-0.036, 0.004) -0.022 (-0.047, 0.004)+ 
One sample 80 
BPACB (μg/g Crea) < 1.54 Ref Ref 
BPACB (μg/g Crea) 1.54 < BPACB < 2.51 -0.007 (-0.057, 0.044) 0.012 (-0.043, 0.068) 
BPACB (μg/g Crea) 2.51 < BPACB < 4.22 0.015 (-0.035, 0.065) 0.015 (-0.045, 0.075) 
BPACB (μg/g Crea) > 4.22 -0.030 (-0.081, 0.022) 0.022 (-0.040, 0.085) 
BPACB (μg/g Crea) Per unit increase in BPACB -0.027 (-0.065, 0.010) 0.005 (-0.035, 0.045) 
BPACB = creatinine based total BPA concentration
* P-value <0.05, + P-value <0.10
Beta coefficient represents the average decrease in SD of foetal weight per gestational week.
Adjusted for maternal age, educational level, ethnicity, parity, smoking during pregnancy, alcohol use during pregnancy, 
height at intake, weight before pregnancy, folic acid supplement use, and gender.
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ABStRACt
Background: Congenital heart defects (CHDs) are the most common major malformations 
in newborns. In this study we examined the associations between the occurrence of CHDs in 
children and periconceptional occupational parental exposures to chemicals.
Methods: In an age-matched case-control study with standardised data collection at 15 
months after birth, 424 mothers and 421 fathers of a child with CHD, and 480 mothers and 
477 fathers of a non-malformed child, filled out questionnaires on periconceptional general 
and job characteristics. A job-exposure-matrix, which links the information on job title and a 
description of work tasks to an expert judgement on exposure to chemicals in the workplace, 
was used.
results: The overall prevalence of occupational exposure to chemicals was 5.0% in cases and 
6.2% in controls for mothers (Odds ratio (OR) adjusted = 0.92; 95% confidence interval (CI) 0.26-
3.25), while 22.3% and 15.9% for fathers, respectively (ORadjusted = 1.23; 95%CI 0.39-3.91). 
No association of maternal occupational exposure to chemicals with risk of CHDs was found. 
Paternal exposure to phthalates was associated with a higher incidence of CHDs in general 
(ORadjusted = 2.08; 95%CI 1.27-3.40). Paternal exposure to phthalates was associated with peri-
membranous ventricular septal defect (ORadjusted = 2.84; 95%CI 1.37-5.92), to polychlorinated 
compounds with atrioventricular septal defect (ORadjusted = 4.22; 95%CI 1.23-14.42) and to 
alkylphenolic compounds with coarctation of the aorta (ORadjusted = 3.85; 95%CI 1.17-12.67).
Conclusions: Periconceptional paternal (but not maternal) occupational exposure to chemi-
cals is associated with an increased risk of CHDs in children. The results, however, must be 
interpreted cautiously as exposure probabilities are a crude measure of exposure.
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intRoduCtion
Congenital heart defects (CHDs) constitute the largest group of congenital anomalies, account-
ing for nearly 30% of children with major congenital anomalies diagnosed prenatally or in 
infancy in Europe.1 The worldwide prevalence ranges from 6 to 8 per 1000 live births, and CHDs 
are associated with a high morbidity and mortality rate.2 Risk factors, such as socio-economic 
status, maternal infections3 and other environmental factors such as chemical exposure, have 
been associated with CHDs in epidemiological research.4 Approximately 15% of CHDs can be 
attributed to known causes and 85% is related to interactions between subtle genetic varia-
tions and environmental exposures that interfere with embryonic cardiogenesis.5
Women constitute a substantial part of the labour force in Europe, and their participation is 
increasing, from 54% in 2002 to 58% in 2010 for women aged between 15 and 64 years.6 With 
this increase in labour force participation, the likelihood that these women will be exposed 
to a variety of chemical, physical and psychological risk factors at work during pregnancy is 
also increased.7 Women in paid employment generally have better pregnancy outcomes than 
those without paid jobs.8,9 This is in contrast to women with a low socio-occupational status, 
which seemed to predispose to congenital anomalies of the respiratory, heart and circulatory 
systems.10 Furthermore, certain work-related factors, such as exposure to chemicals,11 physi-
cally demanding work12 and psychological job strain,13 may adversely influence pregnancy 
outcome. Thus, hazardous workplace conditions may have adverse effects on pregnancy 
outcome but have also been related to birth defects in the offspring.14
Occupational exposure to chemicals, especially during the periconceptional period, influ-
ences the reproductive system in both women and men and may lead to adverse health effects 
in children.15 Studies on occupational exposure to chemicals or endocrine disrupting chemicals 
have shown associations with increased risks of congenital malformations, such as hypospadias 
and cryptorchidism, as well as a reduced sperm count.16-21 Studies on certain occupations, such 
as hairdresser and laboratory workers, showed little evidence for associations with congenital 
malformations.22-25 A review by Thulstrup and Bonde concluded that there is limited evidence 
linking occupational exposures during pregnancy to birth defects.26 Epidemiological evidence 
of associations between occupational exposure to chemicals and CHDs is scarce and contra-
dictory.27-30 Prospective cohort studies on these associations are difficult because of the low 
prevalence of CHDs in the general population, requiring large sample sizes. Therefore, case-
control studies with standardised postnatal data collection are the best alternative.31 Since 
biomonitoring of chemicals is expensive and often not available, the job-exposure-matrix 
(JEM) is a valuable tool for valid exposure assessment in studies on reproductive outcome after 
chemical exposure.32 The aims of our study were: 1) to study associations between CHDs and 
periconceptional parental occupational exposure to chemicals, and 2) to study whether chemi-
cal exposure is associated with different phenotypes of CHD.
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mAtERiAlS And mEtHodS
design and study population
The HAVEN study is a case-control family study, designed to investigate determinants in the 
pathogenesis and prevention of CHDs, and has been described in detail.31,33,34 In summary, 
recruitment of case and control children took place between June 2003 and January 2010 and 
case children with CHD were enrolled with both parents from four university medical centres: 
the Erasmus Medical Centre in Rotterdam, Leiden University Medical Centre in Leiden, VU 
University Medical Centre in Amsterdam, and Amsterdam Medical Centre, the Netherlands. 
Healthy control children and both parents were enrolled in collaboration with the child health 
care centres of ‘Thuiszorg Nieuwe Waterweg Noord’ in the large urban region of Rotterdam as 
part of the Western area of the Netherlands. Thus, the domain population comprised case- and 
control children born from 2002 onwards, all living in the Western area of the Netherlands. 
74.7% of the responders in the case families and 61.4% of the responders of the control families 
participated in the present study. We did not have permission from the medical ethical commit-
tee to collect data on non-responders and those who did not want to participate.
Children with CHD diagnosed in the first 15 months after birth by paediatric cardiologists 
were identified from the hospital registry and invited to participate. Diagnoses were confirmed 
by echocardiography and/or cardiac catheterisation and/or surgery. Healthy control children 
of a similar age to case children and without any major congenital malformation (ascertained 
in regular health checks by child physicians) and both parents were randomly selected from 
the medical records from child health centres and invited to participate. The age of the case 
and control children was matched based on frequencies within age categories. At the time of 
data collection, 15 months after delivery, case and control families visited the hospital for the 
standardised collection of information on general characteristics and outcomes. In the present 
study we included 424 case children with both parents and 480 control children with both 
parents resulting in a total of 904 sets of children and their parents. The cases and controls were 
not matched on characteristics other than age. The definition of CHD phenotypes was based on 
reported gene-environment interactions35-37 in the aetiology i.e. perimembranous ventricular 
septal defect (pVSD, n = 113), Tetralogy of Fallot (n = 52), atrioventricular septal defect (AVSD, 
n = 44), coarctation of the aorta (CoA, n = 44), hypoplastic left heart syndrome (HLHS, n = 20), 
aortic valve stenosis (n = 9), pulmonary valve stenosis (n = 63), transposition of the great arter-
ies (TGA, n = 63), and miscellaneous (n = 16). The Central Committee of Human Research in 
The Hague and the Medical Ethical Committees of the participating hospitals reviewed and 
approved the study protocol (CCMO07.1052/MA/P03.0200, approval date March 27, 2003; 
MEC212.508/2002/91, approval date April 16, 2002). Written informed consent was obtained 
from all participants.
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data collection
At the time of data collection, 15 months after the end of the index-pregnancy, questionnaires 
were filled out by the mother and the father at home. During the hospital visit the question-
naires were verified by a researcher. The periconceptional period was defined as four weeks 
prior to conception until eight weeks after conception. The questionnaires requested informa-
tion on parental age, height and weight, educational level, ethnicity, cigarette smoking, folic 
acid, alcohol and medication use, gender of the child and family history of CHDs. Ethnicity 
and educational level were classified according to the definitions of Statistics Netherlands.38 A 
positive family history of CHDs was defined by one or more CHDs in the family of the mother or 
father in the third degree or closer. The maternal use of folic acid in the periconceptional period 
was defined as the daily use of at least 400µg folic acid during the complete periconceptional 
period. Inconsistent users were classified as non-users. We defined cigarette, alcohol, and 
medication use as any use during the periconceptional period. Standardised anthropometric 
measurements were performed, including maternal weight and height.
geographic variation
As an individual’s residence might be associated with occupational opportunities, area of 
residence by city, zip code and street name were collated into a measure of urban density, 
based on a method called ‘area address density’, a unit of measurement used by the Statistics 
Netherlands from 2003 onwards. Five degrees of urban density were distinguished, namely: 
1) very high density regions (> 2500 addresses per square kilometre), 2) high density regions 
(1500-2500 addresses per square kilometre) 3) moderate density regions (1000-1500 addresses 
per square kilometre) 4) low density regions (500-1000 addresses per square kilometre) and 5) 
very low density regions (<500 addresses per square kilometre).39
Job-exposure-matrix
In the questionnaire work status and occupation were ascertained. Work status was based on a 
single question on current economic status, and subjects with paid employment were asked to 
fill out an open question providing a description of the job. We assessed occupational exposure 
to chemicals by applying a JEM, with a focus on endocrine disrupting chemicals.32 Job descrip-
tions were coded into job titles by the Dutch Standard Classification of Occupations, and linked 
to the JEM, which was based on the judgement of occupational hygienists who estimated for 
particular jobs the likelihood of exposure to seven categories of chemicals, namely pesticides, 
polychlorinated compounds, phthalates, bisphenol A, alkylphenolic compounds, heavy metals 
and miscellaneous agents.
Exposure assessment by the JEM was blinded to the outcome, and blinded to participants.
Six fathers were excluded from analysis because of incomplete answers on work status and 
job description. The JEM focusses on the most important chemicals with relevant exposures 
in the occupational setting. The occupational hygienists scored the probability of exposure to 
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each chemical group for all job titles, in three levels: ‘unlikely’(0), ‘possible’(1), and ‘probable’(2). 
For this study we collate categories one and two into one category indicating the possible 
occurrence (yes/no) of exposure to chemicals. An overall classification of ‘possible exposure 
to chemicals’ was collated if one of the seven chemical exposure categories was scored as ‘yes’. 
Different JEMs have been successfully used as a valuable tool for exposure assessment in epide-
miological studies on the health risks of chemicals, with a focus on endocrine disruption.9,17,40,41
Statistical analysis
General characteristics of mothers, fathers and children were compared between the groups 
using Mann-Whitney U test for continuous variables and Chi-square test for dichotomous 
variables. We used logistic regression analyses to study the associations between occupational 
exposure to chemicals and CHDs. For mothers we selected the following potential confound-
ers: maternal age, educational level, ethnicity, parity, CHD in family, periconceptional alcohol 
use, periconceptional medication use, periconceptional use of folic acid and urban density. 
For fathers we selected the following confounders: paternal age, educational level, ethnicity 
and urban density. In the univariable and multivariable logistic regression analyses, multiple 
comparisons are made, thus we applied a Bonferroni correction. The agreement between the 
various exposure categories was calculated by the weighted Cohen’s kappa.42 We performed 
statistical analysis using the Statistical Package for the Social Sciences version 15.0. Statistical 
significance was set at P < 0.05.
RESultS
A total of 424 case and 480 control children and both parents (excluding three fathers from 
both case and control groups) were included. The general characteristics of the study popula-
tions are shown in Table 1. Cases showed a significantly lower birthweight after adjustment for 
gestational age, compared with control children. Case and control mothers were significantly 
different for ethnicity, parity, alcohol use and CHD in the family. The urban density was signifi-
cantly different between the case and control families.
TaBle 1. General characteristics of the case families of a child with a congenital heart defect (CHD) and 
control families of a non-malformed child enrolled in the HAVEN study
Variables Cases (n = 424) Controls (n = 480)
Characteristics of children
Age at intake (months) 14.81 (2.66) 15.47 (2.47) 
Gender 
Male 238 (56.1%) 270 (56.2%) 
Female 186 (43.9%) 210 (43.8%) 
Birthweight adjusted for GA (median, min-max) 3252 (795-5150) 3512 (1625-5920)* 
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CHD 
Isolated 318 (75.0%) - 
Non-isolated 106 (25.0%) - 
Characteristics of mothers 
Age (years) at birth of index child (mean, SD) 31.8 (4.7) 31.0 (4.5)* 
Educational level 
Low 111 (26.2%) 105 (21.9%) 
Intermediate 177 (41.7%) 239 (49.8%) 
High 136 (32.1%) 136 (28.3%) 
Ethnicity 
European Dutch Native 369 (87.0%) 394 (82.1%)* 
European Others 15 (3.5%) 14 (2.9%) 
Non-European 40 (9.4%) 72 (15.0%) 
Primiparaa 182 (42.9%) 238 (49.6%)* 
Mulitparaa 242 (57.1%) 241 (50.2%) 
Pregnancy 
Spontaneous pregnancy (yes)a 400 (94.6%) 456 (95%) 
Previous abortion (no) 305 (71.9%) 355 (74%) 
BMI (kg/m2)(median, min-max)b 24.4 (11.9-41.5) 24.3 (16.0-52.2) 
CHD in family (yes) 29 (6.8%) 17 (3.5%)* 
Periconceptional: 
Folic acid 220 (51.9%) 254 (52.9%) 
Smoking 77 (18.2%) 101 (21.0%) 
Alcohol 166 (39.2%) 155 (32.3%)* 
Medication 84 (19.8%) 81 (16.9%) 
Characteristics of fathers 
Age (years) at birth of index child (mean, SD) 34.4 (5.3) 34.0 (5.1) 
Educational level 
Low 112 (26.6%) 128 (26.8%) 
Intermediate 141 (33.5%) 195 (40.9%) 
High 168 (39.9%) 154 (32.3%) 
Ethnicity 
European Dutch Native 361 (85.8%) 400 (83.9%) 
European Others 14 (3.3%) 7 (1.5%) 
Non-European 46 (10.9%) 70 (14.6%) 
CHD in family (yes) 22 (5.2%) 19 (3.9%) 
Occupational and geographical characteristics 
Paid employment mother 310 (73.1%) 371 (77.3%) 
Paid employment father 401 (94.6%) 451 (94.0%) 
Urban density 
Very high density area 105 (24.8%) 240 (50.0%)* 
High density area 117 (27.6%) 223 (46.5%)* 
Moderate density area 80 (18.9%) 11 (2.3%)* 
Low density area 68 (16.0%) 4 (0.8%)* 
Very low density area 53 (12.5%) 2 (0.4%)* 
Values are absolute numbers (percentages) unless otherwise indicated. a) Numbers do not add up owing to 1 missing 
value in each variable b) Numbers do not add up owing to 5 missing values in this variable.
* Significant p-value <0.05.
Mann-Whitney U test was used for continuous variables and chi-square test for dichotomous variables.
GA: gestational age.
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Table 2 presents the associations between CHDs and periconceptional parental occupational 
exposures to chemicals. The overall prevalence of occupational exposure to chemicals for case 
mothers was 5.0% and 6.2% for control mothers, and for fathers these figures were 22.3%, and 
15.9%, respectively. No association of maternal occupational exposure to chemicals with risk of 
CHDs was found. After adjusting for potential confounders, we found an association between 
paternal occupational exposure to phthalates (adjusted odds ratio (OR) = 2.08; 95% confidence 
interval (CI) 1.27-3.40) and CHDs. When maternal and paternal risk factors were adjusted for 
each other, the ORs remained largely the same.
TaBle 2. Associations between periconceptional parental occupational exposures and CHDs in the offspring
Job exposure matrix exposure prevalence CHDs
Cases
n=424
N (%)
Controls
n=480
N (%)
OR (95% CI)
unadjusted
OR (95% CI)
adjusted
Mothersa
Exposure to: 
Pesticides 6 (1.4%) 9 (1.9%) 0.75 (0.27-2.13) 0.25 (0.05-1.36) 
Phthalates 15 (3.5%) 8 (1.7%) 2.16 (0.91-5.16) 1.95 (0.67-5.61) 
Alkylphenolic compounds 16 (3.8%) 24 (5.0%) 0.75 (0.39-1.42) 0.45 (0.19-1.07) 
Heavy metals 3 (0.7%) 4 (0.8%) 0.88 (0.19-3.81) 1.40 (0.29-6.74) 
Any of these substances 21 (5.0%) 30 (6.2%) 0.78 (0.44-1.39) 0.92 (0.26-3.25) 
Cases
n=421 
N (%) 
Controls 
n=477 
N (%) 
OR (95% CI)
unadjusted 
OR (95% CI)
adjusted 
Fathersb
Exposure to: 
Pesticides 23 (5.5%) 19 (4.0%) 1.39 (0.75-2.60) 0.72 (0.31-1.67) 
Polychlorinated compounds 37 (8.8%) 35 (7.3%) 1.22 (0.75-1.97) 1.72 (0.98-3.02)+ 
Phthalates 63 (15.0%) 45 (9.4%) 1.69 (1.12-2.54)* 2.08 (1.27-3.40)* # 
Alkylphenolic compounds 40 (9.5%) 26 (5.5%) 1.82 (1.09-3.04)* 1.60 (0.85-2.99) 
Heavy metals 25 (5.9%) 19 (4.0%) 1.52 (0.83-2.80) 1.47 (0.71-3.06) 
Any of these substances 94 (22.3%) 76 (15.9%) 1.52 (1.08-2.12)* 1.23 (0.39-3.91) 
a) adjusted for maternal age, educational level, ethnicity, parity, CHD in family, periconception alcohol use, 
periconception medication use, periconception folic acid use, urban density.
b) adjusted for paternal age, educational level, ethnicity, urban density.
* significant, p-value <0.05,
+ p-value <0.10 and >0.05,
# significant after Bonferroni correction p-value < 0.008
OR: odds ratio, CI: confidence interval.
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Table 3 presents the results of the multivariable analysis showing associations between 
paternal occupational exposure to chemicals and separate CHD phenotypes. Paternal occu-
pational exposure to polychlorinated compounds was associated with AVSD (ORadjusted = 
4.22; 95%CI 1.23-14.42), to phthalates was associated with pVSD (ORadjusted = 2.84; 95%CI 
1.37-5.92) and to alkylphenolic compounds was associated with CoA (ORadjusted = 3.85; 95%CI 
1.17-12.67).
Kappa values for maternal exposure to phthalates and alkylphenolic compounds, and 
paternal exposure to polychlorinated compounds and phthalates, were 0.66 and 0.72, respec-
tively. When we adjusted the association between paternal phthalate exposure and CHDs for 
exposure to polychlorinated compounds, the OR changed to 2.39 (95%CI 1.12-5.09) (data not 
shown).
diSCuSSion
This age-matched case-control study suggests that periconceptional occupational exposure 
of the father-to-be to chemicals, in particular phthalates, is associated with an increased occur-
rence of CHDs. Periconceptional maternal occupational exposure to chemicals overall or to 
specific chemicals was not associated with CHDs in the offspring.
Exposure assessment in this study was based on job title and activities, provided by 
fathers and mothers separately. The questionnaire focussed on the periconceptional period, 
and although the questionnaire was filled out approximately 15 months after child birth, the 
researcher verified every answer in a personnel interview. Job characteristics were available in 
TaBle 3. Associations between periconceptional paternal occupational exposure and the risk of separate 
CHD phenotypes in the offspring
Job exposure matrix CHD phenotypes
pVSD (n=113) TOF (n=52) AVSD (n=44) CoA (n=44) TGA (n=63)
Fathersa
Exposure to: 
Pesticides 1.35 (0.44-4.18) 1.46 (0.38-5.69) 0.38 (0.04-3.59) 1.19 (0.25-5.64) 1.00 (0.23-4.35) 
Polychlorinated compounds 2.13 (0.91-5.00)+ 2.45 (0.85-7.00)+ 4.22 (1.23-14.42)* 1.09 (0.25-4.73) 0.94 (0.26-3.37) 
Phthalates 2.84 (1.37-5.92)* 2.32 (0.93-5.76)+ 3.21 (0.98-10.54)+ 1.76 (0.57-5.46) 2.03 (0.76-5.45) 
Alkylphenolic compounds 2.19 (0.89-5.36)+ 2.31 (0.84-6.35) 1.16 (0.24-5.63) 3.85 (1.17-12.67)* 1.80 (0.50-6.55) 
Heavy metals 1.97 (0.69-5.65) 2.71 (0.88-8.41)+ 0.50 (0.04-5.93) 2.40 (0.60-9.60) 0.63 (0.12-3.50) 
Data are OR (95% CI).
a) adjusted for paternal age, educational level, ethnicity, urban density.
* significant, p-value <0.05,
+ p-value<0.10 and >0.05,
# significant after Bonferroni correction p-value <0.002.
pVSD: perimembranous ventricular septal defect, TOF: Tetralogy of Fallot, AVSD: atrioventricular septal defect, CoA: 
coarctation of the aorta, TGA: transposition of the great arteries.
C
h
ap
te
r 
2.
5
144
99.9% of the parents, because work history in general is recalled quite easily. Recall bias is very 
unlikely, as we did not ask for specific exposures but only for a description of the job and, more-
over, the JEM ensures that exposure is classified independently from the outcome i.e. CHD, and 
is blinded to participants. A limitation of a JEM is that it does not account for variability within 
job titles. We tried to reduce the misclassification by assessing exposure based on both job title 
and description of the work tasks. The outcome of this matrix, however, must be interpreted 
cautiously as exposure probabilities are only a crude measure of exposure.
Little is known about potentially harmful environmental factors in the aetiology of CHDs. 
Several other studies investigated associations between occupational hazards, including 
exposure to chemicals, and specific phenotypes of congenital malformations or congenital 
malformations as a group.19,26 Some of these studies found indications for effects of chemicals 
on foetal development but the evidence remains equivocal. The evidence on CHDs in particular 
is scarce. The associations found in this study between the periconceptional paternal occupa-
tional exposure to chemicals and CHDs could possibly be linked to effects of these substances 
on semen quality. Several studies have shown the potential for preconception occupational 
exposure to chemical substances to reduce semen quality.43,44 Chemical exposure might dis-
turb the epigenetic programming during maturation of the sperm cells, which may result in 
derangements in imprinted genes in particular in embryonic tissue, which may subsequently 
lead to birth defects.45-47 Maternal occupational exposure to chemicals might be harmful dur-
ing both maturation of the oocyte and embryogenesis. Exposure to pesticides and bisphenol 
A have been shown to impair growth and development in laboratory animals and possibly in 
humans.48,49
In this case-control study we studied couples with a child with CHD at the time of data collec-
tion, at approximately 15 months after the index pregnancy. This is considered a methodologi-
cal strength of this study because this standardised data collection reduces misclassification in 
the selection of children with and without CHD. Parents of children who were diagnosed with 
a CHD in the first 15 months after birth were invited to participate, ensuring that the majority 
of children with CHD are included in our study, as most congenital malformations are diag-
nosed in the first year of life.50 Potential misclassification of control children cannot be ruled 
out completely because although these children underwent regular physical examinations, 
including cardiac auscultation, they did not undergo doppler echocardiography. Children who 
died because of the CHD before the age of 15 months are not included in the study population, 
which may have led to some selection in the severity of the included CHDs. Probably, this selec-
tion is not associated with exposure to chemicals, and when exposure would be associated 
with the severity of CHDs, the selection may have caused an underestimation of the observed 
effect estimates. The stratified analyses have to be interpreted with caution because of small 
numbers and multiple comparisons. After Bonferroni correction the association between 
phthalate exposure and CHDs remained significant but owing to the small numbers in the phe-
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notype analyses, the association between phthalates and pVSD (p-value 0.005) is just above the 
Bonferroni corrected p-value of 0.002.
To study the effect of possible selective participation among cases and controls, we primar-
ily looked at educational level as a modifier of the observed associations between exposure 
and outcome. This analysis showed that education did not influence the observed associations. 
In addition, we observed that educational level was significantly associated with occupational 
exposure to chemicals, which was independent of case or control status. Therefore, we con-
clude that it is not very likely that selective participation confounded our results.
The exposure to phthalates, polychlorinated compounds and alkylphenolic compounds 
in this study population was related to occupations such as painter, electrician, metalworker, 
woodworker and the agricultural and horticultural trades. As mothers and fathers working in a 
specific occupation can be exposed to multiple chemicals, we calculated agreement between 
the different exposure categories. For mothers we found good agreement between exposure 
to phthalates and alkylphenolic compounds (kappa = 0.66), as mothers are likely exposed to 
both substances within similar jobs. For fathers we also observed good agreement between 
exposure to polychlorinated compounds and phthalates (kappa = 0.72). When we adjusted the 
association between paternal phthalate exposure and CHDs for exposure to polychlorinated 
compounds, the OR changed to 2.39 (95%CI 1.12-5.09). Owing to the interrelationship among 
these exposure groups, we had limited power to disentangle the specific role of phthalates 
and polychlorinated compounds in the observed occurrence of CHDs. Background exposure 
to various chemicals through diet and environment may also occur. However, it is unlikely that 
background exposure with a high prevalence is associated with occupational exposure with a 
low prevalence. Thus, background exposure will most likely not confound the relation between 
occupational chemical exposure and congenital anomalies. Furthermore, the level of exposure 
to chemicals within occupations is generally much higher than background exposure through 
diet and environment.51 We did not assess background exposure, which may have contributed 
to unexplained variance in our outcome CHD, and therefore residual confounding cannot be 
completely ruled out.
Despite the fact that we recruited controls from the same source population in the Nether-
lands as the cases, we acknowledge that the area from which the cases were sampled is larger 
than the region from which the controls were sampled. However, based on the characteristics 
of both areas and populations it is unlikely that this has resulted in selection bias. We did 
observe differences between cases and controls regarding urban density and as the degree of 
urbanisation is related to occupational opportunities, we corrected for the degree of urbanisa-
tion to reduce any potential differences in sampling. There were no significant differences in 
occupational exposure to chemicals across the different centres for case recruitment.
While in the past ten years our knowledge of genetic contributions to CHDs has increased,52 
only a minority can be attributed to heritable genetic defects.28 A review by Kopf and Walker 
shows in animal studies that the developing cardiovascular system is sensitive to many 
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environmental pollutants, such as dioxins, polychlorinated biphenyls and some pesticides.53 
Reviews on the influence of parental occupational exposure on congenital malformations 
have identified a large number of potentially hazardous occupational exposures, most notably 
pesticides, organic solvents and heavy metals.54,55 Previous studies in humans showed associa-
tions between maternal exposure to fungicides or organic solvents and TGA and HLHS in the 
offspring.28,30 A study in Baltimore showed that the proportion of congenital malformations 
that could have been prevented by eliminating known environmental risk factors was small, 
suggesting that many other environmental risk factors remain unknown.56 In future studies 
additional measurements of exposures through biomarkers in human tissues and fluids is 
recommended to give more precise information on the level of exposure to certain chemicals 
and their potential consequences for CHDs.57,58
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ABStRACt
Objective: To study the associations between physically demanding work and occupational 
exposure to chemicals and hypertensive disorders during pregnancy within a large birth cohort 
study, the Generation R Study.
Methods: Associations between occupational characteristics and hypertensive disorders 
during pregnancy were studied in 4465 pregnant woman participating in a population-based 
prospective cohort study from early pregnancy onwards in the Netherlands (2002-2006). Moth-
ers who filled out a questionnaire during mid-pregnancy (response 77% of enrolment), were 
included if they conducted paid employment, had a spontaneously conceived singleton live 
born pregnancy, and did not suffer from pre-existing hypertension (n = 4465). Questions on 
physically demanding work were obtained from the Dutch Musculoskeletal Questionnaire and 
concerned questions on manually handling loads of 25 kg or more, long periods of standing 
or walking, night shifts, and working hours. To assess occupational exposure to chemicals, job 
titles and task descriptions were linked to a job-exposure-matrix (JEM), an expert judgement 
on exposure to chemicals at the workplace. Information on hypertensive disorders during 
pregnancy was obtained from medical records.
results: We observed no consistent associations between any of the work-related risk factors, 
such as long periods of standing or walking, heavy lifting, night shifts, and working hours, nor 
exposure to chemicals with hypertensive disorders during pregnancy.
Conclusion: This prospective birth cohort study suggests that there is no association between 
physically demanding work and exposure to chemicals and hypertensive disorders during 
pregnancy. However, the low prevalence of pregnancy induced hypertension and preeclamp-
sia, combined with the low prevalence of occupational risk factors limit the power for inference 
and larger studies are needed to corroborate of refute these findings.
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intRoduCtion
Hypertensive disorders during pregnancy are among the leading causes of maternal and neona-
tal morbidity worldwide, and include pregnancy induced hypertension (PIH) and preeclampsia.1,2 
PIH and preeclampsia complicate about 7% of all pregnancies3 and severe preeclampsia is a major 
cause of severe maternal morbidity (e.g. stroke and liver rupture) and adverse perinatal outcomes, 
such as prematurity and intrauterine growth restriction.4 Risk factors for PIH and preeclampsia 
include family or obstetric history of preeclampsia, first pregnancy, obesity, higher maternal age, 
pre-existing diabetes, renal disease, hypertension, and chronic autoimmune disease.5-9 Evidence 
for the influence of environmental and occupational factors is contradictory to a few studies 
that have suggested that these factors may play a role in the aetiology of hypertensive disorders 
during pregnancy.10 However, the underlying mechanisms for occupational risk factors, such as 
physically demanding work and exposure to chemicals, are unclear.
Physically demanding work, such as prolonged standing and frequent lifting, may increase 
catecholamine levels11-13 which may affect constriction/dilatation of blood vessels.14 High 
levels of catecholemines have been demonstrated in patients suffering from preeclampsia.15 
Furthermore, increased catecholamine levels are hypothesised to decrease uterine blood flow 
and may therefore influence early placentation.12 Contradictory findings have been reported 
on physically demanding work and occurrence of PIH or preeclampsia. Mozurkewich et al. 
showed in a meta-analysis, based on four studies, that physically demanding work was sig-
nificantly associated with PIH and preeclampsia (OR 1.60, 95%CI 1.30-1.96).16 A more recent 
and larger review by Bonzini et al., based on eight studies, concluded that for preeclampsia 
and PIH, although several positive findings were reported, the evidence base was too limited 
to allow firm conclusions. This second review excluded less articles than Mozurkewich et al., 
and included five more years of research, covering almost twice the number of articles. No 
meta-analysis could be performed, due to the large heterogeneity in exposure definitions, 
and the available evidence was not sufficient to justify mandatory restrictions on any of the 
occupational activities during pregnancy.17 This latter review included some new studies that 
showed modest to no effect of several aspects of physically demanding work, such as working 
hours, standing, lifting, physical activity, and shift work on PIH and preeclampsia.18-23 However, 
a recent study by Haelterman et al., which is not included in either review, showed that pro-
longed standing increased the risk of preeclampsia.24
Occupational exposure to chemicals in relation to hypertensive disorders during pregnancy 
has been rarely studied. Some studies on maternal exposure to chemicals have suggested 
that organic solvents25 and pesticides26 may increase the risk of hypertensive disorders. Based 
on these previous studies, we hypothesised that occupational risk factors, such as physically 
demanding work and exposure to chemicals, may influence the occurrence of PIH or pre-
eclampsia. Since studies on occupational risk factors showed conflicting results, it is unclear 
how working pregnant women should be managed. Further studies are needed to elucidate 
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the role of occupational risk factors in the pathogenesis of PIH and preeclampsia, so that pre-
ventive measures, if needed, can be taken.
The aim of this study was to assess, in a population-based prospective cohort study, the 
associations between physically demanding work and exposure to chemicals with hyperten-
sive disorders during pregnancy.
mAtERiAl And mEtHodS
design and study population
The Generation R Study is a population-based prospective cohort study on growth, development, 
and health from early foetal life until young adulthood in Rotterdam, The Netherlands. The study 
design has been described in detail previously.27 Briefly, all pregnant women who had an expected 
delivery date between April 2002 and January 2006 and living in the study area of Rotterdam were 
invited to participate. In total, 9778 women (response 61%) were enrolled in the study of which 8880 
women during pregnancy and another 898 at the birth of their child. The information required for 
this study was collected in the questionnaire completed during mid-pregnancy (around approxi-
mately 30 weeks of gestation) by 6830 women (77% of enrolment) and information on pregnancy 
complications was obtained from medical records. For this study we selected women who were pre-
natally enrolled, with paid employment before or during pregnancy, with no history of pre-existing 
hypertension (blood pressure ≥140/90 mmHg before 20 weeks of gestation)4 and with a sponta-
neously conceived singleton liveborn pregnancy (n = 4465). Spontaneously conceived refered to 
pregnancies achieved without assisted reproductive techniques, such as ovulation induction or in 
vitro fertilisation. For each mother, we included the first pregnancy within the Generation R cohort 
in our study, since some women participated with more than one child in the study. The flowchart 
of the study population is depicted in Figure 1. The study was approved by the Medical Ethics Com-
mittee at Erasmus University Medical Centre Rotterdam, The Netherlands (MEC 198.782/2001/31).
Written consent was obtained from all participants.
Hypertensive disorders during pregnancy
Information on pregnancy complications was obtained from medical records. Women who 
delivered in hospital and who had chronic hypertension or were reported to have experienced 
PIH (>140/90 mmHg) or hypertension related complications (preeclampsia, proteinuria, 
eclampsia, and/or HELLP syndrome) were selected from hospital registraties. Their individual 
medical records were subsequently studied by qualified medical doctors, who defined preg-
nancy induced hypertension, preeclampsia and eclampsia according to the criteria of the Inter-
national Society for the Study of Hypertension in Pregnancy (ISSHP) and according to those of 
the College of Obstetricians and Gynaecologists (ACOG). Blood pressure measurements were 
performed during pregnancy in early, mid and late pregnancy until gestational week 32-34. 
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Figure 1. Flowchart of the study populationFigure 1: Flowchart of the study population 
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Mothers 9778 
8880 in pregnancy, 898 at birth of their child 
N=6830 women completed questionnaire during mid-
pregnancy 
N=5154 women had paid employment 
N=76 women were 
excluded for twin 
pregnancies 
N=4 women were 
excluded for foetal death 
N=84 women were excluded 
for a pregnancy of non-
spontaneous origin 
N=310 foetuses were 
excluded because mothers 
were already included in the 
study with an earlier 
pregnancy 
N=215 women were 
excluded for pre-existing 
hypertension 
N= 4465 women were included in the analysis 
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Details of these procedures have been described elsewhere.28 Briefly, the following criteria were 
used to identify woman with PIH: development of systolic blood pressure ≥ 140 mmHg and/
or diastolic blood pressure ≥90 mmHg after 20 weeks of gestation in previously normotensive 
women. These criteria plus the presence of proteinuria (defined as two or more dipstick read-
ings of 2+ or greater, one catheter sample reading of 1+ or greater, or a 24-hour urine collection 
containing at least 300 mg of protein) were used to identify woman with preeclampsia.29
occupation and working conditions
The mid-pregnancy questionnaire contained questions about work status, occupation, and 
working conditions and focussed on the periconception and pregnancy period. Work status, 
based on a single question on the current economic status with seven categories (paid labour, 
self-employed, unemployed, disabled, homemaker, student, or other), was used to select 
women with paid employment, consisting of women within the first two categories. This 
question was followed by questions whether the mother had worked before conception in 
this current occupation, and the starting and (optional) stop date of this current occupation. 
We selected women who started working before conception and women who started working 
somewhere during the first trimester of pregnancy. Further questions on job title, type of busi-
ness, name of employer, and activities in the job were used to classify jobs into the Dutch Classi-
fication of Occupations30 and subsequently link these codes to a Job-Exposure-Matrix (JEM) for 
chemical exposure. This new JEM was developed according to a general strategy, comprising 
of a literature search to identify chemicals, information gathering on occupations at risk, and 
literature on occupational settings in which the selected chemicals were encountered and 
exposure measurements were performed. This reference material served as a starting point for 
the expert assessment. Three experts were asked to estimate exposures based on their knowl-
edge of tasks and working environment in various occupations. Finally, exposure probability 
scores were added based on the judgement of three experts. For various chemicals, subjects 
experience a certain level of exposure through diet, environment or widely used consumer 
products. The JEM exposure score refers to the probability of occupational exposure, which is 
assumed to exceed the background level in the general population. The exposure probability 
scores were assigned by means of consensus discussions in which the original scores were 
taken into account where possible, but no prior individual assessments were performed. The 
JEM comprises ten categories of chemicals, namely polycyclic aromatic hydrocarbons (PAH), 
polychlorinated organic compounds, pesticides, phthalates, organic solvents, bisphenol A, 
alkylphenolic compounds, flame retardants, metals, and miscellaneous agents.31 For 353 job 
titles, probability scores were classified into three levels: ‘unlikely’(0), ‘possible’(1), and ‘prob-
able’(2). For this study we collate the last two categories into one category indicating possible 
exposure to chemicals. The category ‘any chemicals’ combines all women exposed to one of 
the groups of chemicals defined in the JEM. Different country specific JEMs have been used 
in various studies, and the JEM is a valuable tool for exposure assessment in epidemiological 
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studies on the health risks of chemical exposure.31-35 The questions on physically demanding 
work were based on the Dutch Musculoskeletal Questionnaire36 and concerned questions on 
manually handling loads of 25 kg or more, long periods of standing, long periods of walking, 
long periods of driving, night shifts, and working hours. These questions were part of the mid-
pregnancy questionnaire distributed around approximately 30 weeks of gestation. A four-point 
scale was used with ratings ‘seldom or never’, ‘occasionally’, ‘often’, and ‘very often’ during a 
regular workday.36 We reclassified long periods of standing and walking into three categories, 
namely ‘seldom or never’, ‘occasionally’, and ‘often/very often’. We reclassified long periods of 
driving, manual handling of load of 25 kg or more and night shifts into two categories, namely 
‘seldom or never’ and ‘occasionally/often/very often’. The number of weekly working hours of 
the mothers with paid employment was assessed by means of an open question, ‘How many 
hours per week do you work?’. Working hours were categorised into ‘1-24’, ‘25-39’, and ‘40 or 
more hours a week’.37
Potential confounders
The following variables were considered as possible confounders in the association between 
physically demanding work, exposure to chemicals and hypertensive disorders during preg-
nancy: maternal age, pre-pregnancy weight, height, educational level, ethnicity, parity, smok-
ing, alcohol use, and folic acid supplement use. Information about maternal age, educational 
level, ethnicity, parity, and folic acid supplement use was obtained by questionnaire at enrol-
ment in the study. Maternal smoking habits and alcohol use were assessed in three prenatal 
questionnaires in each trimester and classified into three categories, namely no smoking or 
alcohol use, smoking or alcohol use until pregnancy was known, and smoking or alcohol use 
during pregnancy.38 Maternal height was measured at intake in the study. Body mass index 
(BMI) was calculated as weight divided by squared height.
Statistical analysis
We used bivariable and multivariable logistic regression analyses to study the association 
between maternal characteristics, occupational risk factors and hypertensive disorders during 
pregnancy. We reclassified age, a continuous variable, into four categories for ease of inter-
pretation. Individual characteristics significantly associated with PIH or preeclampsia were 
considered for the multivariable analyses. The final model consisted of the following confound-
ers: maternal age, educational level (both included by default), ethnicity, parity, and BMI. Two 
sensitivity analyses were carried out, first we stratified the analyses for Dutch versus non-Dutch 
women, secondly we assessed whether women who quitted working before 34 weeks of gesta-
tion because of pregnancy complaints had a higher risk of PIH or preeclampsia. This informa-
tion on the gestational week women stopped working was available for 3537 women (68.6%). 
Missing values in confounders were handled by multiple imputations (fully conditional speci-
fication, Markov Chain Monte Carlo method) by generating five independent datasets for all 
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analyses, using SPSS version 17.0 for windows. Variables included in the imputation procedure 
(these variables were both imputed and used as predictors of missing data) were: maternal 
age, educational level, ethnicity, parity, pre-pregnancy weight, height at intake, smoking dur-
ing pregnancy, alcohol use during pregnancy, folic acid supplement use, foetal gender, and 
gestational age at birth. Table 1 presents the proportion of missing values for each variable that 
was imputed. All multivariable analyses were performed with the multiple imputation datasets, 
and pooled estimates were calculated across these five independent datasets. The maximal 
allowed threshold for imputations was set on a maximum of missing values of 30%.39 All logistic 
regression analyses were performed using Statistical Package of Social Sciences version 17.0 for 
Windows (SPSS Inc, Chicago, IL, USA).
RESultS
The characteristics of the study population are shown in Table 1. Age at enrolment ranged from 
17.0 to 46.0 years with a mean age of 31.1 years. The largest ethnic group was from Dutch 
origin (63.7%), and Surinamese and Dutch Antillean women (8.1%), and Turkish and Moroccan 
women (7.2%) were less represented. The prevalence of PIH and preeclampsia in our study 
population was 1.8% (79 cases) and 1.3% (60 cases), respectively. The occupational characteris-
tics are presented in Table 2.
The bivariable analysis in Table 3 shows associations between individual characteristics and 
hypertensive disorders during pregnancy. Multiparous women were at lower risk for both PIH 
and preeclampsia. Compared to Dutch mothers, women from other ethnic minorities showed 
a lower risk on PIH (OR 0.47; 95%CI 0.23-0.94). For preeclampsia, we observed that Surinamese 
and Dutch Antillean women showed a significantly higher risk of preeclampsia (OR 2.23; 95%CI 
1.08-4.57). Overweight and obese mothers had increased risks of PIH and preeclampsia. Smok-
ing and alcohol consumption were not associated with PIH or preeclampsia.
Table 4 shows the bivariable and multivariable logistic regression analyses between occupa-
tional risk factors and hypertensive disorders during pregnancy. There were no consistent asso-
ciations between physically demanding work and chemical exposure with hypertensive disorders 
during pregnancy. For almost all risk factors related to physically demanding work we could not 
find a clear exposure-response relation, and women ‘often’ exposed to a certain occupational risk 
factor were not consistently at higher risk for hypertensive disorders during pregnancy compared 
to women who were ‘occasionally’ exposed. When we restricted the analysis to primigravidous 
women (63% of the study population), the effect estimates remained very similar to the presented 
effect estimates in Table 4 (data not shown). Furthermore, there were no differences in effect 
estimates between Dutch and non-Dutch women. Women quitting their job before 34 weeks of 
gestation were significantly at higher risk of PIH (OR 1.81; 95%CI 1.04-3.14) and at higher risk of 
preeclampsia (OR 1.92; 95%CI 0.96-3.84), although not statistically significant (data not shown).
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TaBle 1. Baseline characteristics of pregnant women participating in a birth cohort study, the Generation 
R Study (n = 4465)
Maternal characteristics results
Age at intake (years) 31.09 (4.5)
Weight before pregnancy (kg) 69.35 (12.44) 
Height measured at intake (cm) 168.78 (7.14) 
Educational level Low 611 (13.7%) 
Mid-low 1273 (28.5%) 
Mid-high 1076 (24.1%) 
High 1365 (30.6%) 
Missing 140 (3.1%) 
Ethnicity Netherlands 2845 (63.7%) 
Surinam and Dutch Antilles 360 (8.1%) 
Morocco and Turkey 322 (7.2%) 
Other 847 (19.0%) 
Missing 91 (2.0%) 
Parity Nulliparous 2826 (63.3%) 
Multiparous 1520 (34.0%) 
Missing 119 (2.7%) 
Body Mass Index (BMI) <25 kg/m2 2724 (61.0%) 
25-30 kg/m2 1016 (22.8%) 
>30 kg/m2 380 (8.5%) 
Missing 345 (7.7%) 
Smoking No 2899 (64.9%) 
Yes, until pregnancy was known 332 (7.4%) 
Yes, during pregnancy 519 (13.8%) 
Missing 715 (16.0%) 
Alcohol No 1459 (32.7%) 
Yes, until pregnancy was known 559 (12.5%) 
Yes, during pregnancy 1757 (39.4%) 
Missing 690 (15.5%) 
Folic acid use No 555 (12.4%) 
Yes, post conception start 1097 (24.6%) 
Yes, preconception start 1662 (37.2%) 
Missing 1151 (25.8%) 
Hypertensive disorders during pregnancy Preeclampsia 60 (1.3%) 
Pregnancy induced hypertension 79 (1.8%) 
Values are means (SD) for normally distributed continuous variables or medians (minimum–maximum) for skewed 
distributed continuous variables, and absolute numbers (percentages) for categorical variables.
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TaBle 2. Occupational characteristics of pregnant women participating in a birth cohort study, the 
Generation R Study (n = 4465)
Occupational characteristics results
Long periods of standing No 2329 (52.2%)
Occasionally 881 (19.7%) 
Often/very often 840 (18.8%) 
Missing 415 (9.3%) 
Long periods of walking No 2036 (45.6%) 
Occasionally 1399 (31.3%) 
Often/very often 634 (14.2%) 
Missing 396 (8.9%) 
Long period of driving No 3499 (78.4%) 
Occasionally/often/very often 572 (12.8%) 
Missing 394 (8.8%) 
Lifting or carrying weights >25kg No 3815 (85.4%) 
Occasionally/often/very often 267 (6.0%) 
Missing 383 (8.6%) 
Night shift (each month) No 3892 (87.2%) 
Occasionally/often/very often 188 (4.2%) 
Missing 385 (8.6%) 
Working hours <25 hours per week 1163 (26.0%) 
25-39 hours per week 2112 (47.3%) 
>40 hours per week 1040 (23.3%) 
Missing 150 (3.4%) 
Exposure to chemicals (JEM) PAH 55 (1.2%) 
Pesticides 22 (0.5%) 
Phthalates 65 (1.5%) 
Organic solvents 213 (4.8%) 
Alkylphenolic compounds 150 (3.4%) 
Metals 51 (1.1%) 
Any chemicals 297 (6.7%) 
Values are means (SD) for normally distributed continuous variables or medians (minimum–maximum) for skewed 
distributed continuous variables, and absolute numbers (percentages) for categorical variables.
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TaBle 3. Associations in a birth cohort study among pregnant women on maternal individual 
characteristics and hypertensive disorders during pregnancy
Maternal characteristics PiH
OR (95% CI)
Preeclampsia
OR (95% CI)
Age before intake <25 years 1.00 1.00
25-29 years 2.07 (0.79-5.46) 2.39 (0.82-6.95) 
30-35 years 1.70 (0.66-4.37) 1.67 (0.58-4.81) 
>35 years 2.19 (0.80-6.01) 1.20 (0.35-4.11) 
Educational level Low 0.82 (0.39-1.72) 1.91 (0.90-4.07) 
Mid-low 1.05 (0.61-1.82) 1.77 (0.92-3.40) 
Mid-high 0.82 (0.44-1.51) 0.53 (0.19-1.44) 
High 1.00 1.00 
Ethnicity Netherlands 1.00 1.00 
Surinam and Dutch Antilles 0.71 (0.31-1.67) 2.23 (1.08-4.57)* 
Morocco and Turkey 0.26 (0.06-1.05) 1.29 (0.50-3.34) 
Other 0.47 (0.23-0.94)* 1.10 (0.55-2.20) 
Parity Nulliparous 1.00 1.00 
Multiparous 0.55 (0.33-0.94)* 0.21 (0.09-0.49)** 
Body Mass Index (BMI) <25 kg/m2 1.00 1.00 
25-30 kg/m2 2.86 (1.66-4.93)** 2.19 (1.26-3.80)* 
>30 kg/m2 7.96 (4.57-13.88)** 2.20 (1.00-4.84) 
Smoking No 1.00 1.00 
Yes, until pregnancy was known 0.92 (0.39-2.17) 0.37 (0.09-1.54) 
Yes, during pregnancy 0.99 (0.48-2.01) 0.81 (0.36-1.80) 
Alcohol No 1.00 1.00 
Yes, until pregnancy was known 0.98 (0.50-1.92) 0.99 (0.45-2.16) 
Yes, during pregnancy 0.85 (0.51-1.42) 0.89 (0.51-1.57) 
Folic acid use No 1.00 1.00 
Yes, post conception start 1.61 (0.74-3.51) 1.16 (0.52-2.55) 
Yes, preconception start 1.44 (0.69-3.01) 1.00 (0.48-2.11) 
*p<0.05 **p<0.01
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diSCuSSion
In this large population-based prospective birth cohort study we were not able to find a 
consistent association between physically demanding work and exposure to chemicals with 
hypertensive disorders during pregnancy. These results suggest that there is no effect of occu-
pational risk factors on the occurrence of hypertensive disorders during pregnancy. The main 
limitation of this study is the limited number of women with PIH or preeclampsia and the low 
prevalence of exposure to chemicals.
The findings in our study corroborates with the conclusions from a recent review that the 
available evidence on the presence of an association between physically demanding work and 
PIH or preeclampsia was not sufficient to propose restrictions in activities during pregnancy.17 
However, another review reported a clear association between physically demanding work 
during pregnancy and preeclampsia.16 We hypothesised that the contradictory findings in 
the scientific literature may be partly due to heterogeneity in the definition of PIH and pre-
eclampsia across studies, and also in the definitions of physically demanding work, which 
makes comparisons difficult. In our study, we used strict criteria to assess hypertensive com-
plications during pregnancy. Medical records were checked and the diagnosis was made by 
qualified medical doctors. The low prevalence of these disorders in our study population can 
be explained by the strict criteria for diagnosis. Furthermore, blood pressure measurements 
in our study were performed until gestational week 32-34. Thereafter, medical records were 
checked for the occurrence of PIH and preeclampsia, this might have led to a lower incidence of 
PIH, since this disease may have no clear pattern of symptoms, and often, hospital admission is 
not required. Another explanation for the low prevalence may be the selection of women with 
paid employment, since these women generally have better pregnancy outcomes than women 
without paid employment.32,37 In our analyses, we choose women with paid employment, to 
avoid ‘health worker bias’.37 Furthermore, women with pregnancy complications may quit their 
job earlier during pregnancy than healthy women, and technically these women would be 
on sick leave. The sensitivity analyses on women who reported stopping working before 34 
weeks because of pregnancy complaints showed that these women were at higher risk of PIH 
and preeclampsia. However, quitting before 34 weeks of gestation was not associated with 
physically demanding work nor exposure to chemicals and, thus, will not have influenced 
the reported associations. Since women from ethnic minorities may also have higher risks of 
adverse pregnancy outcomes, we carried out stratified analyses, however, effect estimates were 
comparable, indicating no differences.
For occupational exposure to chemicals and hypertensive disorders during pregnancy, 
the evidence is scarce and contradictory. Irwin et al. found no relation between occupational 
exposure to chemicals and hypertensive disorders during pregnancy,18 whereas Eskenazi and 
Saldana reported associations between solvents and pesticides with PIH and preeclampsia.25,26 
In our study, exposure to pesticides showed an increased risk of preeclampsia (OR 3.15; 95%CI 
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0.38-25.94). However, this was not statistically significant, probably due to the low number of 
women exposed to pesticides (n = 23). We must conclude that the prevalence of occupational 
exposure to chemicals in the general population is very low, and, thus, the proportion of PIH 
and preeclampsia attributable to occupational exposure will be low.
One of the suggested mechanisms through which physically demanding work could lead 
to hypertensive disorders during pregnancy is an increased uteroplacental vascular resistance 
which follows physical exertion.40 Physically demanding work may cause an increase in cat-
echolamine levels, which may lead to a decreased uterine blood flow and therefore may induce 
PIH and preeclampsia.12 It has also been suggested that part of the excess catecholamine 
release is due to an overactive sympatic nerve system.41 For exposure to chemicals, the underly-
ing mechanisms are largely unclear.
Exposure assessment is an important issue in this study. For assessment of maternal expo-
sure to chemicals we used a recently updated Job-Exposure-Matrix (JEM).31-35 This approach 
assured that exposures status was blinded to participants and researchers, both aspects which 
avoid information bias. The characterisation of exposure in the JEM must be interpreted as 
exposure probabilities. However, if misclassification occurred, this is most likely non-differential 
misclassification, leading to underestimation of the effect estimates. A major drawback of JEMs 
is that they do not account for variability in tasks and working environments within job titles. 
Furthermore, the JEM does not contain specific chemicals, but only contains broad groups 
of chemicals, and the mechanisms of action can vary between specific chemicals in a group. 
However, from the task description, it may become clear that some subjects within a specific 
job title, for example subjects who have odd jobs around a farm (feeding animals) are less 
likely to be exposed to pesticides. Background exposure to various chemicals through diet and 
environment may occur. However, it is unlikely that background exposure is associated with 
occupational exposure, thus, background exposure will not confound the relation between 
occupational chemical exposure and hypertensive disorders during pregnancy. Furthermore, it 
is expected that levels of exposure to chemicals within occupations are generally much higher 
than general exposure through diet and environment. Since we did not assess background 
exposure, it may have contributed to unexplained variance in the outcome hypertensive dis-
orders during pregnancy. In our study we classified physically demanding work in three or two 
relevant levels of exposure, however, this approach does not quantify the exposure into hours 
of physically demanding work performed per day, and therefore is at best a semi-quantitative 
measure. Furthermore, this study did not take into account other sources of physically demand-
ing activities outside employment, such as exercise, housework, and volunteer work. However, 
it is unlikely that these activities are strongly related to physically demanding work risk factors, 
but they may lead, in some extent, to residual confounding.
In order to assess whether there was any overlap between the occupational risk factors in 
this study, we calculated kappa values for all exposure categories. Kappa values ranged from 
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0.00-0.18, indicating that there was almost no overlap between physically demanding work 
and exposure to chemicals in the workplace.
The strength of this study is the population-based approach with recruitment during the 
prenatal period and the availability of a large number of potential risk factors. Within the 
Generation R cohort, Bakker et al. showed that smoking during the first trimester is associ-
ated with maternal cardiovascular adaptations during pregnancy.42 Gaillard et al. showed that 
there is a strong relation between obesity and PIH and preeclampsia.43 Thus, in our analysis 
we could adjust for these well-established risk factors. A limitation of this study is the selec-
tive participation whereby mothers from ethnic minorities, those with lower socio-economic 
status, and mothers or children with medical complications, were less represented in the 
study population than expected in the population of Rotterdam.44 This non-response will lead 
to biased effect estimates if the association between physically demanding work, chemical 
exposure and hypertensive disorders during pregnancy differs between participants and non-
responders. However, this seems unlikely since biased estimates in large cohort studies mainly 
arise from loss to follow up rather than from non-response at baseline.45 Selective participation 
may have influenced the prevalence of exposure to physically demanding work and chemicals, 
but bias is unlikely since physically demanding work and exposure to chemicals was assessed 
independently from and prior to the hypertensive disorders during pregnancy. Although we 
were able to control for a large number of potential confounders, residual confounding cannot 
be ruled out completely. Recall bias in this study is unlikely, since the information obtained was 
not biased by the outcome since the questionnaire was completed in mid-pregnancy. In this 
study we used multiple imputation for missing values in covariates. This reduces bias due to 
non-random missing in the covariates.
In summary, this large population-based birth cohort study suggests that physically 
demanding work and exposure to chemicals did not influence the occurrence of hypertensive 
disorders during pregnancy. However, the very low prevalence of PIH and preeclampsia in our 
study, combined with the low prevalence of occupational risk factors, may have resulted in too 
little discriminatory power to detect such associations.
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ABStRACt
Objectives: Work-related risk factors, such as long work hours, and physically demanding work 
have been suggested to adversely influence pregnancy outcome. The authors aimed to exam-
ine associations between various aspects of physically demanding work with foetal growth in 
different trimesters during pregnancy and the risks of adverse birth outcomes.
Methods: Associations between physically demanding work and foetal growth were studied 
in 4680 pregnant women participating in a population-based prospective cohort study from 
early pregnancy onwards in the Netherlands (2002-2006). Mothers who filled out a question-
naire during mid-pregnancy (response 77% of enrolment), were included if they conducted 
paid employment and had a spontaneously conceived singleton live born pregnancy. Ques-
tions on physical work load were obtained from the Dutch Musculoskeletal Questionnaire and 
concerned questions on lifting, long periods of standing or walking, night shifts, and working 
hours. Foetal growth characteristics were repeatedly measured by ultrasound and were used in 
combination with measurements at birth.
results: There were no consistent significant associations between physically demanding work 
nor working hours in relation to small-for-gestational-age, low birth weight or preterm delivery. 
Women exposed to long periods of standing had lower growth rates for foetal head circumfer-
ence, resulting in a reduction of approximately 1 cm (3%) of the average head circumference 
at birth. Compared with women working <25 hours per week, women working 25-39 hours 
per week, and > 40 hours per week had lower growth rates for both foetal weight and head 
circumference, resulting in a difference of approximately 1 cm in head circumference at birth 
and a difference of 148-198 grams in birth weight.
Conclusion: Long periods of standing and long working hours per week during pregnancy 
seem to negatively influence intrauterine growth.
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intRoduCtion
Developmental diseases, such as structural birth defects, functional alterations, growth restric-
tions, and preterm delivery account for more than 25% of infant mortality and morbidity.1,2 
Environmental exposures and lifestyle behaviours act at different stages of foetal development 
and may result in adverse birth outcomes, such as preterm birth, low birth weight, small-for-
gestational-age, certain congenital defects, and foetal death.3-5 Although women in paid 
employment seem to have better pregnancy outcomes than those without paid jobs,6-8 certain 
work-related risk factors, such as exposure to chemicals,9 long working hours,7,10 high physical 
work load, prolonged standing,11 and psychological job strain12,13 have been suggested to 
adversely influence pregnancy outcome.
Two reviews have summarised the literature on physical workload and adverse pregnancy 
outcomes. Mozurkewich et al. performed a meta-analyses on 29 studies, and concluded 
that physically demanding work may significantly increase risks of preterm delivery (pooled 
OR 1.22; 95%CI 1.16-1.29), small-for-gestational-age (pooled OR 1.37; 95%CI 1.30-1.44), and 
hypertension or preeclampsia (pooled OR 1.60; 95%CI 1.30-1.96).14 A review by Bonzini et al. on 
49 studies described the relation between five common occupational exposures (prolonged 
working hours, shift work, lifting, standing and heavy physical work load) and three major 
adverse outcomes, namely preterm delivery, low birth weight, and preeclampsia/gestational 
hypertension.15 Due to the small effects, low population attributable fractions, and conflicting 
results, mandatory restrictions were not justified.
Variations in study findings may be due to differences in exposure assessment, definitions 
of physical work load and components of indices that were used to score physical workload 
and timing during pregnancy, the same activity may carry different risks if it occurred late in 
pregnancy compared with only a few weeks after conception. Despite the substantial body of 
evidence on physically demanding work and birth outcomes, it is still unclear how occupational 
activities of pregnant women should be managed. Furthermore, studies on physically demand-
ing work have primarily focussed on adverse birth outcomes, which are important from an 
obstetric point of view, but are rather crude measures of foetal growth. To gain more insight in 
how physically demanding work influences birth outcomes, studies on foetal growth charac-
teristics during pregnancy are needed in order to identify critical periods in which exposure is 
deleterious for foetal growth and development.
The aims of this study were to examine associations between various aspects of physically 
demanding work with foetal growth in different trimesters during pregnancy and the risks of 
adverse birth outcomes.
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mAtERiAlS And mEtHodS
Study design
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from foetal life until young adulthood in Rotterdam, the Netherlands.16,17 Briefly, all preg-
nant women who had an expected delivery date between April 2002 and January 2006 and 
lived in the study area of Rotterdam were invited to participate. In total, 9778 pregnant women 
(response 61%) were enrolled in the study of which 8880 women were enrolled during preg-
nancy and another 898 at birth of their child. Extensive assessments were carried out in each 
trimester, including physical examinations, questionnaires, interviews, and biological samples. 
The study was approved by the Medical Ethics Committee at Erasmus University Medical Centre 
Rotterdam, The Netherlands (MEC 198.782/2001/31).
The occupational information required for this study was collected in the questionnaire 
completed during mid-pregnancy (send out at 30 weeks of gestation), which was filled out by 
6830 women (77% of enrolment). The mean gestational age for completing the questionnaire 
was 30.8 weeks (standard deviation 2.4 weeks). For this study we selected women who were 
prenatally enrolled, with paid employment at the time of the questionnaire (5154 women), and 
we excluded women with twin pregnancies (76 women), with pregnancies of non-spontaneous 
origin (84 women), and with foetal death (4 women). For each woman we included the first 
pregnancy within the Generation R cohort in our study, excluding women that participated 
more than once (310 women). The population for analysis consisted of 4680 women, the flow-
chart of the study population in depicted in Supplement 1.
foetal ultrasounds
For this study we used the ultrasound measures of foetal head circumference, and estimated 
foetal weight, since these measures are essential characteristics to describe foetal growth. In 
our research facility, we measured foetal head circumference (HC), abdominal circumference 
(AC), and femur length (FL) to the nearest millimetre using standardised ultrasound procedures 
in the second (median 20.5, minimum-maximum 18.0-25.0 weeks) and third (median 30.4, 
minimum-maximum 25.8-37.0 weeks) trimester. Since use of the last menstrual period for preg-
nancy dating has several limitations,18 and a large number of women in our study population 
did not know the exact date of their last menstrual period (76%), we used crown-rump length 
for pregnancy dating until a gestational age of 12 weeks (2308 women) and biparietal diameter 
for pregnancy dating thereafter (2372 women) in all women.19,20 First trimester measurements 
(3459 women) were primarily used to establish gestational age and therefore not included 
in the growth analyses. Estimated foetal weight (EFW) was calculated using the formula by 
Hadlock et al.21 The intraclass correlation coefficient of foetal growth measurements was 0.95, 
tested on 21 subjects.22
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Verburg et al. showed that foetal growth reference curves for foetal weight and foetal head 
circumference during pregnancy typically have a parabolic pattern. Based on these reference 
curves, standard deviation (SD) scores for all growth characteristics were constructed,18 reflect-
ing the commonly used z-scores for child growth as proposed by the World Health Organisa-
tion.23 The SD score indicates the relative position of the foetus on the observed distribution, 
for example a SD score of one for foetal head circumference indicates for that particular child 
his HC measurement is larger than approximately 84% of all children. This approach enables 
linear analyses of the foetal growth characteristics since the reference curve is a curve with a 
mean SD score of 0.
Birth outcomes
Information about gender at birth, gestational age, weight, length, and head circumference at 
birth was obtained from medical records and hospital registries. Low birth weight was defined 
as birth weight <2500 gram. Small-for-gestational-age at birth was defined as a gestational 
age adjusted birth weight below the 5th percentile in the whole study cohort (n = 8880) (<-1.71 
standard deviation), and preterm birth was defined as a gestational age at <37 weeks at birth.
occupation and working conditions
The mid-pregnancy questionnaire (send out at 30 weeks of gestation) contained questions 
about work status, occupation, and working conditions and focussed on the periconception 
and pregnancy period. The question on current work status, with seven categories (paid labour, 
self-employed, unemployed, disabled, homemaker, student or other), was used to select 
women with paid employment. The question on starting date of the current occupation pro-
vided information if women started working before pregnancy or somewhere during the first 
trimester of pregnancy. For the current study we both selected women with paid employment 
who started before pregnancy, and women who started working during the first trimester.
The number of weekly working hours of the mothers with paid employment was assessed 
by means of an open question, ‘How many hours per week do you work?’. Working hours were 
categorised into ‘1-24’, ‘25-39’, and ‘40 or more hours a week’.7 The questions on physical work-
load were obtained from the Dutch Musculoskeletal Questionnaire and concerned questions 
on manually handling loads of 25 kg or more, long periods of walking, long periods of standing, 
and night shifts. A four-point scale was used with ratings ‘seldom or never’, ‘occasionally’, ‘often’, 
and ‘very often’ during a regular workday. These factors were all considered as separate vari-
ables in the analyses, since multicollinearity was not present (Spearman’s correlation coefficient 
r = -0.14 to 0.23) except for long periods of standing and walking (r = 0.56). We reclassified long 
periods of walking and standing, manual handling of load of 25 kg or more and night shifts 
into three categories, namely ‘seldom or never’ (reference group), ‘occasionally’, and ‘often/very 
often’.24,25 In a postnatal questionnaire we collected information in which pregnancy week 
women had stopped working, and whether this was due to pregnancy complaints.
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Potential confounders
The following variables were considered as possible confounders: maternal age, pre-pregnancy 
weight, height, educational level, ethnicity, parity, smoking, alcohol use, and folic acid supple-
ment use. Information about maternal age, educational level, ethnicity, parity, and folic acid 
supplement use was obtained by questionnaire at enrolment in the study. Maternal smoking 
habits and alcohol use were assessed on the basis of three questionnaires in each trimester 
and classified as no, until pregnancy was known, or during pregnancy.26,27 Maternal height was 
measured at intake in the study.
Statistical analyses
The associations between occupational risk factors and the risk of preterm delivery, small-for-
gestational-age, and low birth weight were analysed with multiple logistic regression analyses. 
In all analyses, the reference group consisted of women who were not exposed to that particu-
lar physical risk factor. Second, cross-sectional analyses were performed using linear regression 
analysis to demonstrate the influence of physically demanding work on head circumference, 
abdominal circumference and estimated foetal weight in the second and third trimester of 
pregnancy, respectively. Third, occupational risk factors associated with birth outcomes were 
selected for the longitudinal analyses of head circumference, and weight (second- and third 
trimester estimated foetal weight and birth weight) using unbalanced repeated measurement 
analysis, which enables optimal use of the available data, taking into account correlations 
within subjects and assessing both time dependant and independent associations. In these lin-
ear longitudinal models, we used standard deviation (SD) scores as parameter of foetal growth 
(dependent variable). The final model can be written as follows (e.g., for foetal weight): SD score 
of foetal weight = ß0 + ß1 x gawks + ß2 x exposuregroup + ß3 x gawks x exposuregroup (gawks 
= gestational age in weeks). In this model, ß0 reflects the intercept and ß2 x exposuregroup 
tests the difference in intercept between exposed and non-exposed group. The coefficient ß3 
reflects the slope (interaction of exposure with gestational age), and tests whether the groups 
of exposed and non-exposed grow at the same rate over time. The latter coefficient is the main 
interest for this article, since this beta represents the average decline or increase in SD for foetal 
weight per gestational week for exposed women versus non-exposed women. The regression 
models were adjusted for lifestyle and socioeconomic confounders used in previous studies 
on maternal occupational exposure6 and known determinants of foetal growth: maternal age, 
educational level, ethnicity, parity, pre-pregnancy weight, height at intake, smoking during 
pregnancy, alcohol use during pregnancy, folic acid supplement use, and foetal gender.
Missing values in confounders were handled by multiple imputations (fully conditional 
specification, Markov Chain Monte Carlo method) by generating five independent datasets for 
all analyses, using SPSS version 17.0 for windows. Variables included in the imputation proce-
dure (these variables were both imputed and used as predictors of missing data) were: mater-
nal age, educational level, ethnicity, parity, pre-pregnancy weight, height at intake, smoking 
 Physically demanding work, foetal growth, and adverse birth outcomes 179
TaBle 1. Baseline characteristics of the study population (n = 4680)
Variables results
Age at intake (yr) 31.08 (4.56) 
Weight before pregnancy (kg) 64.00 (34.00-145.00) 
Height measured at intake (cm) 168.80 (7.12) 
Educational level Low 653 (14.0%) 
Mid-low 1333 (28.5%) 
Mid-high 1129 (24.1%) 
High 1419 (30.3%) 
Missing 146 (3.1%) 
Ethnicity Netherlands 2993 (64.0%) 
Surinam and Dutch Antilles 380 (8.1%) 
Morocco and Turkey 328 (7.0%) 
Other 885 (18.9%) 
Missing 94 (2.0%) 
Parity Nulliparous 2992 (63.9%) 
Multiparous 1565 (33.4%) 
Missing 123 (2.6%) 
Smoking Yes, during pregnancy 546 (11.7%) 
Yes, until pregnancy was known 355 (7.6%) 
No 3031 (64.8%) 
Missing 748 (16.0%) 
Alcohol Yes, during pregnancy 1846 (39.4%) 
Yes, until pregnancy was known 587 (12.5%) 
No 1524 (32.6%) 
Missing 723 (15.4%) 
Folic acid use No 580 (12.4%) 
Yes, post conception start 1163 (24.9%) 
Yes, preconception start 1735 (37.1%) 
Missing 1202 (25.7%) 
Maternal occupational 
characteristics 
Long periods of standing, occasionally 920 (19.7%) 
Long periods of standing, often 883 (18.9%) 
Long periods of walking, occasionally 1467 (31.3%) 
Long periods of walking, often 665 (14.2%) 
Lifting > 25kg, occasionally 217 (4.6%) 
Lifting > 25kg, often 70 (1.5%) 
Night shifts, occasionally 137 (2.9%) 
Night shifts, often 60 (1.3%) 
Work hours 1-24 hours/week 1193 (25.5%) 
Work hours 25-39 hours/week 2222 (47.5%) 
Work hours > 40 hours/week 1087 (23.2%) 
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during pregnancy, alcohol use during pregnancy, folic acid supplement use, foetal gender, and 
gestational age at birth. Table 1 presents the proportion of missing values for each variable that 
was imputed. All multivariable analyses were performed with the multiple imputation datasets, 
and pooled estimates were calculated across these five independent datasets. The maximal 
allowed threshold for imputations was set on a maximum of missings values of 30%. However, 
missing values for parameters of physically demanding work were not imputed and, thus, the 
analysis on each exposure of interest was based on slightly different number of subjects due to 
some missing values.
In total, three sensitivity analyses were performed, the first to evaluate whether women who 
started working before conception differed from women who started working during the first 
trimester, the second to analyse whether women with a certain last menstrual period and regu-
lar cycle differed from women whose pregnancy was dated by means of an ultrasound, and the 
third to study the influence of the subgroup of women who stopped working before 34 weeks 
of gestation because of pregnancy complaints. Results from the logistic regression analyses on 
birth outcomes were used to estimate population attributable fractions (PAFs), expressing the 
proportion of the adverse health outcomes in the general population that is attributable to the 
risk factors of interest.28 The repeated measurement analyses were conducted with the Proc 
Mixed module of the Statistical Analysis System (version 9.2; SAS Institute Inc, Cary NC).
TaBle 1. Baseline characteristics of the study population (n = 4680) (continued)
Variables results
Growth outcomes Second trimester ultrasonography 4197 (89.7%) 
Third trimester ultrasonography 4294 (91.8%) 
Birth outcomes Gestational age at birth (wk) 40.14 (22.71-43.43) 
Birth weight (grams) 3449.81 (549.28) 
Male 2365 (50.5%) 
Head circumference at birth (mm) 33.89 (1.65) 
Length at birth (mm) 50.33 (2.38) 
Low birth weight (<2500 g) Yes 203 (4.3%) 
No 4674 (99.9%) 
Missing 6 (0.1%) 
Small for gestational age (<-1.7 SD) Yes 201 (4.3%) 
No 4463 (95.7%) 
Missing 16 (0.3%) 
Preterm delivery (<37 weeks of 
gestation) 
Yes 231 (4.9%) 
No 4449 (95.1%) 
Values are means (standard deviation) for normal distributed continuous variables or medians (minimum-maximum) for 
skewed distributed continuous variables, and absolute numbers (percentages) for categorical variables.
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RESultS
Table 1 shows the baseline characteristics of the study population. In total, 38.6% of the women 
were exposed to long periods of standing at work, 45.5% to long periods of walking at work, 
and 6.1% to heavy lifting at work. About 4.2% of the women regularly worked night shifts. 
Part-time jobs were common among women, since 47.5% worked 25-39 hours per week, 25.5% 
worked less than 25 hours per week, and 23.2% worked more than 40 hours per week.
Table 2 shows the associations between maternal occupational exposure to physically 
demanding work and adverse birth outcomes. There were no consistent associations between 
physically demanding work, long working hours and adverse birth outcomes. Furthermore, 
there was no clear dose-response relation, and women often exposed to a certain occupational 
risk factor were not consistently at higher risk for adverse birth outcomes. In these multivariable 
models with adverse birth outcomes, the following confounders significantly influenced the 
outcome (in descending order of magnitude): maternal age, pre-pregnancy weight, height at 
intake, parity, ethnicity, smoking and folic acid use. Joint effects of several physically demand-
ing work risk factors and working hours were investigated, however, we did not found any 
statistically significant joint effect on adverse birth outcomes (data not shown).
Table 3 shows the cross-sectional analyses between long periods of standing, lifting > 25 
kg, and working hours with head circumference, abdominal circumference and estimated 
foetal weight during the second (~20 weeks of gestation) and third (~30 weeks of gestation) 
trimester in pregnancy. After adjustment for potential confounders, no associations of physi-
cally demanding work or working hours with foetal growth characteristics during the second 
trimester were found. In the third trimester of pregnancy, after adjustments for potential 
confounders, long periods of standing was significantly associated with a decreased foetal 
head circumference. For working hours we observed effects on abdominal circumference and 
estimated foetal weight, however, after adjustment for potential confounders, these effects did 
not remain statistically significant.
Figures 1 and 2 show the association between long periods of standing and working hours 
on longitudinally measured growth (foetal weight and foetal head circumference). Long peri-
ods of standing at work were associated with slower growth rates in head circumference (-0.32 
SD and -0.33 SD at birth), which corresponds to approximately 1 cm difference (3%) compared 
to the average head circumference of 33.9 cm at birth. Women working >25 hours per week 
showed reduced foetal growth rates in both domains of foetal growth, namely foetal weight 
and head circumference. In these models, educational level and ethnicity significantly influ-
enced foetal growth, but did not influence the relation between physically demanding work 
and foetal growth, resulting in comparable effect estimates.
In total, 4177 (89.3%) women filled out the question concerning the starting date of their 
current occupation, 4068 women (97.4%) started working before conception, whereas 109 
(2.6%) women started working somewhere during their first trimester of pregnancy. In the 
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Figure 1. Relative differences in SD scores for women occupationally exposed to long periods of 
standing at work compared to non-exposed women, for foetal weight and foetal head circumference. 
Figure 1: Relative differences in SD scores for women occupationally exposed to long periods of standing at work compared to non-exposed women, for 
foetal weight and foetal head circumference. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are based on repeated linear regression models and reflect the difference in SD score of foetal weight (12467 
measurements), and foetal head circumference (10540 measurements), in the offspring of mothers exposed to long 
periods of standing at work compared to the offspring of non-exposed mothers. The reference value is a SD score of 0. 
* = p-vaue < 0.05. Models were adjusted for: maternal age, height at intake, weight before pregnancy, educational level, 
ethnicity, parity, smoking, alcohol use, folic acid supplement use, foetal gender, and self-perceived health.
Figure 2. Relative differences in SD scores for women who work 25-39 or >40 hours per week compared 
to women who work <25 hours per week, for foetal weight, and foetal head circumference 
Figure 2: Relative differences in SD scores for women who work 25-39 or >40 hours per week compared to women who work <25 hours per week, for foetal 
weight, and foetal head circumference 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are based on repeated linear regression models and reflect the difference in SD score of foetal weight (12611 
measurements), and foetal head circumference (10411 measurements), in the offspring of mothers who work 25-39 
or >40 hours per week compared to the offspring of mothers who work <25 hours per week. The reference value is a 
SD score of 0. * = p-value < 0.05. Models were adjusted for: maternal age, height at intake, weight before pregnancy, 
educational level, ethnicity, parity, smoking, alcohol use, folic acid supplement use, foetal gender, and self-perceived 
health.
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sensitivity analyses starting work before or during conception and having a regular menstrual 
cycle or not did not change the results. Furthermore, women who stopped working earlier than 
planned (before 34 weeks of gestation) often had medical reasons (71.4%) and these women 
had a higher risk of preterm delivery and low birth weight. When excluding these women from 
the analysis, duration of work during pregnancy was not associated with foetal growth and we 
found no negative effect of working till 34-36 weeks of pregnancy on any of the birth outcomes 
in this study population. Stopping working before 34 weeks of gestation was not associated 
with physically demanding work or working hours.
diSCuSSion
This population-based prospective cohort study suggests that long periods of standing at 
work, and working > 25 hours per week were associated with lower foetal growth rates for 
foetal weight and head circumference in pregnancy. These findings were not reflected in 
adverse birth outcomes. Additional cross-sectional analyses showed that the differences are 
demonstrable from the third trimester onwards.
Several mechanisms have been suggested to explain the possible adverse influence of 
physically demanding work during pregnancy on the foetus. Heavy physical work is thought 
to reduce the blood flow to the uterus and placenta, thereby reducing the availability of 
oxygen and nutrients for the foetus.29,30 Furthermore, lifting and trunk bending may increase 
intra abdominal pressure, which in turn may lead to preterm delivery, especially in the last 
trimester when space in the abdominal cavity is maximally constrained.10 Also an increased 
release of catecholemines, through mediation of the sympatic nerve system, has been hypoth-
esised to play a role.31 Occupational risk factors, such as working in a specific occupation,8,32 
shift work,33,34 job stress,12,13,35 standing, lifting,36 and work hours37-39 have been related to 
adverse birth outcomes. Two reviews have suggested an influence of physically demanding 
work on pregnancy outcomes.14,15 In addition to previous studies, which looked at adverse 
birth outcomes, we have looked at foetal growth measured in the second and third trimester 
of pregnancy. Although birth outcomes are important from an obstetric perspective, they are 
rather crude measures of foetal growth during pregnancy. We could not demonstrate an effect 
of working hours > 25 hours per week on adverse birth outcomes, however, effects on foetal 
growth rates during pregnancy could be demonstrated, suggesting that the latter analyses are 
more sensitive for picking up more subtle differences in foetal weight and head circumference. 
The population attributable fractions (PAFs) for the occupational risk factors in this study were 
small, for SGA with the highest contribution of lifting > 25 kg, PAF 4.2%, for preterm delivery 
with the highest contribution of working > 40 hours per week, PAF 1.5%, and for low birth 
weight with the highest contribution of lifting > 25 kg per week, PAF 3.6%. In this community 
based study physically demanding work had little influence on the prevalence of adverse birth 
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outcomes, but in specific occupations with a high prevalence of physically demanding work 
this contribution could be higher.
Long working hours were associated with impaired foetal weight, resulting in a decrease in SD 
at birth varying between -0.27 and -0.36 SD at birth. This corresponds to approximately 150 to 200 
gram difference in birth weight. This effect seems of similar magnitude than the effects of other 
well-known lifestyle factors, such as smoking and caffeine intake with reported reductions of -0.3 
SD and -0.1 to -0.3 SD.27,40 However, we must note that the population attributable fractions of 
specific categories of physically demanding work were very low, and the effects on foetal growth 
were subtle since these effects were not reflected in adverse birth outcomes. The results of the 
current study hampers sound advice for pregnant women exposed to these risk factors.
Women working as nurse, child care giver or saleswoman most often reported lifting heavy 
loads (together accounting for 44.6% of all working women). For standing, several occupa-
tions were reported, most notably saleswoman, working with toddlers, schoolteachers and 
administrative employees (21.5%). Nightshifts were most frequently reported by stewardesses, 
physicians, and nurses (60.3%).
In this study we used ultrasound measurements for pregnancy dating, which seems superior 
to dating based on the last menstrual period.18 A disadvantage is that growth variations in early 
pregnancy are assumed to be zero, impairing analyses on first trimester growth. The repeated 
measurements based on gestational age adjusted SD scores, comparable to standardised 
z-scores, enables us to identify pathological smallness in stead of constitutional smallness. The 
advantage of SD scores as relative measure of difference is that the SD scores can be used in 
linear regression models, whereas absolute differences in foetal growth were highly skewed 
since growth curves during pregnancy have a typical parabolic shape that must be described 
by fractional polynomials instead of normal distributions.
The strength of this study is the population-based approach with recruitment during the 
prenatal period and the availability of a large number of potential confounders. A limitation 
of this study is lower selective participation among mothers from ethnic minorities and with 
lower socio-economic status.41 The non-response would lead to biased effect estimates if the 
association between physically demanding work and foetal development would be different 
between those included and those not included in the analyses. However, this seems unlikely 
since biased estimates in large cohort studies mainly arise from loss to follow up rather than from 
non-response at baseline.42 Information on psychosocial stress or general fatigue, which could 
correlate with working hours and foetal growth, was not available in this study. Furthermore, 
this study did not take into account other sources of physically demanding activities outside 
employment, such as exercise, housework, and volunteer work. However, it is unlikely that these 
activities are strongly related to physically demanding work risk factors, but they may lead, in 
some extent, to residual confounding. Women working in physically demanding jobs could have 
a more unhealthy lifestyle that was not fully adjusted for in the analysis by including smoking 
and alcohol use as confounders. Education is an important determinant of health behaviour, but 
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adjustment for educational level did not affect the relation between physically demanding work 
and birth outcomes or foetal growth. This suggests that life style related risk factors most likely do 
not bias the relation between long working hours and foetal growth.
A limitation of this study is the semi-quantative nature of the exposure information in four 
self-reported categories. This did not allow us to investigate duration of standing and walking 
per week or frequency of lifting heavy weights. Recall bias is unlikely, since the information 
obtained was not biased by the outcome since the questionnaire was completed in mid-
pregnancy. In this study we used multiple imputations for missing values in covariates. This 
reduces selection bias due to non-random missing in the covariates.
In the current study we selected women with paid employment around week 30 of preg-
nancy and this might have resulted in a more healthy and affluent study population since these 
women generally have better pregnancy outcomes than women without paid employment. 
Women in paid employment might have stopped working earlier during pregnancy due to 
pregnancy complaints, and technically these women would be on sick leave. The sensitivity 
analyses on women who reported stopping working before 34 weeks because of pregnancy 
complaints showed that these women were at higher risk of preterm delivery and low birth 
weight. However, this was not associated with physically demanding work and, thus, will not 
have influenced the reported associations. When excluding these women from the analysis, 
duration of work during pregnancy was not associated with foetal growth. We were unable 
to find a clear negative effect of working till 34-36 weeks of pregnancy on any of the birth 
outcomes in this study population. When we corrected the longitudinal models for the dura-
tion of work during pregnancy (thus pregnancy week when women stopped working) it did 
not change the effect estimates, suggesting that the relation between physically demanding 
work and foetal growth is independent of work duration.
In the study, we found that physically demanding work during pregnancy was associated 
with lower foetal growth rates. We believe that optimising the work environment is important 
since participation of women in the reproductive age in the work force continues to increase. 
Preventive measures reducing certain occupational conditions, such as shift work, night hours, 
standing, lifting, and noise, have proven to reduce the risks of adverse birth outcomes.33,43 
In the current study we were unable to pinpoint the effects of physically demanding work in 
specific trimesters or of cumulative exposure over pregnancy, since occupational activities 
were only measured once during pregnancy. We were able to demonstrate differences in foetal 
growth during the third trimester, and we hypothesised that differences might already origi-
nate earlier during pregnancy, but were too small to be noticed. Preventive measures therefore 
may be most beneficial when focussing on the weeks before the third trimester. However, this 
study does not present concrete information on the required reduction in duration and level 
of work demands, which hampers sound advice. The results of this study need to be confirmed 
by future research.
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ABStRACt
Background: Recently, over-the-counter mild analgesic use during pregnancy has been 
suggested to influence the risk of reproductive disorders in the offspring. We examined the 
influence of maternal exposure to mild analgesics during pregnancy on the occurrence of 
cryptorchidism and hypospadia in their offspring.
Methods: Associations between maternal exposure to mild analgesics during pregnancy and 
cryptorchidism or hypospadia in the offspring were studied in 3184 women participating in 
a large population-based prospective birth cohort study from early pregnancy onwards in 
the Netherlands (2002-2006), the Generation R Study. Cryptorchidism and hypospadia were 
identified during routine screening assessments performed in child health care centres by 
trained physicians. The use of mild analgesics was assessed in three prenatal questionnaires 
in pregnancy, resulting in four periods of use, namely, periconception period, first 14 weeks of 
gestation, 14-22 weeks of gestation, and 20-32 weeks of gestation. Logistic regression analyses 
were used to study the associations between maternal exposure to mild analgesics and crypt-
orchidism and hypospadia.
results: The cumulative prevalence over 30 months of follow up was 2.1% for cryptorchidism 
and 0.7% for hypospadia. Use of mild analgesics in the second period of pregnancy (14-22 
weeks) increased the risk of congenital cryptorchidism (adjusted OR 2.12; 95%CI 1.17 to 3.83), 
primarily due to the use of acetaminophen (paracetamol) (adjusted OR 1.89; 95%CI 1.01 to 
3.51). Among mothers of cryptorchid sons, 33.8% reported (23 of 68) the use of mild analgesics 
during pregnancy, compared with 31.8% (7 of 22) of mothers with a boy with hypospadia, and 
29.9% (926 of 3094) of mothers with healthy boys.
Conclusion: Our results suggest that intrauterine exposure to mild analgesics, primarily 
paracetamol, during the period in pregnancy when male sexual differentiation takes place, 
increases the risk of cryptorchidism.
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intRoduCtion
Congenital anomalies are a significant cause of stillbirth and infant mortality and are also 
important contributors to childhood morbidity.1 Although cryptorchidism (undescended 
testis) is one of the most common abnormalities in newborn boys worldwide, the aetiology 
in boys without chromosomal abnormalities is largely unknown.2,3 Reproductive disorders, 
including cryptorchidism, hypospadia, and poor semen quality are hypothesised to constitute 
a testicular dysgenesis syndrome, in which environmental and genetic factors play a role.4,5
Use of medication, such as diethylstilbestrol (DES) and valproic acid therapy, during 
pregnancy increases the risk of congenital malformations, including cryptorchidism and 
hypospadia.6-8 Recently, some evidence was presented that over-the-counter mild analgesic 
use may also increase the risk of cryptorchidism in the offspring.9 In the Netherlands, approxi-
mately 40% of the population uses over-the-counter self medication such as acetaminophen 
(paracetamol) and non-steroidal anti-inflammatory drugs (NSAIDS), which are also used by 
pregnant women.10,11
Experimental rat models have shown that normal androgen action during a critical male 
programming window (gestational day 15.5 to 17.5) is crucial for the programming of the testis 
decent.12 Factors that diminish androgen action during that time may have detrimental conse-
quences for male sexual differentiation.4 Exposure of pregnant rats to phthalate esters during 
gestational days 15-17 resulted in hypospadia, cryptorchidism, testicular injury, and nipple 
retention in male offspring, and this was attributed to reductions in testosterone synthesis.13 A 
recent study by Kristensen et al. showed that paracetamol, even at low plasma concentrations 
such as 1 μM, is a potent inhibitor of testosterone production, reducing anogenital distance 
and testosterone production in rats.9 Furthermore, COX inhibitors, such as acetaminophen, 
ibuprofen, and acetylsalicyclic acid have shown endocrine disrupting properties in rainbow 
trout, affecting steroid hormone synthesis.14
These experimental observations have found echos in human observational studies. As 
early as 1996, Berkowitz and Lapinski reported that the use of analgesics during pregnancy 
was a risk factor for cryptorchidism.15 A recent study by Jensen et al. among 47400 live born 
children in the Danish National Birth Cohort showed that exposure to acetaminophen in both 
the first and second trimester increased the risk of cryptorchidism.16 Kristensen et al. were able 
to substantiate these observations among a different cohort of Danish pregnant women, and 
observed that combined use of acetaminophen with other analgesics further increased the risk 
of cryptorchidism.9 However, similar associations were not observed among Finnish mothers 
and their boys, possibly because this disorder is comparatively rare in Finland.9 Further research 
is therefore urgently needed to corroborate or refute these findings.
The aim of this study was to investigate whether the use of mild analgesics during pregnancy 
by mothers was associated with an increased occurrence of cryptorchidism and hypospadia in 
their offspring. We conducted this study within the Generation R Study, a large prospective 
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birth cohort study from early pregnancy onwards examining determinants of growth, develop-
ment and health from foetal life until young adulthood.17
mAtERiAlS And mEtHodS
Study design
The Generation R Study is a population-based prospective cohort study on growth, develop-
ment, and health from early foetal life until young adulthood in Rotterdam, the Netherlands. 
The study design has been described in detail previously.17 Briefly, all pregnant women who 
had an expected delivery date between April 2002 and January 2006 and lived in the study area 
of Rotterdam were invited to participate. In total, 9778 pregnant women (response 61%) were 
enrolled in the study of which 8880 women were enrolled during pregnancy and another 898 at 
birth of their child. Extensive assessments were carried out during early pregnancy (gestational 
age < 18 weeks), mid-pregnancy (gestational age 18-25 weeks), and late pregnancy (gestational 
age > 25 weeks), including physical examinations, questionnaires, interviews, and biological 
samples. The study was approved by the Medical Ethics Committee at Erasmus University Medi-
cal Centre Rotterdam, The Netherlands (MEC 198.782/2001/31). Written informed consent was 
obtained from all participants. The information required for this study was collected in three 
prenatal questionnaires completed during the first trimester (8116 women, 91% enrolment), 
the second trimester (7145 women, 80% enrolment), and the third trimester (6830 women, 
77% enrolment). In total, 5177 partners completed a questionnaire during mid-pregnancy 
(82% of enrolment). The analyses were restricted to boys, and the presence of cryptorchidism 
and hypospadias was ascertained during ten visits of children to the child health care centres 
(0-48 months). The flowchart of the study population is depicted in Figure 1.
medication use
The three self-administered questionnaires assessed medication use during pregnancy 
and were send out by post at gestational week 12, 20, and 30 with an average lag period 
to response of approximately two weeks. The first questionnaire (sent out at 12 weeks of 
gestation) contained the following question ‘Did you use any medication during the past six 
months?’, whereby we explicitly asked for medication prescribed by a physician and medication 
bought over-the-counter such as analgesics. This question was followed by a scheme in which 
mothers had to fill out the name of the medication, reason for use, age at start using, use during 
pregnancy, and if they stopped using when the pregnancy was known.
The second questionnaire (sent out at 20 weeks of gestation) contained the following ques-
tion ‘Did you use any medication during the past two months?’ and the third questionnaire 
(sent out at 30 weeks of gestation) a similar question but focussing on the past three months.
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We defined four time periods, namely, use during the periconception period (use before and 
during the first trimester of pregnancy), use during the first period (first 14 weeks of gestation), 
use during the second period (14-22 weeks of gestation) and use during the third period (20-32 
weeks of gestation). Women enrolled during early pregnancy (85% of the study population) 
completed the first questionnaire around 14 weeks of gestation (mean). Women who reported 
Figure 1. Flowchart of the selected study population
Figure 1: Flowchart of the selected study population 
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- first questionnaire during early pregnancy, n=8116 (91%) 
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7893 mothers and children available for follow up 
studies (3982 boys and 3911 girls)  
Complete information on medication 
For 3184 boys and their mothers information on 
medication use during pregnancy was complete 
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medication use before pregnancy and use during the first weeks of pregnancy until the 
pregnancy was known or thereafter were classified as periconception users, and women who 
used during the first weeks of pregnancy until the pregnancy was known or thereafter (strict 
selection from the group of periconception users) were classified as first period users (0-14 
weeks of gestation). Women who were included after 20 weeks (15% of the study population), 
respectively 30 weeks (5% of the study population), were included in the second and/or third 
period analyses. Summarising, for 2724 (85.6%) women information on three time periods was 
available, for 443 (13.9%) women information on two time periods was available, and for 17 
(0.5%) women information on one time period was available. Use of mild analgesics in these 
four time periods was classified into use of paracetamol as over-the-counter medication, and 
use of all other painkillers, including NSAIDS and aspirin, on prescription or over-the-counter.
Reproductive disorders
The presence of cryptorchidism and hypospadia was assessed during routine screening assess-
ments performed in child health care centres. Child health care centres are notified of live births 
within two days after registration in the municipal birth register. Child health care centres invite 
all parents to participate in a national preventive child healthcare programme, free of charge. A 
total of ten visits were planned at different ages, namely 0-6 months (five visits, 6591 children, 
84% enrolment), 6-12 months (one visit, 6414 children, 81% enrolment), 12-18 months (two 
visits, 6088 children, 77% enrolment), 18-24 months (one visit, 4478 children, 57% enrolment), 
and 24-36 months (one visit, 5335 children, 68% enrolment). All visits included physical exami-
nations, performed by trained physicians, including manipulation of the testes and inspection 
of the genitalia.2
Testes deviating from the normal distal scrotal position were gently but firmly manipulated 
with warm hands, along the normal pathway of the descent, to their most distal position.18 Boys 
were diagnosed as cryptorchid if one or both testes were non-palpable, or when they could 
not be manipulated to a stable position in the scrotum. Retractile testis can be manipulated 
to a stable scrotal position were not considered cryptorchid, whereas cases of retentio testis 
manipulated to a scrotal position that returned to their abnormal position after release of pres-
sure were classified as cryptorchid. The physicians reported whether the tests were performed, 
and reported the position of the testis after manipulation, as non-palpable, inguinal, ectopic, 
high scrotal, stable scrotal, or non-assessable due to the presence of hydrocele. Hypospadias 
were also diagnosed and classified in the children. Trained physicians assessed whether hypo-
spadia was present and which type it was (glandular of a more severe type), as described earlier 
by Pierik et al.19
When cryptorchidism or hypospadia was present at one of the ten visits to the child health 
care centres, children were classified as a prevalent case. This resulted in a cumulative period 
prevalence of cryptorchidism and hypospadia over 30 months of follow up.
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Potential confounders
For mothers, information on age, weight, education, country of origin, parity, underlying 
diseases, folic acid supplement use, and general health was collected from the first question-
naire available. Smoking habits and alcohol use (no/until pregnancy was known/ and after 
pregnancy was known), infectious diseases during pregnancy (yes/no), fever during pregnancy 
(yes/no), and use of co-medication (yes/no) were collected from three prenatal questionnaires. 
The body mass index (BMI in kg/m2) was calculated by weight divided by squared height. The 
occurrence of ‘underlying disease’ was defined as the presence of any disease from a structured 
list of 23 questions on specific diseases in the first questionnaire. General health was reclassified 
from five categories varying from excellent to poor into two categories comparing moderate 
and poor health to good to excellent health. Gestational age at birth and birth weight were 
obtained from medical records and hospital registries. Information on paternal characteristics, 
such as paternal age, BMI, education, country of origin, underlying diseases, smoking before 
pregnancy, alcohol use before pregnancy, occupational exposure to endocrine disruptors and 
pesticides, medication use before pregnancy, and family history of congenital cryptorchidism, 
was collected from a mid-pregnancy questionnaire especially designed for partners of partici-
pating women.
Statistical analyses
Statistical analyses were performed using SPSS v17.0 (Chicago, IL, USA). Differences between 
categorical variables were tested with the Fisher’s exact test, and differences between continu-
ous variables were tested with one-way ANOVA. We used logistic regression models to estimate 
the associations between several life style related risk factors as well as mild analgesic use with 
cryptorchidism and hypospadia as dependent variables. Maternal and paternal age and BMI 
were investigated both as categorical and as continuous variable. Medication use was stratified 
per pregnancy period and evaluated for overall use of analgesics, use of paracetamol, and use 
of other painkillers. The reference group only contained women who did not use any medica-
tion during pregnancy.
Potential confounders were selected based on evidence on relevant determinants of 
cryptorchidism and hypospadias in an earlier case-referent study conducted in the same area 
prior to the current birth cohort study.20 Both maternal and paternal factors were considered. 
First, we selected all reported potential confounders from both mother and father, including 
age, educational level, ethnicity, parity, BMI, smoking during pregnancy, alcohol use during 
pregnancy, underlying diseases, self perceived general health, gestational age at birth, birth 
weight, occupational exposure to endocrine disruptors, occupational exposure to pesticides, 
medication use before and during pregnancy, and for women only folic acid supplement use, 
infectious disease during pregnancy, and fever during pregnancy. Second, maternal age, mater-
nal educational level, maternal BMI, maternal general health, maternal use of co-medication, 
maternal underlying diseases and maternal fever during pregnancy were included by default, 
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while the other variables were retained in the multivariable model as confounders when they 
changed the OR of mild analgesic use by more than 10%.21 We tested the confounders during 
the period with the largest OR for mild analgesic use and applied the final set of confounders 
to the other periods. The final model for both cryptorchidism and hypospadia consisted only of 
the following confounders which were included by default: maternal age, maternal educational 
level, maternal BMI, maternal general health, maternal use of co-medication, maternal underly-
ing diseases and maternal fever during pregnancy. Missing values in covariates were handled 
by multiple imputations (MCMC method) by generating five independent datasets for all 
analyses. Imputations were based on the relations between all covariates included in this study. 
The threshold for imputation was 30% of missing values, all covariates were imputed.22 The 
pooled estimate from the multivariable models were used to construct the Tables. We carried 
out a sensitivity analyses to assess the influence of the time enrolment on the effect estimates, 
comparing women included after 20 weeks of gestation with women enrolled before 20 weeks 
of gestation. The results from the multivariable analyses were used to estimate the population 
attributable fraction (PAF), expressing the proportion of the adverse health outcome in the 
general population that is attributed to exposure to the risk factor of interest. The PAF is a func-
tion of both the relative risk and the proportion of exposed persons in the population.23 In this 
study ORs were used for the calculations of the PAF.
RESultS
The cumulative period prevalence of cryptorchidism and hypospadia in our study population 
were 2.1% and 0.7% respectively. The baseline characteristics of the mothers are shown in Table 
1. The univariable and multivariable analyses of the lifestyle related and environmental risk 
factors are shown in Table 2. We found that being overweight (BMI category 25-30 kg/m2) was 
associated with an increased risk of having a child with cryptorchidism. The effects of maternal 
age (OR per year increase 1.01; 95%CI 0.96-1.06) and BMI (OR per unit kg/m2 increase 1.04; 
95%CI 0.99-1.09) as continuous variables on the occurrence of cryptorchidism were not statisti-
cally significant. For hypospadia the effects were close to unity (OR 0.96; 95%CI 0.88-1.04 and 
OR 1.04; 95%CI 0.95-1.14, respectively). The multivariable analysis showed that after adjusting 
for use of mild analgesics during pregnancy, the effect estimates of life style and environmental 
factors were comparable. No other statistically significant differences were present among the 
groups.
Tables 3 and 4 present the results of the univariable and multivariable analyses on maternal 
use of mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia. 
In total, 29.9% of the mothers in our study population used mild analgesics during pregnancy 
(956/3184). There was moderate agreement between mild analgesics users during the distin-
guished periods with kappa values varying between 0.23 and 0.40.
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TaBle 1. Baseline characteristics of the pregnant women (n=3184) included in the analyses
Variables Cryptorchidism
(n=68)
Hypospadia
(n=22)
normal
(n=3094)
Maternal characteristics
Maternal age at intake (years) 30.53 (5.00) 29.07 (5.61) 30.29 (5.12) 
Educational level 
Low 18 (26.5%) 6 (27.3%) 669 (21.6%) 
Mid 35 (51.5%) 13 (59.1%) 1482 (47.9%) 
High 11 (16.2%) 3 (13.6%) 802 (25.9%) 
Missing 4 (5.9%) 0 141 (4.6%) 
Ethnicity 
Netherlands 32 (47.1%) 12 (54.5%) 1623 (52.5%) 
Surinam and Dutch Antilles 7 (10.3%) 0 321 (10.4%) 
Morocco and Turkey 10 (14.7%) 6 (27.3%) 437 (14.1%) 
Other 15 (22.1%) 4 (18.2%) 615 (10.1%) 
Missing 4 (5.9%) 0 98 (3.2%) 
Parity 
First child 34 (50.0%) 15 (68.2%) 1710 (55.3%) 
Second child or higher 33 (48.5%) 7 (31.8%) 1367 (44.2%) 
Missing 1 (1.5%) 0 17 (5.5%) 
Conception 
Spontaneous 63 (92.6%) 18 (81.8%) 2892 (93.5%) 
Infertility treatment 1 (1.5%) 0 53 (1.7%) 
Missing 4 (5.9%) 4 (18.2%) 149 (4.8%) 
Health in general 
Good 54 (79.4%) 19 (86.4%) 2566 (82.9%) 
Moderate/poor 2 (2.9%) 1 (4.5%) 172 (5.6%) 
Missing 12 (17.6%) 2 (9.1%) 356 (11.5%) 
Underlying diseases 
No 12 (17.6%) 5 (22.7%) 644 (20.8%) 
Yes 41 (60.3%) 14 (63.6%) 1855 (60.0%) 
Do not know 4 (5.9%) 2 (9.1%) 309 (10.0%) 
Missing 11 (16.2%) 1 (4.5%) 286 (9.2%) 
Fever during pregnancy 
No 57 (83.8%) 19 (86.4%) 2571 (83.1%) 
Yes 10 (14.7%) 3 (13.6%) 508 (16.4%) 
Missing 1 (1.5%) 0 15 (0.5%) 
Infection or inflammation during pregnancy 
No 52 (76.55) 15 (68.2%) 2342 (75.7%) 
Yes 5 (7.4%) 5 (22.7%) 399 (12.9%) 
Missing 11 (16.2%) 2 (9.1%) 353 (11.4%) 
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Among mothers with cryptorchid sons 33.8% (23 of 68) reported the use of mild analgesics 
during pregnancy, compared with 31.8% (7 of 22) in mothers with a boy with hypospadia, and 
29.9% (926 of 3094) in mothers with healthy boys (adjusted OR 1.25; 95%CI 0.73-2.13 and OR 
0.98; 95%CI 0.38-2.52, respectively). Mild analgesics primarily consisted of paracetamol (75%), 
followed by NSAIDS (13%), and other painkillers such as aspirin (12%).
A total of 484 (20.8%) and 252 (10.9%) mothers reported the use of mild analgesics during 
the periconception period and the first period, respectively. Use of mild analgesics in the peri-
conception and first period was not associated with cryptorchidism or hypospadia (adjusted 
OR 0.89; 95%CI 0.42-1.88, OR 0.94; 95%CI 0.36-2.46 for cryptorchidism, adjusted OR 1.36; 95%CI 
0.47-3.94, OR 2.05; 95%CI 0.64-6.58 for hypospadia).
TaBle 1. Baseline characteristics of the pregnant women (n=3184) included in the analyses (continued)
Variables Cryptorchidism
(n=68)
Hypospadia
(n=22)
normal
(n=3094)
Use of co-medication 
No 43 (63.2%) 9 (40.9%) 1734 (56.0%) 
Yes 25 (36.8%) 13 (59.1%) 1356 (43.8%) 
Missing 0 0 4 (0.1%) 
Body Mass Index (kg/m2) 25.28 (4.75) 25.37 (4.16) 24.54 (4.29) 
Missing 0 0 16 (0.5%) 
Smoking during pregnancy 
No 46 (67.6%) 17 (77.3%) 2086 (67.4%) 
Yes, until pregnancy was known 3 (4.4%) 1 (4.5%) 234 (7.6%) 
Yes, after pregnancy was known 7 (10.3%) 2 (9.1%) 449 (14.5%) 
Missing 12 (17.6%) 2 (9.1%) 325 (10.5%) 
Alcohol use during pregnancy 
No 22 (32.4%) 10 (45.5%) 1271 (41.1%) 
Yes, until pregnancy was known 6 (8.8%) 1 (4.5%) 384 (12.4%) 
Yes, after pregnancy was known 29 (42.6%) 9 (40.9%) 1132 (36.6%) 
Missing 11 (16.2%) 2 (9.1%) 307 (9.9%) 
Folic acid use 
No 8 (11.8%) 5 (22.7%) 639 (20.7%) 
Yes, post conception start 16 (23.5%) 6 (27.3%) 758 (24.5%) 
Yes, preconception start 25 (36.8%) 7 (31.8%) 1015 (32.8%) 
Missing 19 (27.9%) 4 (18.2%) 682 (22.0%) 
Birth outcomes 
Gestational age at birth 40.4 (33.4-42.9) 39.7 (35.4-42.7) 40.1 (25.3-43.4) 
Birth weight 3436.0 (615.6) 3339.3 (739.1) 3491.9 (556.9) 
Values are numbers (percentages) for categorical variables, and means (standard deviation) for continuous variables.
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TaBle 2. Univariable and multivariable logistic regression of maternal characteristics and life style related 
factors and the association with cryptorchidism and hypospadia
Variables Cryptorchidism Hypospadia Cryptorchidism Hypospadia
OR (95%CI) OR (95%CI) aOR (95%CI) a aOR (95%CI) a
Maternal age at intake
<25 years 1.00 1.00 1.00 1.00 
25-29 years 1.28 (0.57-2.88) 0.43 (0.12-1.52) 1.28 (0.57-2.86) 0.43 (0.12-1.52) 
30-35 years 1.37 (0.64-2.90) 0.64 (0.23-1.79) 1.35 (0.63-2.87) 0.63 (0.22-1.78) 
>35 1.34 (0.56-3.20) 0.50 (0.13-2.02) 1.32 (0.55-3.16) 0.50 (0.12-2.00) 
Educational level 
Low 1.96 (0.92-4.18) 2.40 (0.60-9.62) 1.91 (0.89-4.10) 2.32 (0.58-9.34) 
Mid 1.72 (0.87-3.41) 2.35 (0.67-8.25) 1.78 (0.91-3.49) 2.31 (0.66-8.12) 
High 1.00 1.00 1.00 1.00 
Ethnicity 
Netherlands 1.00 1.00 1.00 1.00 
Surinam and Dutch Antilles 1.11 (0.48-2.53) - 1.09 (0.48-2.48) - 
Morocco and Turkey 1.16 (0.57-2.38) 1.86 (0.69-4.98) 1.12 (0.55-2.31) 1.84 (0.68-4.96) 
Other 1.24 (0.67-2.30) 0.88 (0.28-2.74) 1.33 (0.70-2.51) 0.88 (0.28-2.75) 
Parity 
First child 1.00 1.00 1.00 1.00 
Second child or higher 1.21 (0.75-1.97) 0.58 (0.24-1.44) 1.18 (0.73-1.91) 0.58 (0.24-1.43) 
Health in general 
Good 1.00 1.00 1.00 1.00 
Moderate/poor 0.55 (0.13-2.29) 0.79 (0.10-5.90) 0.60 (0.12-2.96) 0.72 (0.10-5.35) 
Underlying disease 
No 1.00 1.00 1.00 1.00 
Yes 1.19 (0.62-2.27) 0.97 (0.35-2.71) 1.07 (0.57-2.00) 1.03 (0.37-2.88) 
Fever during pregnancy 
No 1.00 1.00 1.00 1.00 
Yes 0.89 (0.45-1.75) 0.80 (0.24-2.71) 0.86 (0.44-1.72) 0.78 (0.23-2.68) 
Inflammation or infection during pregnancy 
No 1.00 1.00 1.00 1.00 
Yes 0.56 (0.22-1.42) 1.96 (0.71-5.41) 0.63 (0.24-1.66) 1.84 (0.67-5.08) 
Use of co-medication 
No 1.00 1.00 1.00 1.00 
Yes 0.74 (0.45-1.22) 1.85 (0.79-4.33) 0.70 (0.42-1.17) 1.87 (0.78-4.48) 
Body Mass Index 
<25 kg/m2 1.00 1.00 1.00 1.00 
25-30 kg/m2 1.83 (1.08-3.10)* 2.18 (0.90-5.29) 1.81 (1.07-3.07)* 2.17 (0.90-5.27) 
>30 kg/m2 1.44 (0.69-3.03) 1.02 (0.23-2.63) 1.45 (0.69-3.03) 1.02 (0.23-4.63) 
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In the second period (14-22 weeks of gestation), containing 2864 women, 480 (16.8%) 
women reported the use of mild analgesics. Use during the second period in particular 
increased the risk of congenital cryptorchidism (adjusted OR 2.12; 95%CI 1.17-3.83). The risk 
remained statistically significant for the individual compound paracetamol (adjusted OR 1.89; 
95%CI 1.01-3.51). Associations with hypospadia were not observed.
In the third period (20-32 weeks of gestation), 363 out of 2709 (13.4%) women reported 
the use of mild analgesics. Maternal use of mild analgesics during the third period was not 
associated with congenital cryptorchidism or hypospadia (adjusted OR 1.56; 95%CI 0.78-3.11, 
and OR 0.32; 95%CI 0.04-2.44, respectively).
The results of the sensitivity analyses indicated that there was no change in the effect 
estimates when we restricted our analysis to women included before 20 weeks of gestation, 
however, due to the smaller sample size, the confidence intervals widened.
The PAFs for the use of mild analgesics in the second and third trimester varied between 0.09 
and 0.24 (95%CI 0.00-0.29, and 0.04-0.43, respectively).
TaBle 2. Univariable and multivariable logistic regression of maternal characteristics and life style 
related factors and the association with cryptorchidism and hypospadia (continued)
Variables Cryptorchidism Hypospadia Cryptorchidism Hypospadia
OR (95%CI) OR (95%CI) aOR (95%CI) a aOR (95%CI) a
Smoking during pregnancy 
No 1.00 1.00 1.00 1.00 
Yes, until pregnancy was known 0.58 (0.18-1.88) 0.52 (0.07-3.96) 0.57 (0.19-1.76) 0.48 (0.06-3.60) 
Yes, after pregnancy was known 0.71 (0.32-1.58) 0.55 (0.13-2.37) 0.74 (0.34-1.62) 0.58 (0.13-2.53) 
Alcohol use during pregnancy 
No 1.00 1.00 1.00 1.00 
Yes, until pregnancy was known 0.90 (0.36-2.24) 0.33 (0.04-2.59) 0.69 (0.28-1.65) 0.27 (0.04-2.09) 
Yes, after pregnancy was known 1.48 (0.85-2.59) 1.01 (0.41-2.50) 1.15 (0.68-1.95) 0.84 (0.35-2.00) 
Folic acid use 
No 0.51 (0.23-1.13) 1.14 (0.36-3.59) 0.75 (0.37-1.51) 1.17 (0.38-3.58) 
Yes, post conception start 0.86 (0.45-1.62) 1.15 (0.38-3.43) 0.82 (0.40-1.65) 1.29 (0.39-4.32) 
Yes, preconception start 1.00 1.00 1.00 1.00 
a Adjusted for maternal use of mild analgesics during pregnancy.
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diSCuSSion
This large population-based prospective cohort study suggests that maternal exposure to mild 
analgesics during the second period (reflecting gestational weeks 14-22) in pregnancy is asso-
ciated with an increased prevalence of cryptorchidism in the offspring, whereas no associations 
were observed during the first and third period of pregnancy. However, we must note that the 
current study has several limitations, most important the limited number of cases of cryptorchi-
dism and hypospadia. We must also note that the definition of the different pregnancy periods 
was based on the average response time to the questionnaires, which will result in some lack of 
precision of the exact duration of the period. The distinguished pregnancy periods necessarily 
overlap, since standardised questions with fixed recall periods were used. Also, the users of 
analgesics in the different trimesters partly overlapped (kappa values 0.23 to 0.40), which can-
not exclude the possibility of a contribution of the previous trimester to the internal dose in the 
subsequent trimester. Despite these limitations, our findings suggest that intrauterine expo-
sure to mild analgesics during pregnancy might increase the risk of cryptorchidism. Since the 
TaBle 4. Multivariable analysis of maternal use of mild analgesics during pregnancy and the association 
with cryptorchidism and hypospadia
use of painkillers Cryptorchidism Hypospadia
OR adjusted1 (95%CI) OR adjusted2 (95%CI)
Use of mild analgesics during the periconception period 0.89 (0.42-1.88) 1.36 (0.47-3.94)
Specific substances 
Paracetamol 1.02 (0.44-2.36) 1.19 (0.33-4.32) 
Other painkillers 0.61 (0.14-2.58) 1.71 (0.37-7.81) 
Use of mild analgesics during the first period 0.94 (0.36-2.46) 2.05 (0.64-6.58) 
Specific substances 
Paracetamol 1.38 (0.52-3.64) 2.24 (0.60-8.32) 
Other painkillers - 1.65 (0.21-13.08) 
Use of mild analgesics during second period 2.12 (1.17-3.83)* 0.53 (0.12-2.34) 
Specific substances 
Paracetamol 1.89 (1.01-3.51)* 0.54 (0.12-2.41) 
Other painkillers 8.93 (1.84-43.24)* - 
Use of mild analgesics during third period 1.50 (0.75-3.00) 0.31 (0.04-2.35) 
Specific substances 
Paracetamol 1.56 (0.78-3.11) 0.32 (0.04-2.44) 
Other painkillers - - 
1 Adjusted for maternal age, educational level, BMI at intake, general health, use of co-medication, underlying diseases, 
and fever during pregnancy.
2 Adjusted for maternal age, educational level, BMI at intake, general health, use of co-medication, underlying diseases, 
and fever during pregnancy.
* p value < 0.05.
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proportion of women using mild analgesics during pregnancy is high, the population impact 
may be substantially. This observation corroborates findings from experimental rat studies and 
two recent observational studies.
The strength of this study is the population-based approach with recruitment during 
the prenatal period which enabled us to assess, and adjust for, a large number of potential 
confounders. Since smoking, alcohol use, and folic acid supplement use had many missing 
values, we used multiple imputation to handle missing values in our covariates. This reduces 
selection bias due to non-random missing in the covariates. Another strength of the study lies 
in the frequent assessments that took place in the child health care centres, with assessments 
for cryptorchidism during five screening visits in the first six months. Spontaneous testicular 
descent occurs in up to 75% of cryptorchid testis during the first three months of life when 
reproductive hormone activity is high.24 The majority of children in our study visited the 
child health care centres in the first six months (89,4%), and subsequent visits made it pos-
sible to examine children who did not visit the child health care centre between 0-6 months, 
resulting in a cumulative period prevalence. We used questionnaires to assess the exposure 
to paracetamol and other mild analgesics. These analgesics are bought over-the-counter and 
therefore it was not possible to check information from pharmacies or general practitioners. We 
explicitly asked for use of painkillers which can be bought over-the-counter, and we observed 
that the number of women who reported use of mild analgesics in our study (29.9%) was com-
parable to Danish women reporting mild analgesic use in self-administered questionnaires in 
the study of Kristensen et al. (26.1% and 30.9%). In our cohort information on medication use 
was collected prior to the information on congenital malformations, which were diagnosed 
after birth and, thus, recall bias is unlikely. Although misclassification may have occurred, we 
believe that this is most likely non-differential misclassification, leading to an underestimation 
of the observed effect estimates. An analysis restricted to women included before 20 weeks of 
gestation showed very similar results.
Some other limitations need to be addressed. Selection bias due to non-response would 
be present if the association of medication use with cryptorchidism or hypospadia differed 
between those with (n = 3184) and those without (n = 524) information on medication use. 
Although the general characteristics of women with data on medication use were slightly 
different from those without data on medication use, no difference in the occurrence of 
cryptorchidism and hypospadia was observed. Thus, selection bias due to non-response on 
medication use seems unlikely but cannot be excluded.
Another shortcoming of our design is the lack of information on the frequency and dose 
of painkiller use. Also, given the overlap between analgesics users in different periods during 
pregnancy, it is difficult to ascertain with certainty that mild analgesics use during one specific 
period is associated with an increased risk of cryptorchidism. However, agreement between the 
different periods during pregnancy was calculated by means of Kappa values, which ranged 
between 0.23 to 0.40, indicating low agreement between these different pregnancy periods. 
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Despite this suboptimal design, we showed an association between use of mild analgesics 
during the second period in pregnancy and cryptorchidism. This study could increase the 
awareness for this important topic and stimulate researchers to set up larger studies.
We calculated population attributable fractions, ranging from 9%-24%, which suggest, if 
causality could be established, that at best about 24% of all cases of cryptorchidisms in our 
study population could be attributed to use of mild analgesics during pregnancy. This illus-
trates that for the majority of cryptorchidism cases other causes must be responsible, such as 
suboptimal maternal health, low birth weight, and small-for-gestational-age.20,25
Women who use painkillers during pregnancy may suffer from an underlying disorder 
which prompts medication use. The majority of women in our study used the analgesics for 
common pain such as headache and muscle ache. Confounding by indication may be pres-
ent in mothers who regularly use painkillers, but adjustment for underlying diseases did not 
change the effect estimates by more than 10%. The analyses were adjusted for general health, 
use of co-medication, underlying diseases and fever during pregnancy as important proxy 
variables for indication to treat. None of the paternal risk factors in this study changed the 
association between maternal use of mild analgesics and cryptorchidism or hypospadia with 
more than 10%, thus paternal risk factors were not considered to be potential confounders. 
The study by Pierik et al. showed various paternal risk factors associated with the occurrence of 
cryptorchidism,20 however, in the current study these paternal risk factors did not confound the 
association between mild analgesic use of the mother during pregnancy and the occurrence 
of cryptorchidism. These paternal risk factors seem independent risk factors for cryptorchidism, 
but were not associated with the use of mild analgesics of the mother during pregnancy. How-
ever, residual confounding cannot be completely ruled out.
Cryptorchidism and hypospadia are among the most frequent congenital abnormalities 
in male births.2 Maternal life style factors and environmental exposures during pregnancy 
are suspected to interfere with the normal testicular decent and possibly increase the risk of 
cryptorchidism.3,26 Experimental rat models have indicated that the testis decent from the 
intra-abdominal position into the scrotum takes place in two phases, a transdabdominal phase 
and an inguinoscrotal phase.12,27 However, in humans, discussion exists over the exact time 
window in which the testis descent takes place. Hutson et al. described that the transdabdomi-
nal phase occurs between 8-14 weeks of gestation,27 whereas Foresta et al. defines this phase 
between 10-23 weeks of gestation.25 Further research is needed to identify the exact critical 
time window in which testicular descent takes place.
Impairment of normal androgen action, through exposure to endocrine disrupting 
chemicals or medication in these crucial time windows, is associated with adverse reproductive 
developmental endpoints in experimental animals.28 Recently, Kristensen et al. showed that 
paracetamol, even at low plasma concentrations of 1 μM, is a potent inhibitor of testosterone 
production, resulting in impaired masculinisation in rat models.9 These findings are also 
confirmed by two observational studies that showed similar associations between use of mild 
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analgesics and cryptorchidism, in particular for the second trimester.9,16 We did not find an 
association between use of mild analgesics during pregnancy and hypospadia in the offspring, 
however we had very few cases (n = 22) of hypospadia in our study. Therefore, we were unable 
to study with sufficient discriminatory power the hypothesised underlying mechanism of 
impairment of normal androgen action, resulting in abnormal sexual differentiation, for hypo-
spadias, and the origin of hypospadia, genetic, endocrine or environmental remains unclear.29
Mild analgesics such as NSAIDs act by inhibiting cyclooxygenases COX 1 and 2. Acetamino-
phen (paracetamol) is thought to block the peroxidase function of COX enzymes,30 although the 
precise mechanism by which the drug exerts its action is still uncertain.31 COX enzymes catalyse 
a key step of the synthesis of prostaglandins from arachidonic acid. It has been shown that the 
testosterone-dependent differentiation of the male reproductive tract requires the continuing 
synthesis of prostaglandins.32 Suppression of prostaglandin production by interfering with the 
arachidonic acid cascade at the level of release of arachidonic acid from cell membrane lipids 
or by inhibiting COX enzymes diminishes foetal androgen action and compromises male sexual 
differentiation.33 Accordingly, Kristensen et al. demonstrated that acetaminophen is capable 
of suppressing foetal androgen synthesis in male rats exposed ex vivo to the drug during 
late foetal life. The day before birth the male foetuses showed reduced anogenital distances, 
another sign of diminished androgen action.9 In a subsequent paper, Kristensen et al. were able 
to pinpoint the suppression of prostaglandin synthesis by acetaminophen and other NSAIDs to 
the inhibition of COX enzymes.34 Importantly, the same authors revealed many other putative 
endocrine disrupting chemicals, including phthalates and other phenolic agents as possessing 
prostaglandin-inhibitory potential. In the light of these observations, it appears biologically 
plausible that not only NSAIDs, but also other endocrine disrupting chemicals may contribute 
to increasing the risks of developing cryptorchidism by interfering with prostaglandin synthe-
sis. It becomes necessary to address this possibility in further epidemiological studies.
In conclusion, we found an association between maternal use of mild analgesics, in particular 
paracetamol, during the second period in pregnancy (14-22 weeks of gestation) and congenital 
cryptorchidism. Since the number of women using mild analgesics during pregnancy is high 
(approximately 30-40%) further research is urgently needed to corroborate these findings, so 
that preventive measures, if needed, can be taken.
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1. intRoduCtion
Workplace health is an important issue, since women who intend to become pregnant and 
pregnant women are at risk for several reproductive outcomes, thus, it is important to identify 
occupational risk factors for prevention. Although women in paid employment generally have a 
better reproductive health than those without paid employment, certain work-related risk fac-
tors, such as exposure to chemicals, physically demanding work, and psychological job strain, 
may influence women’s reproductive abilities. In this thesis, several studies are presented that 
focus on occupational risk factors, in particular exposure to chemicals and physically demand-
ing work, and its association with several aspects of reproductive health, such as fecundity, 
intrauterine growth, pregnancy complications and congenital malformations. Insight in these 
issues is important in order to improve the clinician’s ability to counsel couples who are trying 
to conceive or women who have concerns about their pregnancy.
As described in the introduction, the primary objectives of this thesis are:
1.  To study the influence of occupational exposure to chemicals on reproduction, specifically 
fecundity, intrauterine growth, hypertensive disorders during pregnancy, and birth out-
comes.
2.  To study the influence of physically demanding work on intrauterine growth, hypertensive 
disorders during pregnancy, and birth outcomes.
3.  To study the relation between exposure to endocrine disruptors (EDs) and the occurrence 
of congenital malformations, including congenital heart defects (CHDs) and male repro-
ductive tract abnormalities, such as cryptorchidism and hypospadia.
This chapter will present the main findings from this thesis. Furthermore, methodological 
issues will be discussed and new insights and directions for future research will be presented.
Pa
rt
 5
220
2. SummARy of tHE mAin findingS
Study aim 1; chemicals and reproduction
Our first study aim addresses occupational exposure to chemicals in relation to various aspects 
of human reproduction, including fecundity, intrauterine growth, hypertensive disorders, 
and birth outcomes. Since 1970, epidemiologic research has demonstrated several causal 
relationships and many possible associations between environmental exposures and adverse 
pregnancy and adult health concerns.1 Disorders of reproduction and hazards to reproductive 
health and associated functions have become prominent issues in recent decades after reports 
of adverse effects of several chemicals on reproductive function.2
Chemicals, endocrine disruptors and fecundity
Factors related to postponement of motherhood,3,4 smoking,5,6 and alcohol or caffeine intake7 
may interfere with the reproductive system.1 However, the attention has grown for work-
related and environmental factors which may also reduce fertility.8 In the early 1990s, studies 
began to associate environmental contaminants with altered reproductive performance in 
wild populations of fish, amphibians, reptiles and birds.9 Together with concerning trends in 
human reproductive health, such as the rising incidence in testicular cancer,10 and low average 
sperm counts,11 this led to the hypothesis that chemical contaminants may negatively affect 
the reproductive process causing reduced fertility and adverse pregnancy outcomes in the 
general population. With a systematic review we aimed to summarise the existing literature 
on exposure to chemicals and time to pregnancy (TTP), as a measure of couple’s fecundity 
(Chapter 2.1). From this review we can conclude that there are strong indications that certain 
occupational exposures, such as pesticides and lead, adversely influence male and female fertil-
ity. These conclusions are in line with earlier reviews on pesticide exposure and fertility.12-14 
Regarding occupational exposure to lead, the evidence is quite consistent, showing that lead 
exposure reduces fertility and prolongs TTP.15,16 This was further substantiated by findings 
within the Generation R cohort (Chapter 2.2). We showed that paternal occupational exposure 
to polycyclic aromatic hydrocarbons (PAHs), heavy metals and overall exposure to chemicals 
with endocrine disrupting properties was associated with a prolonged TTP. For pesticides, we 
found for both maternal and paternal occupational exposure decreased hazard ratios, however, 
these were not statistically significant, probably due to the low prevalence of exposure to 
pesticides.
Chemicals and foetal growth
Several studies from the 1990s onwards found that risk factors for foetal development, such 
as poor maternal nutrition, can results in an increased risk of adult onset of chronic conditions 
such as coronary heart disease.17,18 These findings led to the foetal origins of disease hypoth-
esis (commonly known as the ‘Barker Hypothesis’), which proposes that exposures to adverse 
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insults during critical or sensitive windows of development can permanently reprogram normal 
physiologic responses, and thus give rise to illnesses and metabolic and hormonal disorders 
later in life.19,20 Two large reviews have summarised the epidemiologic literature on exposure 
to environmental contaminants during pregnancy and adverse birth outcomes, such as low 
birth weight, intrauterine growth retardation (IUGR), and preterm delivery,21,22 suggesting a 
variety of links. Suggestive evidence associates pesticides and polychlorinated biphenyls 
with decreased foetal growth and pregnancy length. Further studies in a large birth cohort in 
Sweden on parental occupation in relation to foetal growth and pregnancy length gave further 
rise to the hypothesis that occupational exposures may influence foetal growth.23,24 The articles 
described in this thesis focus on the impact of maternal exposure to chemicals during preg-
nancy on pregnancy outcome. Since various birth outcomes have been studied extensively 
in relation to chemical exposure, and birth outcomes are a rather crude marker of intrauterine 
circumstances, we focussed on the effects of chemicals on intrauterine growth.25-30 The study 
on occupational exposure to chemicals, suggests that maternal occupational exposure to PAHs, 
phthalates, alkylphenolic compounds, and pesticides adversely influenced several domains of 
foetal growth during pregnancy and also adversely influenced placental weight (Chapter 2.3). 
This study supported existing evidence from human studies regarding occupational exposure 
and adverse pregnancy outcomes.1
Measurement strategy is becoming more important the last decades, and the characterisa-
tion of exposure with the Job-Exposure-Matrix (JEM) must be interpreted with caution, since 
this is a rather crude measure of exposure. Biomonitoring data on occupational exposures is 
rare, but would be a step forward for a better exposure assessment strategy. With the study on 
prenatal exposure to bisphenol A (BPA), we examined the effects on urinary concentrations of 
BPA on intrauterine growth, and we were able to study whether a single urinary measurement 
is a good proxy for exposure to BPA, or whether we would prefer to measure two or even three 
samples during pregnancy. In this study, we showed that higher concentrations of creatinine-
based BPA in prenatal urine were associated with a slower foetal growth rates for both foetal 
weight and head circumference (Chapter 2.4). Most importantly, this study clearly showed, 
that the number of measurements per individual strongly influenced the effect estimates for 
foetal head circumference and foetal weight. When fewer measurements were used these 
estimates were close to unity, and when three available measurements were used, the esti-
mates were highly statistically significant. The BPA-foetal growth relation may fit the profile of 
a setting where, for a fixed total number of measurements, more replicates and fewer subjects 
maximises power.31
Study aim 2; physically demanding work and reproduction
The risks of physically demanding work during pregnancy on foetal growth, adverse birth out-
comes and hypertensive pregnancy complications are addressed in study aim 2. Occupational 
risk factors, such as working in a specific occupation,32,33 shift work,34,35 job stress,36-38 standing, 
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lifting,39 and work hours40-42 have been related to adverse birth outcomes. Two reviews have 
suggested an influence of physically demanding work on pregnancy outcomes, albeit of mod-
est magnitude.43,44 In the study on physically demanding work and foetal growth, we were 
unable to demonstrate clear adverse effects of physically demanding work and working hours 
on adverse birth outcomes. However, effects of prolonged standing on foetal head circumfer-
ence and long working hours on both foetal head circumference and foetal weight could be 
demonstrated in the longitudinal analyses (Chapter 3.2). Furthermore, we studied the effects 
of physically demanding work, working hours, and exposure to chemicals on hypertensive 
pregnancy complications (Chapter 3.1). This study suggests that there was no influence of 
physically demanding work and exposure to chemicals on hypertensive disorders during preg-
nancy. However, the low prevalence of hypertensive disorders during pregnancy combined 
with the low prevalence of occupational risk factors limit the conclusions and larger studies are 
needed to corroborate these findings.
Study aim 3; endocrine disruptors and congenital anomalies
Chemicals and congenital malformations
Congenital malformations are the leading cause of infant morbidity, accounting for more than 
20% of all infant deaths, and congenital heart defects (CHDs) constitute the largest group of 
congenital anomalies, accounting for nearly 30% of children with major congenital anomalies 
diagnosed prenatally or in infancy in Europe.45 During the past 20 years, environmental risk 
factors for human birth defects have drawn attention from the public and scientific communi-
ties.46 Epidemiological evidence of associations between occupational exposure to chemicals 
and CHDs is scarce and contradictory.46-49 Since prospective cohort studies are difficult because 
of the low prevalence of CHDs, case-control studies with a standardised postnatal data col-
lection are the best alternative. In this study we found an association between occupational 
exposure of the father to specific chemicals and an increased risk of CHDs (Chapter 2.5).
mild analgesics and the occurrence of cryptorchidism and hypospadia
Two large cohort studies in Denmark found an association between the use of mild analgesics 
during pregnancy with the occurrence of cryptorchidism in the offspring,50,51 and gave rise 
to the hypothesis that mild analgesics could influence the androgen dependent descent of 
the testis.52 Normal androgen action during the critical programming window of testis descent 
is crucial for the descent of the testis, and factors that diminish androgen action during that 
time,53 such as paracetamol, have detrimental consequences for male sexual differentiation. 
We were able to substantiate these findings and found an association between maternal expo-
sure to mild analgesics during the second trimester in pregnancy with an increased prevalence 
of cryptorchidism (Chapter 4.1).
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Summary
The studies described in Part 2 show that occupational exposure to chemicals adversely 
influenced the reproductive abilities of women. Furthermore, some indications for effects of 
physically demanding work on intrauterine growth were found in Part 3, however, no effects of 
physically demanding work and exposure to chemicals were found on hypertensive pregnancy 
complications. In Part 4 we demonstrated that use of mild analgesics during pregnancy may 
influence the occurrence of cryptorchidism in the offspring. We schematically summarised our 
main findings in Table 1.
3. mEtHodologiCAl ConSidERAtionS
The studies described in this thesis have mainly been conducted within the Generation R Study, 
a population-based prospective cohort study. In such a study, groups of individuals who are 
alike in many ways but differ by a certain characteristic, are classified according to an exposure, 
followed over time, and compared for a particular outcome.54
Observational prospective studies have specific strengths and limitations. Among the 
strengths of cohort studies are that they provide incidence data, they assess temporal relation-
ships between exposure and effect, they can measure and subsequently adjust for a broad 
set of confounding variables, and they can measure multiple outcomes. There are also some 
limitations to cohort studies, including that they are time-consuming and expensive, they can-
not study rare outcomes, and they need a lot of manpower. Furthermore, they are sensitive 
to bias that may threaten the internal validity; these include selection bias, information bias 
and confounding. However, experimental studies are unfeasible and unethical for many of the 
research topics described in this thesis. The extent to which the results presented in this thesis 
are influenced by these types of bias will be discussed in the next paragraphs.
TaBle 1. Schematic overview of the described findings in the studies on occupational risk factors in 
relation to reproductive health
exposure Fertility Hypertensive 
complications
Foetal growth adverse 
birth 
outcomes
Congenital 
Malformations
Maternal chemical exposure No effect No effect ↓ FW/HC/FL n.a. No effect
Paternal chemical exposure ↑ TTP ↓ CHDs 
Physically demanding work No effect ↓ HC No effect 
Long working hours No effect ↓ FW/HC No effect 
Mild analgesics ↑ CRYPT 
TTP, time to pregnancy; FW, foetal weight; HC, head circumference; FL, foetal length; CHD, congenital heart defect; CRYPT, 
cryptorchidism; n.a., not in this thesis.
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3.1 Assessment of exposure and outcome
occupational exposure to chemicals
The ideal method for assessing occupational or environmental exposures of subjects in epide-
miological studies is quantitative measurement of external concentrations in the air or on the 
skin, or measurement of internal dose in body tissues or other human material. Unfortunately, 
in many study designs, this ideal is difficult or impossible to achieve. JEMs are used as surrogate 
exposure measures next to the occupation or industry as proxy for exposure. JEMs list occupa-
tion and/or industries on one axis, and exposure agents on the other, and the cells of the matrix 
indicate the presence, intensity, frequency, and/or probability of exposure to a specific agent 
in a specific job.
The JEM for EDs used in this thesis has several limitations. The characterisation of exposure 
in the JEM must be interpreted as an exposure probability, which is only a crude measure of 
exposure. Furthermore, the JEM does not contain specific chemicals, but only broad groups of 
chemicals, and mechanisms of action may vary between specific chemicals in a group. Another 
major drawback is that JEMs do not account for variability in tasks and working environments 
within job titles. But, from the task description it may become clear that some subjects within 
a specific job title are less likely to be exposed to certain chemicals. If misclassification occurs, 
this will most likely be non-differential misclassification, since exposure status was blinded to 
participants and researchers.
We observed that the exposure prevalence for occupational exposure to chemicals was very 
low. In some situations this has resulted in lack of power to detect associations. For example, 
in the study on occupational exposure to EDs and TTP (Chapter 2.2) we found an effect of 
maternal exposure to pesticides on TTP. However, due to the small number of women exposed 
(n = 15) the resulting hazard ratio was not significant (HR of 0.62; 95%CI 0.34-1.12).
An alternative for JEMs is biomonitoring of chemicals in body fluids, such as maternal blood 
or urine. But feasibility issues, costs, and time may restrict biological monitoring in epide-
miological studies and it is rare that biological samples can be obtained from the entire study 
population, particularly in large epidemiological studies. In Chapter 2.4 we described prenatal 
exposure to BPA measured in maternal urine in relation to foetal growth. BPA was only mea-
sured in 220 women, mainly due to high costs for determination of these chemicals in urine. 
Within Generation R, we collected urine samples between February 2004 and November 2005 
of a part of our study population, response rates varied between 85-97% of eligible women, 
generally a selection of women mainly from Dutch origin, with higher education and less life-
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style related risk factors. Although we randomly selected urine samples from this population, 
selection effects may have occurred, since the number of women in the analyses is small.
Epidemiological exposure-response analysis of chemicals, such as BPA, is complicated by the 
fact that exposure to chemicals may occur in mixtures and it may therefore be difficult to single 
out and attribute specific health effects to a specific agent. Within the JEM we noticed that 
maternal occupational exposure to phthalates, organic solvents and alkylphenolic compounds 
were interrelated (Kappa values 0.47-0.77). Thus, it was impossible to disentangle the specific 
role of certain chemicals. Among fathers there was little overlap in the exposure categories. In 
Chapter 2.2 we also investigated the agreement between maternal and paternal occupational 
exposure to chemicals, and we found that there was little overlap illustrated by Kappa values 
ranging between 0.03 and 0.13. Mutual adjustments did not change the effect estimates, thus, 
residual confounding by exposure pattern of the partner could be largely ruled out.
Background exposure to various chemicals through diet and environment may occur. Pre-
vious research within the Generation R Study55 showed that almost all pregnant women are 
exposed to a variety of chemicals, and that levels are comparable between pregnant and non-
pregnant women.56 However, there is reason to believe that occupational exposure is generally 
much higher than background exposure through diet and environment.57 For example, for 
phthalates, Hines et al. showed that in several occupations the urinary phthalate concentra-
tions exceeded the levels of the general population.58 However, biomonitoring data comparing 
occupational exposures with exposure from non-occupational sources are scarce. In this thesis 
we did not assess background exposure and, thus, it is not possible to distinguish the impor-
tance of different routes of exposure. Since it is unlikely that the widespread environmental 
exposure is associated with occupational exposure in specific jobs, background exposure will 
most likely not confound the observed relation between occupational chemical exposure and 
various reproductive outcomes.
Physically demanding work
A large review by Bonzini et al. concludes that a limitation of the available evidence on physi-
cally demanding work and adverse pregnancy outcomes is related to the definition and ascer-
tainment of exposure.44 Many of the occupational activities studied are complex constructs, 
and cannot be characterised by a simple, undimensional metric. In Chapter 3.1 and 3.2 we 
described two studies on physically demanding work and long working hours in relation to 
pregnancy complications and pregnancy outcome. A limitation of these studies is the semi-
quantitative nature of the exposure information in four self-reported categories. This did not 
allow us to investigate duration of standing and walking per week or frequency of lifting heavy 
weights. For example, for occupational lifting the following aspects might be important for 
classification of exposure: frequency of lifting tasks in a working day, the duration of such tasks, 
the heaviness of the weights lifted, and perhaps also the postures in which lifting is carried 
out. Exposure was ascertained by a questionnaire during mid-pregnancy. The accuracy of 
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self-reported data is likely to differ according to their nature. For example, hours of work and 
night work should be relatively easy to recall, whereas frequency of lifting may be more dif-
ficult to remember. Unfortunately, the information collected by questionnaire in Generation R 
was insufficiently accurate to allow clear counseling of pregnant women working in physically 
demanding jobs.
Exposure to mild analgesics
The major shortcoming in the design of this study was the lack of information on the frequency, 
dosage and specific time period of painkiller use. The assessment by questionnaire, where we 
specifically asked for over-the-counter self medication, showed that 29.9% of the women in our 
study used mild analgesics during pregnancy, which was comparable to Danish women report-
ing mild analgesic use by self-administered questionnaire in the study of Kristensen et al.51
Assessment of ttP
Assessment of TTP was by self-administered questionnaire during mid-pregnancy, which 
included a question on the natural origin of the pregnancy (yes/no) and, in case of a positive 
answer, women with a planned pregnancy were asked about the number of months it took 
the couple to conceive. Refusal to answer these questions is rare, as this question is readily 
accepted in a wide range of cultures.59 Validation studies of TTP have shown that self-reports 
on TTP give an accurate representation of the true TTP distribution.60,61 To investigate com-
mon biases related to answering the TTP questions, such as wantedness bias and pregnancy 
planning bias, we carried out several sensitivity analyses, and these analyses indicated little 
evidence for the presence of these biases.
Assessment of foetal growth and hypertensive pregnancy complications
The ultrasound measures used for the determination of foetal growth were also used for 
pregnancy dating in the first trimester of pregnancy, since a large proportion of women in the 
Generation R Study did not have a regular cycle and certain date of the last menstrual period. A 
disadvantage of pregnancy dating by ultrasound is that growth variation in crown-rump length 
and biparietal diameter in early pregnancy are assumed to be zero, impairing detailed analyses 
on foetal growth in the first trimester. Examining foetal growth characteristics instead of birth 
weight is a more appropriate approach to assess the effects of occupational and environmental 
risk factors, since it enables identification of specific critical periods during pregnancy for the 
influence of exposure on patterns of foetal growth and development. However, due to the 
use of ultrasound measurements for pregnancy dating, we were unable to assess whether 
these risk factors influenced early growth during the first trimester. In Chapter 3.1 strict 
criteria were used to assess hypertensive complications during pregnancy. Medical records 
were checked and the diagnosis was made by qualified medical doctors. The low prevalence of 
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these disorders in this study can be explained by the strict criteria for diagnosis. The very low 
prevalence of pregnancy induced hypertension and preeclampsia in this study, combined with 
the low prevalence of occupational risk factors, may have resulted in too little discriminatory 
power to detect associations.
Assessment of congenital heart defects
Children diagnosed with a CHD in the first 15 months after birth by a pediatric cardiologist 
were identified from the hospital registry and invited to participate. Diagnoses were confirmed 
by echocardiography and/or catheterisation and/or surgery. The study moment of 15 months 
after child birth reduces misclassification in the selection of children with and without CHD. 
Since most congenital malformations are diagnosed in the first year of life, this approach 
assured including most children with CHD in the study. Children who died of CHD before 15 
months are not included in the study population, which may have led to some selection in the 
severity of the included CHDs.
Assessment of reproductive disorders
The presence of cryptorchidism and hypospadia was assessed during routine screening assess-
ments performed in child health care (CHC) centres, and 93.2% of the children eligible for our 
current study visited the child health care centres. In an earlier study by Pierik et al. on the 
prevalence of cryptorchidism and hypospadia in Rotterdam, physicians were trained to per-
form standardised examinations of the male genitalia.62,63 During the course of the study, new 
CHC physicians were also instructed on the standardised examination, and every six months 
a meeting with the CHC physicians was organised to re-inform the physicians on the study 
procedures. Due to this extensive training, we believe that the assessment of both disorders 
was fairly accurate in the current study in Generation R.
3.2 interpretation in statistical analyses
Missing data frequently occurs in follow up studies. The proper method to handle missing 
values is dependent on the type of missings. An impropriate method to handle missing values 
can threat the validity of the study. There are three types of missings: missing completely 
at random, missing at random, and missing not at random. Missing completely at random 
means that missing data is completely due to coincidence, for example when due to logistic 
problems, i.e. questionnaires were not sent in a certain period. Missing at random is present 
when missings are related to variables in the study, for example a specific group of people has 
more often missing values, but this is not related to the outcome under study. Missing not at 
random occurs when missings are associated with both determinant and outcome, for example 
children from low-income families having more overweight do not show up at the child health 
centres. There is no statistical analysis that can test what kind of missings one is dealing with, 
however, it is possible to detect different types of missings when characteristics are measured 
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more than once. For most studies in this thesis, we considered missings to be random. The best 
way to deal with missing at random is multiple imputation.64 This method has been applied in 
Chapters 2.3, 2.4, 3.1, 3.2, and 4.1. Missing values in lifestyle and socioeconomic confounders 
were handled by multiple imputations (fully conditional specification, Markov Chain Monte 
Carlo method) by generating five independent datasets for all analyses, using SPSS version 17.0 
for windows. In general, all possible covariates as described in the baseline characteristics, were 
included in the imputation procedure (these variables were imputed and used as predictor).
3.3 internal validity
Selection bias
Selection bias may occur if the association between the determinant and the outcome is differ-
ent in those who participate in the study and those who were eligible, but do not participate or 
are lost to follow up.65 The Generation R Study is a population-based prospective cohort study, 
and its aim was to include all eligible pregnant women in a predefined area of Rotterdam. First, 
of all eligible children at birth, 61% participated in the Generation R Study. The percentage of 
women from ethnic minorities and lower socio-economic status, and of women or children 
with medical complications is lower among the participants than expected from the population 
figures in Rotterdam.66 This selection towards a more healthy study population may probably 
affect the prevalence of exposure to occupational risk factors, and consequently the statistical 
power in our studies. Since women with lower socio-economic status participated less in our 
study, and these women and men are more likely to be exposed to occupational hazards, the 
exposure prevalence of occupational risk factors was less than expected.
This selective non-response only harms the validity of the study when the association 
between determinant and outcome differs between those included and those not participat-
ing in the study. This is difficult to ascertain, because we do not know the associations between 
determinant and outcome of those not included in the study. One can argue that selection 
bias will be small, because the outcome is unknown at the start of the study, but this is not 
always true, because the outcome under study may be associated with social, educational, and 
health related determinants of non-response. In many studies in this thesis, educational level 
was not a confounder in the association between occupational risk factors and reproductive 
outcomes. Two comparable pregnancy recruited birth cohorts from Scandinavia were able to 
compare some well-established associations between those included in the study and those 
not participating, and similar associations were found.65,67 Another study by Nohr et al. showed 
that biased estimates in prospective cohort studies primarily arise from loss to follow up rather 
than from non-response at baseline.65 In the studies in this thesis, we used information from 
prenatal questionnaires collected during pregnancy, and there is very little loss to follow up 
during pregnancy, minimising selection bias due to loss to follow up.
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In almost all studies performed in this thesis, we restricted our study population to women, 
or men in paid employment. This approach was chosen to avoid healthy worker bias, since 
women in paid employment generally have better pregnancy outcomes than women without 
paid employment.68 Healthy worker bias can threaten the internal validity of studies, it is the 
most common selection bias in epidemiological studies, and occurs because relatively healthy 
individuals are likely to gain employment and to stay employed.
In Chapter 2.2 we asked women who did become pregnant about their TTP relating to their 
current pregnancy. The advantage of this design is that when women are asked about the cur-
rent pregnancy, recall bias is minimal. The disadvantage of our design is that sterile couples are 
not included in the analysis and that subfecund couples are underrepresented. The inclusion of 
unsuccessful attempts is preferable in TTP studies; since it would ensure that estimates are not 
conditional on achieved conception. However, since we performed this study within Genera-
tion R, a population-based prospective cohort study on pregnant women, we were not able to 
include unsuccessful attempts and infertile couples in our analyses, and this may have resulted 
in selection bias.
information bias
There are two main types of information bias: recall bias and misclassification. As most informa-
tion in the Generation R Study was collected prospectively, recall bias is very unlikely in these 
studies. However, in the HAVEN study, presented in Chapter 2.5, information on occupational 
characteristics was collected at a standardised study moment of approximately 15 months 
after child birth. Case-control studies are more sensitive for recall bias, since data is collected 
retrospectively. Job characteristics were available in 99.9% of the parents, since work history 
in general is recalled quite easily. Recall bias in this study is very unlikely, since we did not ask 
for specific exposures, but only a description of the job. Moreover, the JEM used in this study 
ensures that exposure is classified independently from the outcome, i.e. CHD.
Misclassification can be non-differential or differential. Non-differential misclassification 
refers to misclassification of the outcome that does not depend on the exposure status and 
vice versa, while in differential misclassification this is the case. Many of the variables of interest 
in this thesis were obtained by self-report via postal questionnaires, and socially acceptable 
behaviour in answering may have occurred. For example, for the questions on physically 
demanding work, mothers may have overreported their exposure to these occupational risk 
factors. Often, exposure information in our studies was collected before assessment of the 
outcome, which makes differential misclassification of exposure unlikely. In addition, the 
examiners who collected information on foetal growth characteristics by ultrasound, and 
information on hypertensive disorders during pregnancy were blinded to the exposure status 
of the participants, which also makes differential misclassification unlikely.
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Confounding
In the Generation R Study a wide range of potential confounding factors was available for 
analysis. Confounding will result in a spurious association between determinant and outcome. 
A confounding factor should be associated with both the determinant and outcome, and 
cannot be an intermediate in the causal pathway. The choice of which variable to include as 
confounder in our analyses was generally based on the following considerations. First, we 
tested which demographic and life style related factors were associated with our outcome of 
interest, and factors that significantly influenced the outcomes were considered as potential 
confounders. Second, all variables that were described in the literature as confounding vari-
ables, or as known determinants of the outcome, were included. Although we had information 
on many variables of interest, we may have missed potential confounders, resulting in residual 
confounding. Residual confounding due to unmeasured variables such as maternal nutrition, 
medication use, and physical activity during pregnancy might be possible in our studies. Thus, 
missing information on other adverse exposures in foetal life may have introduced residual 
confounding in the studies presented in this thesis.
3.4. External validity
Women of lower socio-economic status and of ethnic minorities are less represented in our 
sample, and it is known that the lower educated jobs are often more exposed to occupational 
hazards. Furthermore, we restricted the study population to women, or men in paid employ-
ment. Thus, the findings of these studies may only be generalisable to the population with 
paid employment. The JEM used in our studies was specifically designed for the Netherlands. 
Since working conditions may vary over different countries, it is hard to say whether our results 
are also generalisable to other industrialised countries. Exposure prevalences may differ in dif-
ferent countries, and if the exposure prevalence is low, associations between chemicals and 
reproductive endpoints may not have been found. This is demonstrated by Ye et al., whereby 
the pregnant women in MoBa (Norway) had a higher mean concentration of urinary BPA than 
the Generation R (Netherlands) and the NHANES (US) women.69 Unlike the NHANES women, 
the pregnant women in MoBa and Generation R were not selected to represent the whole study 
population nor all pregnant women in the two countries. Thus, the data do not necessarily 
reflect the national exposure levels in Norway or the Netherlands. It would be interesting to 
investigate the routes of exposure in different countries, in order to identify specific risk groups 
that will give insight in the generalisability of results of biomarker studies.
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4. intERPREtAtion And nEW inSigHtS
4.1 timing of assessment of occupational risk factors
The critical window of susceptibility is a time-sensitive interval during foetal development 
when exposures to environmental contaminants can disrupt or interfere with the physiology of 
a cell, tissue, or organ (Figure 1).70,71
Cells have the flexibility that allows them to develop in numerous ways during the early stages 
of foetal development. For example, the cells in the middle mesoderm layer of the embryo have 
the potential to become the kidneys, skeleton, or muscle. As the cells develop more specialised 
characteristics, called differentiation, their flexibility decreases. If an insult, such as exposure to 
an environmental contaminant, occurs to the embryo prior to this differentiation, normal foetal 
development may still occur as other cells are able to take over for those that have been injured. 
However, if the insult occurs after differentiation or during times of increased cell proliferation, 
abnormal development can result in structural or functional defects, altered growth, and even 
foetal death. These times of sensitivity to environmental contaminants are referred to as critical 
windows of susceptibility.73
Unfortunately, in many studies in this thesis we were unable to investigate exposures in 
specific pregnancy periods. Consider morphologic development, while some structures 
form within one or two weeks of conception,74 some portions of the central nervous system 
continue to develop throughout the entire pregnancy.75 However, it is also known that occu-
pational exposures, based on job title and work history, are generally continuous until the third 
trimester of pregnancy. In a study by Hertz-Picotto et al. variability in various exposures was 
described and a new measure of variability, the ratio of overall prevalence to time window 
specific prevalence was introduced.76 This study shows that exposures related to location of 
Figure 1. Windows of susceptibility to environmental insults72
Figure 1: Windows of susceptibility to environmental insults72  
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residence, and employment related exposures tended to be present during the bulk of the 
pregnancy.76
The occupational risk factors in most of the studies described in this thesis were obtained 
from the mid-pregnancy questionnaire (around 30 weeks of gestation), and the questions on 
starting and quitting date allowed us to check, for the majority of women, or men, whether 
they had worked during or before pregnancy. We carried out several sensitivity analyses to see 
whether women who started working before conception, differed from women who started 
working somewhere during the first trimester during pregnancy. In general, we observed 
comparable effect estimates in both analyses.
Although occupational characteristics are generally continuous over pregnancy, future 
studies could consider collecting trimester specific information, in order to study whether there 
are differences in exposures over different periods of pregnancy. The biomonitoring study mea-
suring BPA in different trimester in pregnancy showed no differences in exposure to BPA over 
different trimesters of pregnancy (Chapter 2.4). However, in Chapter 4.1 prenatal exposure to 
paracetamol and mild analgesics varied over different trimester of pregnancy, thus, insight is 
needed whether exposure characteristics change over the course of pregnancy and whether 
exposure effects differ in specific time windows during pregnancy.
4.2 Biological pathways
Chemicals acting as endocrine disruptors (Eds)
There are a number of mechanisms whereby EDs can modulate endocrine system and poten-
tially cause adverse effects on human health. The generally accepted paradigm for receptor-
mediated responses include hormone binding to its receptors at the cell surface, cytoplasm 
or nucleus, followed by a complex series of events that lead to changes in gene expression.77 
The main nuclear receptors involved in ED action are: estrogen receptor (ER) α and β, androgen 
receptor, thyroid receptor, aryl hydrocarbon receptor, and the glucocorticoid receptor. More 
recently, attention has been focussed on the progesterone receptor that appears to be more 
sensitive than ER-α and as shown in Chapter 4.1 also a target for paracetamol. Other relevant 
mechanisms for EDs include inhibition of hormone synthesis, transport, or metabolism and 
activation of receptor through receptor phosphorylation or the release of cellular complexes 
necessary for hormone action. In the case of hormone synthesis, considerable research has 
been conducted on the aromatase inhibitors; in fact they can prevent the conversion of andro-
gens to estrogens through a cytochrome P450 system. Several fungicides have been shown to 
cause aromatase inhibition as well as some widespread organotins.78 In addition, there is grow-
ing awareness that multiple receptor systems act in concert to regulate biological functions.
The studies presented in Chapter 2.1 and 2.2 showed adverse effects of occupational expo-
sure to chemicals on fecundity and one of the proposed mechanisms is endocrine disruption. 
Endocrine disruption of spermatogenesis may be represented by four mechanisms, including 
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(1) epigenetic changes to the genome, (2) apoptosis of the germ cells, (3) dysregulation of 
androgenic signaling, and (4) disruption of Sertoli and other spermatogenesis support cells.79 
The impact of estrogens on spermatogenesis is only poorly understood. It has been shown 
that administration of estrogens to prostate cancer patients and to male to female transsexu-
als results in atrophy of the seminiferous tubules.80,81 However, this effect might be indirect, 
mediated through a negative feedback on the secretion of gonadotropins. Disturbances in 
spermatogenesis were also observed in aromatase knockout mice,82 this finding indicates a 
functional role of these hormones in relation to normal sperm production. Thus, in principle, 
both an excess and a lack of estrogenic action may be deleterious for spermatogenesis.
Many EDs can interact with the female reproductive system and lead to endocrine disrup-
tion in the ovary.83 Within the reproductive system, the ovarian follicle can be considered as 
a very fragile micro-environment where interactions between hormones, growth factors, the 
oocyte and its surrounding somatic cells are essential to generate a fully competent oocyte. 
Disruption of this finely tuned (endocrine/paracrine) balance can lead to anovulation,84 cystic 
deformation85 or a diminished oocyte quality which jeopardises further embryo develop-
ment.86 Although originally thought to exert their effects via binding transcription factors 
receptors, EDs can alter endocrine function through a variety of mechanisms. Chemicals may 
alter the expression and/or activity of enzymes required for synthesis and/or catabolism of 
ovarian sex steroids, and may alter the expression of hormone receptors and/or their ability to 
bind their endogenous ligand. More studies, however, are needed to further understand the 
mechanisms of action of currently known EDs, identify and characterise new EDs, and expand 
toxicological research beyond commonly studied receptors and pathways. Although in vitro 
experiments suggest a role for EDs in disturbing the tightly regulated endocrine and paracrine 
signaling in the different cells of the ovarian follicle,87-89 these exposure experiments can only 
be related to the in vivo situation if environmental relevant ED concentrations are considered. 
Information on the contaminant status of female follicular fluid is indispensable, which implies 
the need for continuous monitoring of EDs in follicular fluid.90-93 An example of which way 
forward is a recent study by Petro et al. which showed that ED contamination in the follicular 
micro environment was linked to fertilisation success rate and the chance of development of 
oocytes into high quality embryos.94
Hormones play a vital role in a complex series of events, during which the single cell of 
the fertilised egg forms into the millions of cells that make up the newborn. Any disruption in 
maternal or foetal hormone levels has the potential to negatively affect foetal development. 
The EDs most commonly associated with reproductive anomalies are the xenoestrogens such 
as bisphenol A (BPA), polychlorinated biphenyls (PCBs), and antiandrogens such as phthalates. 
BPA’s toxicity and reproductive dysfunction has been linked to BPA’s binding of the estrogen 
receptor as well as nuclear-receptor independent activation of key cellular signaling system.95 
BPA can target the placenta directly.96 Mouse cytotrophoblast cells cultured in physiologic doses 
of BPA demonstrate abnormal labyrinthine development and increased rates of apoptosis.97 
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In addition, BPA decreases placental aromatase activity leading to lower levels of estrogen 
production and decreased the amount of estrogen and progesterone receptor expression in 
the placenta.98,99 These underlying mechanisms possibly play a role in the observed effects of 
BPA on intrauterine growth (Chapter 2.4). Further research could focus on measuring BPA in 
amniotic fluid to see whether these concentrations are related to adverse foetal development 
and placenta function, or possibly the determination of receptor expression in the placenta 
when collected after birth.
Alternative routes for toxic effects of chemicals on reproduction
Various pathways have been described how occupational and environmental chemicals may 
affect human reproduction. Direct toxicological effects have been described for example for 
exposure to lead. In Chapter 2.2 an association was found between paternal occupational 
exposure to heavy metals and prolonged TTP, suggesting adverse effect of these substances on 
spermatogenesis. For lead exposure, mechanistic studies have suggested that lead exposure 
disrupts all levels of the reproductive axis.15 Follow up clinical studies are less definitive than 
animal studies, but support the evidence that the toxicity occurs at all levels of the reproduc-
tive axis, with some studies concluding that the primary site of toxicity is the central nervous 
system, with other concluding that the gonad is the most sensitive organ.15,100,101 Recent 
evidence suggests that lead interferes with the ability of spermatozoa to undergo the acro-
some reaction, thus leading to infertility.102 Genetic variability in response to lead exposure is 
suggested by the finding that ion channel polymorphisms may cause differential sensitivities 
to lead exposure, both in the animal model and clinical studies.103
Furthermore, there is increasing evidence that induction of oxidative stress may affect 
fecundity and also foetal development. An increase in oxidative stress can been seen in ≤80% 
of clinically proven infertile men, and exposure to environmental toxicants is a major factor 
contributing to such an increase.104-106 In a recent review, the disruptive effects of environ-
mental toxicants on cell junctions mediated by non-receptor tyrosine kinases and cytokines 
through oxidative stress are highlighted, because such damage is often observed in low level 
exposure before apoptosis occurs.107 It is recognised that the foetus is vulnerable to the minut-
est concentration of toxic chemicals as compared to adults. This may be due to the fact that the 
foetus is growing at a rapid rate and is immature in a number of functional aspects. In Chapter 
2.3 and 2.4 we described that chemical exposure adversely affects intrauterine growth and 
placental weight. Teratogenicity via bioactivation and direct formation of reactive oxygen spe-
cies by a number of xenobiotics, and the level of oxygen in the intrauterine environment plays a 
critical role in pregnancy by affecting embryo development and placentation. Oxidative stress 
is thought to alter cellular function potentially resulting in in utero death or teratogenicity.108 
Embryonic processes regulating the balance of reactive oxygen species formation, oxidative 
DNA damage and repair, and oxygen species mediated signal transduction may be important 
determinants of teratological risk.109
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The findings in Chapter 2.5 on paternal occupational exposure to chemicals, that may 
act as EDs, on the occurrence of CHDs are possibly linked to the effects of these chemicals 
on spermatogenesis. Environmental pollutants have been linked with epigenetic variations, 
including induced changes in DNA methylation, histone modifications and microRNAs.110-113 
Dynamic chromatin remodeling is required for the initial steps in gene transcription, which can 
be achieved by altering the accessibility of gene promotors and regulatory regions.114 Epigen-
etic factors, including DNA methylation, histone modification, and microRNAs participate in 
these regulatory processes.115,116 Changes in these epigenetic factors have been shown to be 
induced by exposure to environmental pollutants and some of them were linked with different 
diseases.117-119 Chemicals might disturb the epigenetic programming during maturation of the 
sperm cells, which may result in derangements in imprinted genes in particular in embryonic 
tissue, which may subsequently lead to birth defects.120-122 Furthermore, alterations in these 
epigenetic processes by exposure to chemicals during early pregnancy may also results in 
altered foetal development, for example decreased foetal growth. Studies investigating the 
effects of chemicals on these epigenetic processes are urgently needed, for example studies 
comparing DNA methylation in exposed and unexposed workers during pregnancy. And if 
possible, link these effects to adverse effects on foetal development and pregnancy outcome.
Endocrine disruption or not, that’s the question
It is clear that the endocrine system presents a number of target sites for the induction of 
adverse effects by environmental agents. There are numerous examples demonstrating that 
reproductive and developmental processes may be exquisitely sensitive to exposure and there 
are effects induced by presumed EDs in a variety of species.123 Although animal studies have 
raised concern on the influence of EDs on reproduction, exposure levels far above those found 
in humans have been needed to evoke reproductive toxicity in the animal models. Human 
data are inconclusive and have raised the question of whether EDs can have any impact on 
hormonal function and thus health consequences when natural hormones are present. Indeed, 
many contaminants with hormone-like activity are much less potent than endogenous hor-
mones themselves;124 17-β-estradiol was for instance estimated to be 17000 times more potent 
than p,p’-dichlorodiphenyltrichloroethane. However, humans are exposed to a multitude of 
agents, and when present in sufficient number and/or concentration, they might in principle 
act together to impact on the actions of endogenous hormones. Whether such impacts will be 
physiologically relevant is still not known, but in a worst case scenario, there are no threshold 
levels below which there are no effects at all. Not only is there a need for better test procedures 
(both in vivo and in vitro) to characterise the potential of EDs to disrupt endocrine function, but 
there is also a need for more information on the transport, fate and bioavailability of chemicals 
released into the environment and exposures occurring through certain occupations.
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The results of the studies on chemical exposure in both general populations in this thesis 
may be possibly linked to endocrine disruptive effects of these chemicals. However, the find-
ings cannot be used to exclude the possibility of other biological mechanisms.
Physically demanding work and foetal growth
We found effects of long periods of standing on foetal head circumference, and effects of long 
working hours on both foetal weight and foetal head circumference (Chapter 3.2). Several 
mechanisms have been suggested to explain the possible adverse influence of physically 
demanding work during pregnancy on the foetus. Work involves muscle action, causing an 
increase of sympathetic vasomotor activity in working muscles proportional to the severity of 
work. Hence, when cardiac output increases rapidly during muscular activity, most blood goes 
to the working muscles and proportionally less arrives in the other viscera, which during preg-
nancy, includes the placental bed. Thus, heavy physical work is thought to reduce the blood 
flow to the uterus and placenta, thereby reducing the availability of oxygen and nutrients for 
the foetus.125-127 Physically demanding work has also been described in relation to an increased 
release of catecholemines. An increased release of catecholemines, with resultant arteriolar 
constriction, has been hypothesised to play a role in the aetiology of adverse pregnancy 
complications.128 It would be interesting to see whether physically demanding work influences 
early placentation, by measuring the effects of physically demanding work on uteroplacental 
blood flow and resistance, and whether it influences catecholamine levels.
Paracetamol and reproductive disorders
In Chapter 4.1 we found an association of mild analgesics use during the second trimester 
of pregnancy with an increased occurrence of cryptorchidism in the offspring. Our findings 
corroborate findings from earlier epidemiological studies and the underlying biological 
mechanisms for this trimester specific association has been described previously. Experimental 
rat models have shown that normal androgen action during a critical male programming 
window (gestational day 15.5-17.5), which is though to correspond to the second trimester of 
pregnancy in humans, is crucial for the programming of the testis descent.52 Acetaminophen 
(paracetamol) possesses highly selective analgesic and antipyretic effects that results from its 
inhibitory actions on the synthesis of prostaglandins. Prostaglandins are generated by the oxy-
genation of arachidonic acid to the unstable intermediate prostaglandin H2 by prostaglandin 
H2 synthase, of which there are two major isoforms, also commonly referred to as cyclooxi-
genase (COX) 1 and 2, respectively.129 Acetaminophen is an inhibitor of both COX enzymes in 
purified enzyme preparations.130
The testosterone dependant differentiation of the male reproductive tract requires the con-
tinuing synthesis of prostaglandins.131 Suppression of prostaglandin production by interfering 
with the arachidonic acid cascade at the level of release of arachidonic acid from cell membrane 
lipids or by inhibiting COX enzymes diminishes foetal androgen action and compromises male 
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sexual differentiation.132 Accordingly, Kristensen et al. demonstrated that acetaminophen is 
capable of suppressing foetal androgen synthesis in male rats exposed ex vivo to the drug 
during late foetal life. The day before birth the male foetuses showed reduced anogenital dis-
tances, another sign of diminished androgen action.51 In a subsequent paper, Kristensen et al. 
were able to pinpoint the suppression of prostaglandin synthesis by acetaminophen and other 
NSAIDs to the inhibition of COX enzymes.133 Importantly, the same authors revealed many other 
putative EDs, including phthalates and other phenolic agents, possess prostaglandin-inhibitory 
potential. In the light of these observations, it appears biologically plausible that not only 
NSAIDs, but also other EDs may contribute to increasing the risks of developing cryptorchidism 
by interfering with prostaglandin synthesis. It becomes necessary to address this possibility in 
further epidemiological studies.
4.3 Exposure assessment strategies
Timing of exposure assessment during pregnancy has already been described as an important 
issue in exposure assessment strategies. Another important issue is accurate and valid occu-
pational exposure data, one of the most serious weaknesses in the studies on occupational 
hazards.134
The importance of reliable and valid methods to measure occupational exposures in general 
population studies has become a central focus of research efforts over the past decade.135,136 
Traditionally, studies have been based on the collection of information on job title as a sur-
rogate for occupational exposures. In the early 1980s, the Job-Exposure-Matrix (JEM) method 
was proposed to translate information on job title into specific exposures. In Chapter 2.2, 2.3 
and 3.1 we used an extended version of the JEM by Van Tongeren et al.137 The validity of JEMs, 
however, has been shown to vary greatly from study to study and JEMs are unable to account 
for variability in exposures within occupations.138 Additional difficulties may arise when a JEM 
is applied to populations different from that originally targeted.139 Studies performed by Ken-
nedy et al. and Semple et al. indicate that the general problem of JEM exposure misclassification 
can be partly resolved by refining JEM exposure estimates with tasks specific information from 
questionnaires or interviews.140,141 In Generation R this information on work tasks was available 
from the questionnaire and used to correctly apply the JEM. The new updated JEM incorporated 
more knowledge on chemicals with EDs, and was made more specific by assigning exposure 
probability scores for chemical subcategories. As exposure prevalences in the general popula-
tion are usually low and most pollutants in the workplace are associated with moderate or low 
risks of adverse outcomes, improvement in assessing exposure is crucial to design informative 
epidemiological studies. Results of epidemiological studies should be interpreted in the light 
of the quality of the exposure assessment methods used, and if available, information on the 
validity of the assessment procedure should be included in the scientific report. The way for-
ward, would be to validate the JEM through occupational hygiene samples or measurements 
Pa
rt
 5
238
in biological media. These studies are currently planned within the Generation R Study, and will 
provide insight in the performance of the JEM.
When interpreting the results of epidemiological studies using biological measurements, it 
must also be stressed that exposure measurements are also prone to error. For measurements 
in urine day to day variation is particularly critical for metabolites with a short elimination half 
life. Biomonitoring is normally not feasible for biomarkers with a half life less than two hours. 
For the monitoring of chemicals that have long half lives, it is generally agreed that biomarkers 
of exposure have considerable advantages due to stability and require relatively few measure-
ments to define exposure. Rather than being a complication, the variation between and within 
individuals is valuable in determination of the risk. In Chapter 2.4 we studied BPA concentra-
tions in prenatal urine in three trimesters of pregnancy. This study gave insight in the effects of 
BPA on foetal growth and we were able to evaluate the influence of the measurement strategy 
chosen on the observed effect estimates. This study raises important questions on how many 
subjects must be measured and how many times they need to be measured. The BPA-foetal 
growth relation may fit the profile of a setting where, for a fixed total number of measurements, 
more replicates and fewer subjects maximises power.31 The review in Chapter 2.1 also showed 
that smaller studies with a detailed and accurate exposure assessment more often showed 
significant associations with prolonged time to pregnancy, emphasising the need for detailed 
exposure assessment.
An important objective for future direction of biomarker studies is to study the determinants 
of exposure to certain chemicals. Activities or circumstances that can influence environmental 
exposures can include: food consumption, drinking water sources, products used, work, home 
environment, agricultural or industrial activities, energy production, transportation, and 
waste disposal activities. Also certain demographic, as well as life style related factors may be 
related to the level of exposure to chemicals. In addition, some risk groups may be genetically 
more susceptible to certain exposures of health concerns than other due to human genetic 
variability, or specific genetic polymorphisms, For example, susceptibility of some individu-
als to asthma and asthma triggers such as air pollution is well understood to have a genetic 
component.142 Another example involves differences in leukemia risk associated with prenatal 
pesticide exposure. Children with leukemia were shown to carry specific genetic characteristics 
that altered the ability of their liver to metabolise foreign substances, including pesticides.143 
The critical issues for the use of biomarkers in occupational health research in the future will be:
 − The extent to which biomarkers have been validated. The further development of 
standardised methods, which can be properly evaluated and validated, especially in inter-
laboratory trials, is very important. Mass spectrometry is a universal method of detection 
and therefore it is considered important to develop this further for biomonitoring and 
biomarker studies. The development of toxicogenomics, proteomics, and metabolomics 
is also viewed as very important, especially for studies on mechanistic aspects. The 
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Contamed project is currently working on the development of such methods. By using 
metabolomic profiling and a combination between analytical chemistry with in vitro 
ED mode-of-action screens bioassay-directed fractionations, previously unrecognised 
EDs as well as endogenous biomarker metabolites can be identified. Biomarkers will be 
developed to determine internal ED load, using bioassays, to prepare ground for epide-
miological studies.
 − More research is needed to link biomonitoring data quantitatively to health risks.144 The 
mere presence of chemicals in a biological specimen does not equal risk, and the ability to 
measure chemicals is far outpacing the ability to interpret its meaning.145
 − It is important to establish whether there are levels of exposure with no observable effects.
4.4 Population-based studies
A limitation of a population-based approach in studying occupational risk factors is lack of 
power to identify the specific role of occupational exposure with a low prevalence. For example, 
in the study of maternal occupational risk factors for hypertensive pregnancy complications 
(Chapter 3.1), we were unable to demonstrate a negative effect of occupational risk factors on 
hypertensive complications during pregnancy.
An advantage of population-based studies in occupational epidemiology is that they give 
information on the public health impact of occupational risk factors, and thus the impact on 
population level. This information may be used to guide the need for preconception counseling 
of parent to be. Due to the fact that the prevalence of occupational exposure to chemicals 
of fathers to be is generally higher than the exposure of mothers to be, overall 15.9% versus 
6.2%, the population impact will be higher for fathers. Overall, we may conclude that popula-
tion impact of occupational exposure to chemicals, and physically demanding work is low. 
Two explanations may be sought, as mentioned earlier the low exposure prevalences, but 
also the moderate effects of these occupational risk factors, with Odds Ratios (ORs) ranging 
between 1.5 and 2.5. For exposure to mild analgesics and bisphenol A, the exposure prevalence 
is much higher compared to occupational chemical exposure. The population attributable 
fraction (PAF) for the association between use of mild analgesics during the second trimester 
and reproductive disorders in the offspring is relatively large, 24%. Thus, if causality could be 
established, mild analgesics explain 24% of 1% (prevalence cryptorchidism), we need to inform 
approximately 400 women not to take paracetamol during the second trimester of pregnancy 
to prevent one case or cryptorchidism.
Although the population impact is small, the effects of maternal occupational exposure 
to chemicals and physically demanding work on foetal growth seem of similar magnitude 
than other well-known life style factors (Chapter 2.3 and Chapter 3.2). The effects of certain 
chemicals on foetal growth resulted in a possible difference of approximately 100-400 gram 
difference in birth weight, and long working hours in approximately 150-200 gram difference 
in birth weight. These differences are comparable with other life style factors, and one could 
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argue that women in specific occupations should be informed about their risks. The effects 
of BPA on foetal growth were even larger, with an estimated difference of 683 grams in birth 
weight and 3.9 cm in head circumference at birth. These results need to be confirmed in future 
research, and insight in routes of exposure is critical in order to define targets for prevention.
Since working conditions are a modifiable factor, preconception counseling presents a 
strategy to minimise the environmental and occupational sources of reproductive risks facing 
the preconception person. Occupations in which women have a high exposure probability are 
agricultural and horticultural workers (pesticide exposure), hairdressers, beauticians, furniture 
makers (phthalate exposure), cleaners (alkylphenolic compounds), nurses, child care givers, 
saleswomen (lifting heavy loads), and stewardesses, physicians, nurses (night shifts). Since 
the effects for chemicals and physically demanding work are considerable, one could argue 
that pregnant women, for example women working in agriculture, must be informed about 
the risks of pesticide exposure in the workplace. However, the underlying mechanisms for 
chemical exposure and physically demanding work and adverse foetal development are still 
largely unclear, and results from earlier studies conflicting, warranting further research into this 
important topic.
Integrating all evidence presented in this thesis, we can conclude that the effects of physi-
cally demanding work on pregnancy are moderate, but the prevalence of these occupational 
risk factors is considerable. This is in contrast to exposure to chemicals, where the prevalence 
is very low, but the effects on pregnancy are considerable. Approximately 30% of pregnant 
women take mild analgesics during pregnancy, and mild analgesics seem to increase the risk 
of cryptorchidism, thus, discouraging pregnant women to take mild analgesics seems justified.
5. RECommEndAtionS
The effects of paid employment during pregnancy on foetal and maternal health are topical 
subjects. Anyone searching for background information needed in patient counselling may be 
overwhelmed by the large and sometimes contradictory body of research compiled in the past 
decade. In light of the limitations of existing data, the biomedical literature does not provide 
consistent evidence for the presence or absence of risk for many contaminants. Overall, the 
strongest evidence of environmental contaminant exposures interfering with healthy repro-
ductive function in adult females is for heavy metals, particularly lead. Compounds that can 
influence the normal balance of hormones, including many pesticides and BPA, also appear 
related to adverse reproductive outcomes.
5.1 Recommendations for future research
In my opinion, there are several promising prospects for future research in the field of occupa-
tional epidemiology.
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1. Exposure characterisation
Development of better exposure characterisation, most notably the development of biomark-
ers, is of paramount importance. New biomarkers for exposure need to be developed and 
validated in order to contribute to prevention of occupational related diseases. Biologic mea-
surement collection and biobanking should be incorporated into epidemiologic study designs 
in order to facilitate future research.
2. validation of the Job-Exposure-matrix
The JEM used in several of the studies presented in this thesis needs to be validated (Chapter 
2.2, 2.3, 2.5). Since the JEM provides a rather crude measure of exposure, and no informa-
tion is available on occupational hygiene measurements from companies, or biomonitoring 
of workers, research in this field is urgently needed. For example, with use of biomonitoring, 
concentrations in several occupations can be compared to the concentrations of exposure in 
the general population. These studies will be a step forward in better understanding the risks 
of occupational exposures, and give insight in exposure levels of chemicals of occupationally 
exposed workers.
3. Endocrine disruptors, and other biological pathways
In Chapter 2.2, 2.3, 2.4 and 2.5 we described the effect of chemicals on various aspects 
of reproduction, and a possible underlying mechanism for effect is endocrine disruption. 
To confirm this assumption, mechanistic research into the effects of EDs such as pesticides, 
phthalates, flame retardants, and perfluorinated acids on reproduction is needed. Is it possible 
to demonstrate the endocrine disruptive effects of chemicals on sperm cells, or oocytes? How 
are the endocrine system and markers of healthy reproductive function influenced by the com-
plex mixtures of environmental toxicants routinely encountered by men and women. Possibly 
by exposing laboratory animals to EDs and measuring distortions in endocrine parameters. 
In human cohort studies, occupationally exposed individuals may be tested for endocrine 
distortions, by measuring the effects of chemical exposure on levels of LH, FSH, testosterone, 
estradiol, and other hormones, such as thyroid function. The effects of EDs on foetal growth and 
development may be explored in more detail in animal models, exposing animals to relevant 
concentrations of chemicals, analysing receptor functions in the placenta, or other tissue, 
measuring EDs in amniotic fluids. In pregnancy based cohort studies, the effects of chemicals 
measured in human body fluids on placental function and foetal development can be explored 
more extensively.
Furthermore, genetic studies are needed to identify populations that are genetically sus-
ceptible for exposure to chemicals. Studies may focus on genetic material from exposed and 
unexposed women or men, in order to see whether there are differences in epigenetic profiles 
and other genetic markers.
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4. longitudinal study designs
Wherever possible, research efforts should be coordinated across the life stage using longitudi-
nal study designs. To maximise efficiencies, researchers should cooperate with each other and 
pool data across studies and follow up existing cohort datasets, thus allowing investigators to 
assess offspring health and later life health events for original cohort members.
5.2 Recommendations for clinical practice
The findings in our studies on occupational and environmental risk factors do not present a 
strong foundation for preventive measures yet. From a clinical perspective, important modifi-
able risks appear to be associated with exposures specific to unique populations or occupa-
tional groups (for example pesticide applicators). Questions about such exposures may not 
come up in a typical patient history, but clinicians should consider them during pre-pregnancy 
counseling or if patients encounter reproductive difficulties. As part of promoting a healthy life-
style, physicians can comment on hobbies and occupational exposures as well as encouraging 
patients to avoid unnecessary exposures. Where hazards are known or suspected, for example 
with applying pesticides, women should take any recommended precautions and follow label 
instructions.
From a public health perspective, we should remember that reproductive health is couple 
dependent, and is an accumulation of a lifetime of experiences and exposure scenarios. The 
interdependence of reproductive health endpoints calls for better integration of longitudinal 
studies with multiple endpoints.
6. gEnERAl ConCluSion
This thesis demonstrates that exposure to some chemicals at work as well as physically demand-
ing work have varying influence on all aspects of reproductive health, starting with a delayed 
time to pregnancy, a less prolific growth of the foetus, and birth defects such as congenital 
heart defects and cryptorchidism. The use of mild analgesics during pregnancy also increases 
the risk of cryptorchidism in the male offspring. Thus, work-related and environmental risk fac-
tors may influence reproduction and already have their effects on early development of human 
life. An important proposed underlying mechanism is endocrine disruption, which influence 
can be profound because of the crucial role hormones play in controlling reproduction and 
development. Although the prevalence of occupational exposure to chemicals is relatively low, 
the effects on foetal growth and fecundity are considerable, and one could argue that workers 
in specific occupations must be informed about the risks of chemicals in the workplace. Since 
approximately 30% of pregnant women use mild analgesics during pregnancy, and several 
studies showed an increased risk with reproductive disorders, it seems justified to inform 
women about their risks. Further studies are needed to confirm our findings and to explore 
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the underlying mechanisms. If the results of future studies point in the same direction, efforts 
will be needed to reduce the exposure to occupational risk factors during pregnancy and to 
increase awareness among pregnant women.
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This thesis demonstrates that exposure to some chemicals at work as well as physically demand-
ing work have varying influence on all aspects of reproductive health, starting with a delayed 
time to pregnancy, a less prolific growth of the foetus, and birth defects such as congenital 
heart defects and cryptorchidism. The use of mild analgesics during pregnancy increases the 
risk of cryptorchidism in the male offspring. Thus, work-related and environmental risk factors 
may influence reproduction and already have their effects on early development of human life.
For several work-related and environmental risk factors associations with reproductive 
effects have been established and translated into legislation, such as mandatory provisions for 
pregnant women preparing antineoplastic drugs or being exposed to lead. With the increasing 
labour force participation among women in Western countries, many women will work during 
their reproductive years. This will increase the likelihood that women during their reproductive 
years will be exposed to a variety of risk factors at work that may affect their reproductive abili-
ties and the outcome of their pregnancy, such as spontaneous abortion, hypertensive disorders, 
intrauterine growth restriction, and adverse birth outcomes. Occupational exposures may also 
interact with foetal development, resulting in health effects in the offspring, such as congenital 
malformations and neurobehavioural disorders at young age. However, for many other work-
related and environmental risk factors, the scientific evidence is less consistent. Furthermore, 
little is known about the underlying mechanisms through which work-related risk factors, such 
as exposure to chemicals, and physically demanding work, affect foetal development.
In Part 1, the main objectives of this thesis were described: (1) to examine the effects of 
exposure to chemicals and (2) physically demanding work on various domains of reproduc-
tion, and (3) to study the relation between exposure to endocrine disruptors (EDs) and con-
genital anomalies, including reproductive tract abnormalities. To address these aims, we have 
evaluated the effects of exposure to chemicals on fecundity (time to pregnancy), intrauterine 
growth, hypertensive disorders and birth outcomes. We evaluated the effects of physically 
demanding work on intrauterine growth, hypertensive disorders, and birth outcomes. Further-
more, exposure to EDs (including paracetamol) in relation to congenital heart defects (CHDs), 
cryptorchidism and hypospadia was investigated.
Most studies were embedded in the Generation R Study, a population-based prospective 
cohort study from early pregnancy onwards in Rotterdam, the Netherlands. In total, 8880 preg-
nant women with a delivery date between April 2002 and January 2006 were enrolled during 
pregnancy. Extensive assessments were carried out during the first trimester (gestational age 
< 18 weeks), second trimester (gestational age 18-25 weeks) and third trimester (gestational 
age >25 weeks), including physical examinations, questionnaires, interviews, and biological 
samples. Information on occupational and environmental risk factors was mainly derived from 
prenatal questionnaires. Information on possible confounders and pregnancy characteristics 
were obtained from questionnaires, physical examinations, ultrasound examinations, biological 
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samples and medical records. One study within this thesis was embedded in the HAVEN study, 
a case-control-family study, designed to investigate determinants in the pathogenesis of CHDs. 
Recruitment of case and control children took part between June 2003 and January 2010, for 
case children four university medical centres enrolled the children and parents, and control 
children and parents were enrolled in collaboration with child health care centres. Children 
with CHD diagnosed by paediatric cardiologists in the first 15 months after birth were enrolled. 
The information on occupational and environmental risk factors was obtained from a question-
naire, which was filled out by the mother and father separately.
Part 2 presents different studies that examined the associations between exposure to chemi-
cals before or during pregnancy on various reproductive endpoints. In Chapter 2.1 we systemati-
cally reviewed the literature on occupational exposure to chemicals and time to pregnancy (TTP). 
For lead, strong indications for adverse effects on TTP were present, supporting the mandatory 
provisions for pregnant women being exposed to lead in many countries. These indications were 
also found for pesticide exposure, and one could argue that couples working in agriculture or hor-
ticultural trades must be informed about the risks of pesticide exposure. Epidemiologic evidence 
on other chemicals, such as organic solvents, and other metals remains equivocal, hampering 
clear counselling of couples who are trying to become pregnant. In Chapter 2.2 we hypothesised 
that occupational exposure to chemicals that may act as EDs may lead to a prolonged TTP. We 
observed that paternal occupational exposure to heavy metals and overall exposure to EDs was 
significantly associated with a prolonged TTP. For maternal occupational exposure to EDs we also 
observed decreased fecundity, however, due to the low prevalence of maternal occupational 
exposure to EDs these associations were not statistically significant. Thus, we provided indications 
for adverse effects of occupational exposure to EDs on TTP. Chapter 2.3 showed that maternal 
occupational exposure to chemicals, possibly acting as EDs, influenced various domains of foetal 
growth. Exposure to polycyclic aromatic hydrocarbons was associated with lower growth rates 
for foetal weight, exposure to phthalates with lower growth rates for both foetal weight and 
foetal length, exposure to alkylphenolic compounds with lower growth rates for foetal head 
circumference, and exposure to pesticides with lower growth rates for foetal length. Furthermore, 
we were able to demonstrate that exposure to pesticides and phthalates was associated with a 
decreased placental weight. We provide some evidence that exposure to chemicals may lead to 
suboptimal placental development and subsequently to decreased foetal growth. In Chapter 2.4 
high exposure to bisphenol A (BPA) was associated with impaired foetal growth. Compared with 
women with low concentrations of BPA in urine, women with high concentrations showed lower 
growth rates for foetal weight and head circumference. Furthermore, we were able to evaluate 
the measurement strategy chosen on the observed effect estimates. The BPA-foetal growth 
relation may fit the profile of a setting where, for a fixed total number of measurements, more 
replicates and fewer subjects maximises power. This study showed the need for better exposure 
assessment strategies, and may explain why some studies report negative findings. In Chapter 
2.5 we hypothesised that parental occupational to chemicals might influence the occurrence of 
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CHDs. Paternal occupational exposure to phthalates was associated with a higher incidence of 
CHDs in general, and several chemicals, including phthalates, polychlorinated compounds and 
alkyphenolic compounds were associated with specific CHD phenotypes. Distortion of epigen-
etic mechanisms by chemicals might be underlying the effect of paternal occupational exposure 
to chemicals on the occurrence of CHDs.
In Part 3 we present two studies on the relation between physically demanding work and 
pregnancy. In Chapter 3.1 the effects of several occupational risk factors, including physically 
demanding work, working hours and chemical exposure did not seem to influence the occur-
rence of hypertensive disorders during pregnancy. These findings do not indicate an effect of 
these occupational risk factors on maternal cardiovascular health. Chapter 3.2 showed that 
physically demanding work, specifically long periods of standing, and long working hours, 
influenced the growth rates for foetal weight and head circumference. A negative effect of long 
periods of standing on growth rates for foetal head circumferences was found. For long work-
ing hours, effects on both foetal weight and head circumference were found. These findings 
indicate that physically demanding work during pregnancy, and long working hours during 
pregnancy, may affect intrauterine growth. However, we did not find consistent associations 
between these risk factors and adverse birth outcomes.
Part 4 of this thesis focussed on use of mild analgesics during different periods in pregnancy 
and the risk of cryptorchidism and hypospadia in the offspring. In Chapter 4.1 we showed 
that use of mild analgesics during the second trimester of pregnancy was associated with an 
increased risk of cryptorchidism in the offspring. Since a relatively high proportion of pregnant 
women is using paracetamol during pregnancy, population impact may be substantially. The 
population attributable fraction was calculated for second trimester use, and indicated that 
if causality could be established, approximately 24% of the cases of cryptorchidism could be 
attributed to the use of mild analgesics. Paracetamol, and other mild analgesics inhibit the 
production of androgens in the developing foetus, impairing the androgen dependent descent 
of the testis.
Finally, Part 5 summarises the main findings of the studies in this thesis and discusses the 
methodological considerations and interpretation of the findings. Furthermore, suggestions 
for future research are proposed.
In conclusion, the studies described in this thesis demonstrate that various occupational 
and environmental risk factors may adversely influence various domains of human reproduc-
tion, including fecundity, intrauterine growth, hypertensive disorders during pregnancy, and 
congenital malformations. Further studies are needed to corroborate or refute these findings 
and to elucidate the underlying mechanisms. Results of future studies and the results of the 
current studies may increase the awareness of the potential harmfull effects of certain occupa-
tional and environmental exposures in general, and in particular in pregnant women and their 
unborn child.
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Dit proefschrift toont aan dat blootstelling aan bepaalde chemische stoffen op het werk, als-
mede zwaar fysiek werk, van invloed kan zijn op verschillende aspecten van de voortplanting, 
waaronder een verlengde duur tot zwangerschap, een verminderde groei van de foetus, en 
aangeboren afwijkingen zoals aangeboren hartafwijkingen en cryptorchisme. Daarnaast 
beschreven we dat het gebruik van pijnstillers tijdens de zwangerschap het risico op cryptor-
chisme verhoogt. Aan het werk gerelateerde en omgevingsgerelateerde risicofactoren kunnen 
de voortplanting beïnvloeden en deze effecten kunnen al optreden tijdens de vroege ontwik-
keling van de mens.
Voor verschillende werk gerelateerde en omgevingsgerelateerde risicofactoren zijn er 
effecten beschreven op de voortplanting en dit heeft zich vertaald in wetgeving, zoals voor 
zwangeren die antineoplastische medicijnen klaarmaken of zwangeren die blootgesteld zijn 
aan lood. Door het nog steeds toenemend aantal vrouwen op de arbeidsmarkt in Westerse 
landen, zullen veel vrouwen werken tijdens de vruchtbare jaren. Dit verhoogt de kans dat vrou-
wen tijdens de vruchtbare jaren worden blootgesteld aan verscheidene risicofactoren op het 
werk die de voortplantings capaciteiten en de uitkomst van de zwangerschap, zoals spontane 
miskraam, hoge bloeddruk tijdens de zwangerschap, foetale groeipatronen, en ongunstige 
geboorteuitkomsten, zouden kunnen beïnvloeden. Beroepsmatige blootstellingen kunnen 
de foetale ontwikkeling beïnvloeden, en dat zou kunnen resulteren in ongunstige gezond-
heidsuitkomsten in het nageslacht, zoals aangeboren afwijkingen en gedragsneurologische 
afwijkingen op jonge leeftijd. Voor veel andere werk gerelateerde en omgevingsgerelateerde 
risicofactoren is het wetenschappelijk bewijs minder consistent. Verder is maar weinig bekend 
over het onderliggende mechanisme hoe werk gerelateerde risicofactoren, zoals blootstelling 
aan chemische stoffen, en zwaar fysiek werk, de foetale ontwikkeling kunnen beïnvloeden.
In Deel 1, beschreven we de belangrijkste doelstellingen van dit proefschrift: (1) het onder-
zoeken van de effecten van blootstelling aan chemische stoffen en (2) zwaar fysiek werk op 
verschillende domeinen van de voortplanting, en (3) het onderzoeken van de relatie tussen het 
gebruik van pijnstillers tijdens de zwangerschap en aangeboren afwijkingen, zoals afwijkingen 
aan de voortplantingsorganen bij jongens. Om deze doelstellingen te kunnen onderzoeken, 
hebben we de effecten van blootstelling aan chemische stoffen op de duur tot zwangerschap, 
foetale groeipatronen, hoge bloeddruk tijdens de zwangerschap en ongunstige geboor-
teuitkomsten onderzocht. We evalueerden de effecten van zwaar fysiek werk op de foetale 
groeipatronen, hoge bloeddruk en ongunstige geboorteuitkomsten. Verder hebben we de 
relatie tussen stoffen die het hormoonstelsel beïnvloeden, zoals pijnstillers, en de relatie met 
aangeboren hartafwijkingen, cryptorchisme en hypospadie onderzocht.
De meeste studies in dit proefschrift werden uitgevoerd binnen het Generation R onder-
zoek, een populatie-gebaseerde prospectieve cohort studie vanaf de vroege zwangerschap 
in Rotterdam, Nederland. In totaal namen 8880 zwangere vrouwen met een bevallingsdatum 
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tussen april 2002 en januari 2006 deel aan het onderzoek. Uitgebreide meetmomenten von-
den plaats tijdens het eerste trimester (zwangerschapsduur < 18 weken), tweede trimester 
(zwangerschapsduur 18-25 weken) en derde trimester (zwangerschapsduur > 25 weken) van 
de zwangerschap en omvatte lichamelijk onderzoek, vragenlijsten, interviews, en verzameling 
van lichaamsmateriaal. Informatie over werk gerelateerde en omgevingsgerelateerde risicofac-
toren werd verkregen uit prenatale vragenlijsten, zo ook informatie over mogelijk verstorende 
variabelen, en zwangerschaps kenmerken, lichamelijk onderzoek, echo onderzoek, lichaams-
materiaal en medische dossiers. Een van de onderzoeken in dit proefschrift werd uitgevoerd 
binnen de HAVEN studie, een case-control familie studie, die de determinanten in de patho-
genese van aangeboren hartafwijkingen onderzoekt. Werving van case en controle kinderen 
vond plaats tussen juni 2003 en januari 2010, case kinderen en hun ouders werden gevraagd 
om deel te nemen via vier universitaire ziekenhuizen, en controle kinderen en hun ouders 
werden gevraagd om deel te nemen via de consultatiebureaus. Kinderen met een aangeboren 
hartafwijking gediagnosticeerd door een kindercardioloog in de eerste vijftien maanden na 
de geboorte werden gevraagd om deel te nemen. De informatie over werk gerelateerde en 
omgevingsgerelateerde risicofactoren werd verkregen uit een vragenlijst, die door de moeder 
en vader apart werd ingevuld.
Deel 2 beschrijft verschillende studies die de relatie tussen blootstelling aan chemische stof-
fen voor of tijdens de zwangerschap en voortplantingsparameters onderzochten. In Hoofdstuk 
2.1 hebben we systematisch gezocht in de literatuur naar artikelen over beroepsmatige bloot-
stelling aan chemische stoffen en duur tot zwangerschap en dit samengevat in een review arti-
kel. Voor blootstelling aan lood, bestaan sterke aanwijzingen dat dit de duur tot zwangerschap 
negatief beïnvloedt. Dit ondersteunt de genomen voorzorgsmaatregelingen voor zwangere 
vrouwen die zijn blootgesteld aan lood in verschillende landen. Verder, zijn deze aanwijzingen 
ook gevonden voor blootstelling aan pesticiden, en men zou kunnen beargumenteren dat 
koppels die werken in agrarische beroepen geinformeerd moeten worden over de risico’s van 
blootstelling aan pesticiden. Epidemiologisch bewijs voor de negatieve effecten van andere 
chemische stoffen, zoals oplosmiddelen, en metalen, blijft tweestrijdig, wat counseling van 
koppels die proberen om zwanger te worden bemoeilijkt. In Hoofdstuk 2.2 onderzochten we 
de hypothese dat beroepsmatige blootstelling aan chemische stoffen, die het hormoon stelsel 
kunnen beïnvloeden, zou kunnen leiden tot een verlengde duur tot zwangerschap. Blootstel-
ling van de vader via het beroep aan metalen en blootstelling aan chemische stoffen in het 
algemeen was significant geassocieerd met een verlengde duur tot zwangerschap. Voor moe-
ders observeerden we dat blootstelling aan chemische stoffen via het beroep in het algemeen 
leidde tot een langere duur tot zwangerschap, maar door de lage prevalentie van blootstelling 
onder moeders waren deze associaties niet significant. Samenvattend, we hebben indicaties 
gevonden voor negatieve effecten van beroepsmatige blootstelling aan hormoonverstorende 
stoffen op duur tot zwangerschap. Hoofdstuk 2.3 laat zien dat beroepsmatige blootstelling 
van de moeder aan chemische stoffen tijdens de zwangerschap verschillende domeinen van 
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foetale groei beïnvloedt. Blootstelling aan polycyclische aromatische koolwatervloeistoffen 
was geassocieerd met lagere foetale groeisnelheden voor het foetale gewicht, blootstelling 
aan weekmakers (ftalaten) met lagere groeisnelheden voor zowel foetaal gewicht als foetale 
lengte, blootstelling aan alkylerende stoffen met lagere groeisnelheden voor foetale hoofdom-
trek en blootstelling aan pesticiden met een lagere groeisnelheid voor foetale lengte. Verder 
toonden we aan dat blootstelling aan pesticiden en ftalaten was geassocieerd met een lager 
gewicht van de placenta. Hiermee onderbouwen we mogelijk de hypothese dat blootstelling 
aan chemische stoffen kan leiden tot een suboptimale ontwikkeling van de placenta wat kan 
resulteren in een verminderde foetale groei. In Hoofdstuk 2.4 vonden we dat hoge blootstel-
ling aan bisphenol A was geassocieerd met verminderde foetale groei. Vergeleken met vrouwen 
met lage concentraties bisphenol A in de urine, hadden vrouwen met hoge concentraties een 
lagere foetale groeisnelheid voor foetaal gewicht en hoofdomtrek. Verder, konden we het effect 
van de gekozen meetstrategie op de geobserveerde effectmaat onderzoeken. De bisphenol 
A – foetale groei relatie was afhankelijk van het aantal beschikbare metingen per deelnemer 
en significante verbanden werden vooral gevonden bij minimaal drie metingen per zwangere 
vrouw. Met de resultaten van deze studie toonden we aan dat er betere strategieën noodza-
kelijk zijn om de blootstelling te kwantificeren, en deze resultaten verklaren ook deels waarom 
sommige studies negatieve bevindingen rapporteren. In Hoofdstuk 2.5 onderzochten we de 
hypothese of blootstelling van de ouders aan chemische stoffen het voorkomen van aange-
boren hartafwijkingen beïnvloedt. Beroepsmatige blootstelling van de vader aan ftalaten was 
geassocieerd met een hoger voorkomen van aangeboren hartafwijkingen in het algemeen, en 
verschillende chemische stoffen, waaronder ftalaten, polychloor stoffen en alkylerende stoffen 
waren geassocieerd met specifieke fenotypen van aangeboren hartafwijkingen. Verstoring 
van het epigenetische mechanisme door chemische stoffen kan ten grondslag liggen aan de 
gevonden effecten van beroepsmatige blootstelling aan chemische stoffen en het optreden 
van aangeboren hartafwijkingen.
In Deel 3 van dit proefschrift presenteren we twee studies die de relatie tussen zwaar fysiek 
werk en zwangerschap onderzoeken. In Hoofdstuk 3.1 vonden we geen effecten van verschil-
lende beroepsmatige risicofactoren, waaronder zwaar fysiek werk, werkuren per week en 
blootstelling aan chemische stoffen, op het voorkomen van hypertensieve stoornissen tijdens 
de zwangerschap. Deze resultaten toonden geen effect van deze beroepsmatige risicofactoren 
op de maternale cardiovasculaire gezondheid. Hoofdstuk 3.2 beschrijft dat zwaar fysiek werk, 
specifiek lange perioden van staan en veel werkuren per week, de groeisnelheden voor foetaal 
gewicht en hoofdomtrek beïnvloeden. Er werd een negatief effect van lange perioden staan op 
de groeisnelheid voor foetale hoofdomtrek gevonden. Voor veel werkuren per week werden 
zowel effecten op foetaal gewicht als hoofdomtrek gevonden. Deze bevindingen geven aan 
dat zwaar fysiek werk en lange werkuren tijdens de zwangerschap de intrauteriene groei kun-
nen beïnvloeden. Alhoewel, we vonden geen consistente effecten van deze risicofactoren op 
ongunstige geboorteuitkomsten.
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Deel 4 van dit proefschift richt zich op het gebruik van pijnstillers tijdens verschillende 
periodes in de zwangerschap en het risico op aangeboren afwijkingen, zoals cryptorchisme 
en hypospadie in het nageslacht. In Hoofdstuk 4.1 beschrijven we dat gebruik van pijnstillers 
tijdens het tweede trimester van de zwangerschap is geassocieerd met een verhoogd risico 
op cryptorchisme in het mannelijke nageslacht. Omdat een relatief groot aantal zwangere 
vrouwen paracetamol gebruikt tijdens de zwangerschap, zou de invloed op populatieniveau 
groot kunnen zijn. We berekenden het populatie attributief risico voor pijnstiller gebruik in 
het tweede trimester, en indien causaliteit kan worden aangetoond, zou ongeveer 24% van 
de gevallen van cryptorchisme kunnen worden toegeschreven aan het gebruik van pijnstillers 
tijdens de zwangerschap. Paracetamol en andere pijnstillers verminderen de productie van 
androgenen in de ontwikkelende foetus, en hebben zo een nadelige invloed op de androgeen 
afhankelijke indaling van de testis.
Tenslotte vat Deel 5 de belangrijkste bevindingen van de studies in dit proefschrift samen 
en bediscussieerd de methodologische beperkingen en interpretatie van de bevindingen. Sug-
gesties voor toekomstig onderzoek worden besproken.
We kunnen concluderen dat de studies beschreven in dit proefschrift aantonen dat verschil-
lende beroepsmatige en omgevingsgerelateerde risicofactoren verscheidene domeinen van de 
reproductie kunnen beïnvloeden, zoals de vruchtbaarheid, intrauteriene groei, hypertensieve 
stoornissen tijdens de zwangerschap, en aangeboren afwijkingen. Verdere studies zijn nodig 
om deze bevindingen te onderbouwen of te verwerpen en om de onderliggende mechanis-
men te verklaren. De resultaten van toekomstig onderzoek en de resultaten van de studies uit 
dit proefschrift kunnen het inzicht vergroten over de negatieve effecten van bepaalde beroeps-
matige en omgevingsgerelateerde blootstellingen in het algemeen, en in het bijzonder voor 
zwangere vrouwen en hun ongeboren kind.


PARt 7
liSt of ABBREviAtionS 
AutHoR’S AffiliAtionS
PuBliCAtion liSt 
ABout tHE AutHoR 
PHd PoRtfolio 
dAnkWooRd

267 list of abbreviations
liSt of ABBREviAtionS
AC Abdominal circumference
AS Aortic valve stenosis
AVSD Atrioventricular septal defect
BMI Body Mass Index
BPA Bisphenol A
BPD Biparietal diameter
CHC Child health care centre
CHD Congenital heart defect
CI Confidence interval
CoA Coarctation of the aorta
COX Cyclooxygenase
Crea Creatinine
DCO Dutch classification of occupations
DDT Dichloordifenyltrichloorethaan
DEHP Di(2-ethylhexyl)phthalate
DES Diethylstilbestrol
DF Detection frequency
DNA Desoxyribonucleïnezuur
ED Endocrine disruptor
EFW Estimated foetal weight
ER Estrogen receptor
EU European Union
FFQ Food frequency questionnaire
FL Femur length
FR Fecundability ratio
GA Gestational age
GM Geometric mean
GSD Geometric standard deviation
HC Head circumference
HLHS Hypoplastic left heart syndrome
HR Hazard ratio
ISSHP International Society for the Study of Hypertension in Pregnancy
IUGR Intrauterine growth retardation
JEM Job-Exposure-Matrix
LBW Low birth weight
lnBPACB Log transformed creatinine-based Bisphenol A concentration
LOD Limit of detection
268
Pa
rt
 7
MCMC Markov chain monte carlo
MEC Medical ethics committee
NSAIDS Non-steroidal anti-inflammatory drugs
OR Odds ratio
PAF Population attributable fraction
PAH Polycyclic aromatic hydrocarbons
PCB Polychlorinated biphenyl
PE Preeclampsia
PIH Pregnancy induced hypertension
PS Pulmonary valve stenosis
pVSD Perimembranous ventricular septal defect
RR Relative risk
SAS Statistical Analysis System
SBC Standaard beroepen classificatie
SD Standard deviation
SDS Standard deviation score
SES Socio economic status
SGA Small-for-gestational-age
SOC Standard occupational classification
SPSS Statistical Package Social Sciences
TCPy 3,5,6-trichloro-2-pyridinol
TDS Testicular dysgenesis syndrome
TGA Transposition of the great arteries
TOF Tetralogy of Fallot
TTP Time to pregnancy
WAZ Weight-for-age z-score
WHO World health organisation
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Velen hebben bijgedragen aan de totstandkoming van dit proefschrift. Graag wil ik een aantal 
mensen bedanken voor hun belangrijke bijdrage.
Allereerst wil ik alle deelnemers van Generation R bedanken. Zonder jullie betrokkenheid 
en deelname aan het onderzoek zou er niets te onderzoeken zijn geweest. Dank voor jullie 
jarenlange inzet, tijd en moeite!
Beste Lex, ik had me geen betere promotor dan jou kunnen wensen. Zonder jouw enorme 
toewijding en enthousiasme voor het onderzoek was dit boekje er nooit gekomen. Ik heb onwijs 
veel van je geleerd de afgelopen jaren. Bedankt voor het snelle beoordelen van de manuscrip-
ten, zowel inhoudelijk als tekstueel. Ik waardeer het enorm dat je altijd tijd voor mij vrijmaakte, 
en ik altijd bij je binnen mocht lopen als ik weer eens vastliep met mijn analyses. Dank voor je 
vertrouwen en de mogelijkheden die je mij hebt gegeven om mijn onderzoeksideeën uit te 
voeren, en om het onderzoek te combineren met het werk als arts-assistent in het ziekenhuis. 
Het was een hele fijne samenwerking en ik zie uit naar voortzetting hiervan.
Prof. dr. H.W. Tiemeier, beste Henning, bedankt dat je de rol als secretaris in de kleine com-
missie op je wilde nemen. Bedankt voor je kritische blik en duidelijke commentaar.
Prof. dr. D.J.J. Heederik, beste Dick, dank voor je deelname in de kleine commissie en snelle 
beoordeling. Bedankt voor je kritische blik en hulp met de blootstellingvraagstukken. Prof. dr. 
J.S.E. Laven, bedankt voor lezen en beoordelen van mijn manuscript.
Mijn grote commissie, Prof. Eric Steegers, Prof. Jens Peter Bonde, Prof. Aldert Piersma en Dr. 
Vincent Jaddoe, dank voor uw bereidheid mijn proefschrift door te nemen en zitting te nemen 
in de grote commissie tijdens mijn verdediging. 
Alle co-auteurs, ook van manuscripten die geen deel uit maken van dit boekje, dank voor 
de fijne samenwerking. In het bijzonder Prof. te Velde, beste Egbert, dank voor je uitgebreide 
commentaar, klinische blik en je vertaling van de resultaten naar de dagelijkse praktijk. 
Dr. Roeleveld, beste Nel, bedankt voor je uiterst precieze en scherpe commentaren op mijn 
manuscripten, bedankt voor de fijne samenwerking. Beste Dr. Duvekot, beste Hans, vele jaren 
hebben we hard gewerkt aan twee prachtige artikelen. Bedankt voor je steun en het feit dat 
ik je altijd mocht bellen of bij je binnen kon lopen. Je bent een geweldige gynaecoloog en 
een groot voorbeeld. Beste Dr. Wildschut, beste Hajo, bedankt voor de fijne samenwerking 
aan de ‘perinatal audit’, het was een leerzame tijd en heeft mij geënthousiasmeerd voor het 
onderzoek. Beste Prof. Steegers-Theunissen, beste Régine, bedankt voor de fijne samenwer-
king aan het manuscript van de HAVEN studie. Beste Dr. Pierik, beste Frank, dank voor de fijne 
samenwerking de afgelopen jaren.
From the CONTAMED group I want to thank Prof. Andreas Kortenkamp, Dr. Frances Orton, 
Dr. Ulla Hass, Sofie Christiansen, Julie Boberg, Christine Nelleman, Dr. Elisabeth Hill, Dr. Paolo 
Indiveri, Prof. Nicolas Olea, Prof. Walter Lichtensteiger, Dr. Margret Schlumpf, Dr. Michael Faust 
and Dr. Susan Ring for the inspiring and good collaboration the past three years. Furthermore, 
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I want to thank Prof. Matthew Longnecker, Todd Jusko and Holger Koch for the collaboration 
on the BPA manuscript. 
Beste Ingrid en Jaap Jan, super bedankt voor de fijne samenwerking aan twee mooie 
manuscripten.
In april 2012 ben ik begonnen als ANIOS in het Reinier de Graaf Gasthuis in Delft. Het was 
spannend om zo vanuit het onderzoek de patiëntenzorg weer in te gaan, en ik wil de collega’s 
in Delft bedanken voor het warme en fijne welkom, dat ervoor heeft gezorgd dat ik met heel 
veel plezier ben begonnen aan deze nieuwe fase. In het bijzonder Dr. Bremer, beste Henk, ik 
ben enorm dankbaar dat jij en de vakgroep al na zo’n korte periode van klinisch werk achter 
mij stonden en dat ik ben voorgedragen voor de opleiding. Ik vond het een hele eer de Delftse 
groep te mogen vertegenwoordigen, bedankt voor alle steun! Ik vind het nog steeds enorm 
jammer dat ik vervolgens het Reinier moest verlaten maar denk met veel plezier aan deze 
gezellige tijd terug! In het bijzonder, Ivette, Marie-Louise, Joanne, Heleen, Marije, Margriet, Loes, 
Mijke, Ineke, Nelle, Noortje, Simone, Ingrid, Fenneke en Erica, bedankt voor de gezellige tijd! Ik 
wil ook graag alle gynaecologen en collega assistenten uit het Bronovo ziekenhuis bedanken 
voor de prettige werksfeer waarin ik terecht ben gekomen.
Alle lieve collega’s bij Generation R in het Ae gebouw. Alle focus dames dank voor jullie inzet 
bij de dataverzameling en gezellige momenten op het onderzoekscentrum. Yvon, bedankt 
voor alle gezelligheid achter de balie van het onderzoekscentrum, het was iedere dag een 
feestje! Uiteraard ook Patricia, super secretaresse, dank voor je hulp bij diverse dingen, Alwin, 
Rose, Ronald, Karien, Natalia, dank voor de secretariële en logistieke ondersteuning. Claudia 
K. bedankt voor alle gezellige avonden, de mooie verhalen, en je altijd super snelle reactie op 
dataverzoeken. Jullie aanwezigheid zorgt ervoor dat Generation R zo goed draait. Lieve Rolieke 
en Marieke, bedankt voor alle gezellige koffiemomenten, lekker kletsen op de kamer, gezellig 
lunchen, en voor de borrels buiten het werk. Naast collega’s zijn jullie ook super lieve vriendin-
nen geworden. Rolieke, dank je wel dat je naast me staat op deze grote dag, bedankt voor 
alle gezellige overlegjes en hulp bij de statistiek! Beste Anne, Esther, Marjolein, kamergenoten, 
dank voor alle gezelligheid en lekkers op de kamer. Edith en Layla bedankt voor de etentjes en 
het wijnproeven, altijd in voor een borrel, hopelijk blijft dat zo in de toekomst. Ank en Fleur, één 
van de gezelligste kamers van Generation R waar ik graag kwam, lekker koffie drinken, even 
bijkletsen. Nienke en Nina, mede Gyn promovendi bij Generation R, altijd gezellig, en vroeg op 
op woensdag voor de researchmeetings in het Sophia. Alle andere Generation R promovendi 
bedankt voor de gezellige tijd: Agnes, Akhgar, Alette, Andrea, Ankie, Anne, Annemarie, Dennis, 
Denise, Ehsan, Esther, Eszter, Gerard, Hanan, Hanneke, Ilse, Jens, Jessica, Jolien, Jolien, Lindsay, 
Maartje, Marina, Michelle, Nathalie, Nicole, Noor, Pauline, Rachel, Ralf, Rianne, Rob, Romy, Ryan, 
Sabine, Sandra, en Selma. Jessica bedankt voor al je hulp bij de statistiek, bedankt dat ik altijd 
bij je mocht binnenlopen. Denise, bedankt voor alle gezellige Doppio momentjes na de lunch 
break! 
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Lieve collega’s van de gyn, bedankt voor alle gezellige borrels en etentjes, we komen elkaar 
in de toekomst vast nog vaak tegen! Lieve Jinke, samen onderzoek doen bij Hans, het was een 
mooie en gezellige tijd, op naar nog veel gezellige etentjes en koffietjes!
Natuurlijk wil ik ook graag alle MGZ collega’s bedanken, en mijn huidige A&G collega’s Anne, 
Bouwine, Marie-Louise, Suzan, Merel en Rogier. Suzan, bedankt voor de leuke tijd in Taipei, 
ondanks alle vliegticket stress vanwege de IJslandse vulkaan was het een super leuk congres! 
Dames van het secretariaat, in het bijzonder Sonja, Sanne en Anja, bedankt voor al jullie hulp. 
Lieve Martine, geweldig dat jij op deze belangrijke dag als paranimf naast mij staat, dank-
jewel dat je zo’n goede vriendin bent en dat je altijd voor mij klaarstaat! We hebben al zoveel 
mooie dingen meegemaakt de afgelopen jaren, het samenwonen op de Statenweg was echt 
fantastisch, ik mis de gezellige koffietjes samen op de bank! Lieve Aims en Liz, bedankt dat jullie 
zulke lieve vriendinnen zijn. Door dik en dun, dankjewel dat jullie er altijd voor mij zijn! Lieselot, 
Nicole, en Daniella, bedankt voor alle gezellige weekendjes, borrels, en vakanties de afgelo-
pen jaren, ik hoop dat er nog veel mooie momenten gaan volgen! Lies, bedankt dat je onze 
ceremoniemeester was dit jaar, je bent een lieve vriendin! Lieve Fems, ook al zien we elkaar 
niet zo vaak, het is altijd als vanouds gezellig als we afspreken in Amsterdam of bij je ouders 
in Zeeland! Lieve Michelle, bedankt voor je vriendschap de afgelopen jaren! Arend en Nelleke, 
bedankt voor alle steun en interesse de afgelopen jaren! Ruben, Marjo, Vincent, Mirjam, Jelmer, 
Celine, en Ray, bedankt voor de warme vriendschap, wat is dat toch fijn! Beste Daan, samen 
in de collegebanken en nu tegelijk promoveren! Dank voor alle gezelligheid en koffie in de 
koffiebar! Lieve Sharon, we kennen elkaar al sinds het studententeam van de thorax, vind het 
super leuk dat we nog steeds contact hebben! Dear Ben, thank you for coming to our wedding 
this year, it was amazing! We will see you again in December en we’re looking forward to an 
awesome time together! 
Lieve familieleden, bedankt voor de oprechte interesse door de jaren heen. Lieve Yvon en 
Liset, lieve zusjes, ik ben onwijs trots op wat jullie tot nu toe bereikt hebben en mede dankzij 
jullie onvoorwaardelijke steun heb ik dit kunnen bereiken! Lieve pap en mam, bedankt voor 
het feit dat jullie altijd achter mij hebben gestaan en mij hebben gesteund. Bedankt voor alle 
begrip en geduld, en ook al was het soms lastig om uit te leggen waar ik nu zo druk mee was, 
jullie stonden altijd voor mij klaar! Ik hou van jullie en ben dankbaar voor alles wat ik tot nu toe 
hebt bereikt mede dankzij jullie! Pa en Ma van Leest, Astrid, Ardian, Robin, Nico, Els, en Michael, 
jullie zijn de beste schoonfamilie die ik me kan wensen, en ik ben trots dat ik nu ook een echte 
“van Leest” ben! 
Lieve Thijs, je onvoorwaardelijke steun, hulp en liefde maken dat ik bij jou rust vind. Samen 
hard werken en samen genieten, met jou heb ik daar een balans in gevonden. Ik ben dankbaar 
voor alle mooie momenten samen en dat ik ook deze mijlpaal samen met jou mag beleven.
Ik houd van jou. 

